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Abstract
The aim of the work described in this thesis was to identify the sites and potential roles of
oestrogen action in the development and function of the male reproductive tract,
particularly within the excurrent ducts. The sites of oestrogen receptor-beta (ER(3)
immunoexpression were identified within the testis and epididymis of the marmoset
monkey from perinatal to adult life and compared to those of oestrogen receptor-alpha (ER-
a) and the androgen receptor (AR). One common site of expression, the efferent ducts, was
focused on in the remainder of the studies. Neonatal rats were injected on alternate days
between days 2-12 with DES at 3 doses (10, 1 and 0. lgg/injection) or with ethinyl
oestradiol (EE; lOpg/injection) or with high doses of one or other weakly oestrogenic
compounds (genistein, octylphenol, bisphenol A or parabens) or the agonist/antagonist
Tamoxifen. To establish whether the effects of oestrogen treatment were direct or indirect
(i.e. arising from LH/FSH secretion) all parameters investigated were also analysed in rats
treated neonatally with a gonadotrophin-releasing hormone antagonist (GnRHa). Animals
were investigated at 18, 25, 35 and 75 days (adulthood) of age. Morphology of the
excurrent ducts was assessed with each treatment and at each time point. High dose
oestrogen treatment (10gg of DES or EE) induced gross distension and overgrowth of the
rete testis, though no effects were detected after treatment with weakly oestrogenic
compounds. The efferent ducts demonstrated 3 major dose-dependent changes after
treatment with DES or EE. (1) the efferent duct lumens were abnormally distended. (2) the
normally tall columnar epithelial cells were low cuboidal and lacked much of the apical
cytoplasm and brush border; measurement of epithelial cell height confirmed these
changes. (3) the water channel protein Aquaporin-1 (AQP-1) which is normally expressed
on the apical membrane of non-ciliated cells was greatly reduced in expression after
treatment with potent oestrogens. The effects on the efferent ducts were most pronounced
at days 18 and 25 and seemed to normalise by day 75 (except for rete testis distension).
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The reduction in epithelial cell height was the only parameter which showed a detectable,
significant change after exposure to weak oestrogens. None of these changes were
detectable in rats treated neonatally with GnRHa. Adult oestrogen receptor knockout
(ERKO) mice showed a reduction in AQP-1 immunostaining in the proximal region of the
efferent ducts comparable to that seen after high dose DES treatment. In rats treated
neonatally with 10gg DES there was a pronounced reduction in immunoexpression of the
androgen receptor throughout the testes, rete testis, efferent ducts and epididymis at days
10-25 of age whereas immunoexpression of both oestrogen receptors remained unchanged.
A preliminary study was also made of the effects of neonatal oestrogen treatment on ion
channel expression within the epididymis. Studies of the cystic fibrosis transmembrane
regulator (CFTR) using in situ hybridisation were inconclusive but the immunoexpression
of two other ion channel proteins (H+-ATPase and Na7H+ exchanger), which have a role in
lumenal acidification, were studied after neonatal oestrogen treatment. The number of cells
expressing the Na+/H+ exchanger was unchanged whereas the number of epididymal clear
cells expressing the H+-ATPase channel was significantly reduced after oestrogen
treatment. It was unclear whether this was a direct effect of oestrogen treatment as similar,
but less severe, effects were detected after GnRHa treatment. These studies suggest that
oestrogens play a role in both the development and function of the male reproductive
system, especially of the excurrent ducts. It is concluded that physiological levels of
oestrogen are required for normal testis growth and spermatogenesis, and that oestrogens
are involved in maintaining normal fluid dynamics within the excurrent duct system.
Oestrogens appear to play a role in the development of the efferent duct epithelium as both
cell morphology and function were altered after exposure to oestrogens. The reduced fluid
resorption suggests this function is at least in part modulated by oestrogen. Oestrogen
exposure also influenced androgen action as the level of androgen receptor (as detected by
immunocytochemistry) was negligible or greatly reduced after neonatal oestrogen
treatment. More specific endpoints of oestrogen action have yet to be identified and
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research is required to allow a fuller understanding of the roles of oestrogen and to
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Chapter 1 Literature Review
1.1 Introduction
Until recently, studies into male reproductive health have been largely based on understanding
the physiology of the male reproductive system, including the process of spermatogenesis,
and developing novel contraceptive methods to control male fertility. Over the past 8 years, an
increasing number of papers in the literature have expressed concerns that human male
reproductive health is declining and that the incidence of congenital abnormalities and cancers
of the male reproductive tract is increasing. The causes behind these reported increases are
not known but one hypothesis that has been promoted in both the scientific community and
the media is that exposure to exogenous oestrogen or oestrogen-like compounds
(xenoestrogens, environmental oestrogens) may be involved. Studies that have assessed the
impact on humans of in utero exposure to a potent synthetic oestrogen (diethylstilbestrol)
have shown increases in similar disorders in the male offspring.
The role of oestrogen in male reproductive physiology is not well understood and more
insight is needed into how this steroid affects normal physiology before assessment of any
effects from abnormal exposure can be made with confidence. It is known that the enzyme
aromatase, which converts testosterone into oestrogen, is present within the male reproductive
tract, as are the protein receptors which bind oestrogen (oestrogen receptors a and P; ER- a
and p) and promote oestrogen induced gene transcription.
The experimental work addressed in this thesis was performed to make a contribution to
understanding the role of oestrogen in male reproductive physiology and to give some insight
into the processes that are affected after exogenous exposure to potent oestrogens and some
'environmental oestrogens'. The literature review aims to give an overview of the
physiological control of male reproduction, to explain the structure of the excurrent ducts of
the male reproductive tract and to examine the evidence surrounding the current controversies
regarding the reported changes to male reproductive health.
1.2 Evidence That Decreasing Sperm Counts have Links with
Abnormal Oestrogen Exposure
The hypothesis that factors within the environment that mimic the action of the steroid
hormone oestrogen may be having an impact on sperm counts was proposed in the early
1990s. There were an increasing number of reports in the literature that the human sperm
count had fallen over the past 50 years. Co-incident with these reports there were studies
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suggesting that congenital malformations of the male reproductive tract (hypospadias,
cryptorchidism) and testicular germ cell cancer were also increasing. These pathologies
struck researchers as very similar to those that had arisen after the administration of a potent
synthetic oestrogen, diethylstilbestrol (DES). This compound was administered to pregnant
women and subsequently to laboratory animals and was shown to induce reproductive
abnormalities in the offspring born to these mothers. There is an ever increasing list of
chemicals that are wide-spread in the environment and have been shown to be hormonally
active, some acting as oestrogens or antioestrogens and others as anti-androgens. In general
however, the binding affinity of these chemicals for the relevant steroid receptor is magnitudes
lower than that of the natural ligands.
1.2.1 Declining Sperm Counts
The study that sparked a huge controversy in male reproductive health and highlighted the
debate as to whether there had been a genuine decrease in sperm concentration over the past
50 years was published in 1992. This paper by Carlsen et al. (1992) was a meta-analysis of
the international literature on sperm counts and semen volume from normal men between
1938 and 1990 (Carlsen et al., 1992). The analysis included data from 61 studies on almost
15,000 men and suggested that there had been a decrease in both sperm concentration and
semen volume over time. Sperm concentration was reduced from an average of 113
million/ml to 66 million/ml and semen volume was also reduced from 3.40 ml to 2.75ml
(Carlsen et al., 1992). The debate as to the validity of the conclusions drawn from the data are
still ongoing (Brake and Krause, 1992; Bromwich et al., 1994; Farrow, 1994)(01sen et al.,
1995).
This is not the first analysis of semen quality which has suggested that sperm counts are
falling, in fact there were several reports published in the 1970-80s (reviewed by Irvine, 1997).
A study from 1974, reported on data from 386 men from Iowa who had their semen analysed
prior to vasectomy. The mean sperm count was 48x 106/ml and the authors noted that these
values were far lower than previous studies of semen quality in the literature from the 1930-
50's which reported average sperm counts at 120xl06 (n=200) (reviewed in Irvine, 1997)
145x 106/ml (n=49) (Farris, 1949) and 100.7x 106/ml (n=100) (Faulk and Kaufman, 1950).
In 1981 a report on semen quality among potential semen donors was published which found
that the number of men having acceptable semen quality in 1973 had fallen from 77% to 37%
in 1980 using the same selection standards (Leto and Frensil 1 i, 1981). A review of the
published data was reported in 1980 and the author observed a negative correlation between
later year of publication and lower average sperm production (James, 1980).
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The publication of the meta-analysis by Carlsen et al., prompted other researchers to assess
data they had collected from various groups of men. In 1995, a study published by Auger et
al., compared data collected from 1351 fertile men volunteering for sperm donation in Paris
between 1973 and 1992 (Auger et al., 1995). This study reported an annual rate of decline of
2.1 % in sperm concentration over this period (89 million/ml in 1973 to 60 million/ml in 1992)
(Auger et al., 1995). This study did not find any change in semen volume but did find a
significant reduction in sperm motility and the number of normal spermatozoa (Auger et al.,
1995). When the data were re-analysed by year of birth a reduction in sperm concentration of
2.6% per later year of birth was observed (Auger et al., 1995). A smaller study from Scotland
which examined data from 577 men also found a relationship between sperm counts and year
of birth (Irvine et al., 1996). Donors born in 1959 had a median sperm concentration of 98
million/ml whereas those born after 1970 had a median sperm concentration in the region of
78 million/ml (Irvine et al., 1996). A similar small study from Belgium analysed 416
consecutive candidate semen donors (Van Waeleghem et al., 1996). This study recorded a
decrease in mean sperm concentration from 71xl06/ml between 1977-80 to 58.610/ml
between 1990-1995. However, the trend reported in these studies may not be indicative of a
global phenomenon. Another study using data from the Toulouse region of France, found no
change in sperm concentration between 1977 and 1992 (Bujan et al., 1996) and similarly, a
study from Finland reported no decrease in sperm concentration between 1958 and 1992
(Suominen and Vierula, 1993). It is worth noting that in the French studies, the reduction in
sperm concentration was detected in the urban area whereas the rural area did not show any
deterioration in sperm concentration. Currently, the largest retrospective review on semen
quality contains data from 19,848 semen analyses from 7714 men undergoing IVF for tubal
disease and having normal semen analysis prior to IVF (De Mouzon et al., 1996). This study
reported a significant decrease in semen quality with later year of birth, the mean sperm
concentration for men born before 1939 being 92.5x106/ml, falling to 77.1xl06/ml for men
born after 1965 (De Mouzon et al., 1996).
Studies from the USA have reported no deterioration in semen quality. A study by Fisch et
al., 1996 analysed data from three locations (Minnesota , n=600; New York, n=400; Los
Angeles, n=221) collected prior to vasectomy (Fisch et al., 1996). This study reported a small
but significant increase in sperm concentration between 1970 (77x 106/ml) and 1994 (89x
106/ml) (Fisch et al., 1996). The data has been criticized as some of the means are from
several samples while other subjects are represented by one sample, also the analysis
techniques varied between the different locations and over time. A study from Seattle
compared data from 510 normal men using multiple semen samples collected between 1972-
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1993 (Paulsen et al., 1996). These men were a highly selective sample based on normal blood
chemistry, endocrine profiles and physical examination. The authors calculated the mean
sperm concentration from the 1972 cohort to be 46.5x 106/ml and in 1993 their regression
analysis showed a weak statistically significant increase with time which the authors suggest is
clinically insignificant (Paulsen et al., 1996).
If semen quality is reducing, these studies suggest it may be a regional phenomena. This
would support the hypothesis that factors in the local environment could have an impact on
reproductive health. A study that compared the sperm concentration of the partners of women
undergoing fertility treatment in London found a reduction in sperm concentration between
the periods 1978-1983 and 1984-1989. However, the changes were only detected in men
living in areas where their water supply was derived from the river Thames; no reductions
were found in men living in other water supply areas (Ginsburg and Hardiman, 1992).
The changes observed in the above studies which have analysed sperm counts using later year
of birth may support the reasoning that exposure to adverse conditions during in utero or
during prenatal development may influence reproductive capacity in later life (Toppari et al.,
1996). The data however are inconclusive as all the studies have some flaws, in that they are all
retrospective; data is collected from different subject populations using different selection
criteria and recruitment methods. Also, semen analysis is performed using different
methodologies between laboratories. Systematic analysis over time and within the same
geographical locations are required to monitor this situation. Prospective studies on semen
quality in fertile men are currently under way in the USA, Europe and Japan which are using
standard procedures to try to avoid many of the criticisms of the current data. This study will
hopefully determine region specific differences in semen quality and will serve as a reference
point for future studies on semen quality.
1.2.2 Testicular Cancer
One of the strongest indicators that there is a problem with male reproductive health is the
increasing incidence of testicular germ cell cancer. This has been rising steadily over the past
few decades and in the UK it is now the commonest malignancy of men aged 15-45. Data
from cancer registries show that a 2-4% per annum increase in testicular cancer rates is
evident in the United Kingdom (Boyle et al., 1987; Nethersell et al., 1984: Pike et al., 1987),
the Nordic and Baltic countries (Adami et al., 1996; Hakulinen et al., 1986), Australia (Stone
et al., 1991), New Zealand (Pearce et al., 1987; Wilkinson et al., 1992) and the United States
of America (Spitz et al., 1986). There are marked geographical variations in cancer rate. For
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example, Denmark has a 4 times higher rate of testicular cancer than Finland and in the USA
it appears that Caucasians have a 3 times higher incidence of testicular cancer than African
Americans (Spitz et al., 1986). A study that re-evaluated the data from 9 registries around the
Baltic sea by birth cohort rather than by year of diagnosis supports other data in showing that
testicular cancer has increased in incidence with each later year of birth regardless of whether
a country has a high or low incidence of testicular cancer (Ekbom and Akre, 1998). The
aetiology of testicular cancer is not understood but it is believed that events occurring in utero
during testis development leads to the persistence of fetal gonocytes within the testis leading
to the formation of pre-invasive carcinoma in situ cells (CIS) (Skakkebaek et al., 1987 )
(Ekbom and Akre, 1998; Rajpert-De Meyts and Skakkebaek, 1993; Savage and Lowe, 1990).
It has been hypothesised that these cells can become invasive after increased exposure to
hormones which generally occurs at puberty (Cortes et al., 1987), (Rajpert-De Meyts et al.,
1998). Exposure of the developing fetus to androgens or oestrogens (Savage and Lowe,
1990) are known to be risk factors for testicular cancer (Toppari et al., 1996). It is not known
whether exposure to 'environmental oestrogens' is involved in the increasing incidence of
testicular cancer which has been reported.
1.2.3 Congenital Abnormalities of the Male Reproductive Tract
1.2.3.1 Cryptorchidism
There are data from several reports suggesting that the incidence of cryptorchidism is
increasing. Cryptorchidism is a condition in which the testicles do not descend fully into the
scrotal sac but remain within in the abdomen or inguinal region. In some cases the testicles
will automatically descend into the scrotum but other boys undergo orchidopexy (an operation
to bring the testis into the scrotum). The data used to support an increase in cryptorchidism is
not as strong as the testicular cancer data mainly because the studies use different diagnostic
criteria to define a cryptorchid testis and some include various degrees of retractile testes.
Also, the reported prevalence of cryptorchidism varies substantially between 0.03-13.4%
using data from birth to one year of age from registers (Campbell et al., 1987; Matlai and
Beral, 1985; Mau and Schnakenburg, 1977; Mcintosh et al., 1954). In many studies racial
and ethnic data are pooled and very few studies have examined the temporal changes in the
incidence of cryptorchidism within the same geographical location and using identical criteria
to define the condition. Data from England and Wales which examined the number of boys
undergoing orchiopexy suggested an increase from 1.4% in a 1952 birth cohort to 2.9% in a
1977 birth cohort using the same diagnostic criteria (Chilvers et al., 1984). Similarly, in
Scotland the number of boys diagnosed with cryptorchidism showed a significant increase
between 1961 and 1985 (Campbell et al., 1987). A recent study has concluded that the
Chapter 1 Literature Review 6
highest risk factor for both cryptorchidism and hypospadias is a low birthweight (Weidner et
al, 1999).
1.2.3.2 Hypospadias
Hypospadias is a congenital abnormality of the penis in which the urethral opening does not
appear at the tip of the glans but can occur anywhere along the shaft of the penis. This is
caused by incomplete closure of the urethral folds during penis development. There are a
substantial number of reports in the literature which suggest that the incidence of hypospadias
is increasing. However, as with cryptorchidism, the studies are more difficult to compare as
the criteria used to define the condition and the inclusion/exclusion criteria are different
amongst the published studies. The figures for the prevalence of this condition in the world
literature varies considerably between 0.37 to 41 per 100,000 infants (Toppari et al., 1996).
Increases in hypospadias have been reported in the United Kingdom (Matlai and Beral, 1985),
Hungary (Czeizel, 1985; Czeizel et al., 1986), Sweden (Kallen et al., 1986; Kallen and
Winberg, 1982), Norway (Bjerkedal and Bakketeig, 1975) and Denmark (Kallen et al., 1986).
In the United Kingdom the national register indicated the prevalence of hypospadias has risen
from 7.3 per 10,000 births in 1964 to 16 per 10,000 in the 1980s. Data from 1990 indicated a
reduction in incidence at 11.7 per 10,000 births (Toppari et al., 1996). In Hungary the
incidence of hypospadias was reported as 5.5 per 10,000 births in 1964 and increased to 23.9
per 10,000 births in 1978 and has since remained at this level (Toppari et al., 1996). Results
from similar studies examining the incidence of testicular cancer between in Caucasians and
African Americans have concluded that the incidence of hypospadias is higher in Caucasians
than African Americans (Toppari et al., 1996).
The most recent report on the incidence of hypospadias and cryptorchidism examines the
international trends using data obtained from countries participating in the International
Clearinghouse for Birth Defects Monitoring Systems (ICBDMS) (Paulozzi, 1999). An
upward trend in the rate of hypospadias in the USA was noted from 1970, increasing in
incidence from 20 per 10,000 births to 36 per 10,000 births. Data from the Commonwealth
group (Canada, Australia and New Zealand) showed values between 10-20 per 10,000 births
in the early 1980s and similar values in the early 1990s; although there were fluctuations in
the values there was little net change. Comparing data from Scandinavia (Denmark, Finland,
Norway, Sweden) an upward trend was reported (except in Sweden) with rates more than
doubling in Norway and Denmark between 1970-1993 (6 per 10,000 to 15 per 10,000
births). Finland reported a small increase in the milder forms of hypospadias. In the group
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encompassing Northern Europe (England, France, Holland) and Japan, all the countries except
Holland showed a net increase in hypospadias. The grouping which examined Ireland and the
Mediterranean (Israel, Italy, Spain) only one region of Italy showed an increase in the
incidence of hypospadias. Of the less affluent nations (classed as China, Czech Republic,
Hungary, Mexico and South America) the rates recorded were relatively stable except
Czechoslovakia which registered an increase (Paulozzi, 1999). Far fewer countries recorded
data on cryptorchidism to the ICBDMS. In USA and Canada the national rates increased over
1970s-80s but this may have been due to more inclusive case definitions. In Norway and
France there is no consistent trend detectable while in England the rates recorded dropped
sharply in 1990 after the introduction of an "exclusion list" (Paulozzi, 1999).
The data collated by Paulozzi, (1999) does not indicate a general increase over time but
increases were more frequently recorded within the more affluent nations. This data
highlights the need for prospective, standardised studies to be performed in several
geographical locations to monitor the true incidence of these conditions.
1.2.4 Changes in Wildlife
The changes that have been documented in the literature regarding declining male reproductive
health are not confined to humans. The animal kingdom is also showing various degrees of
abnormalities within the male reproductive system. The most well documented phenotypes
include feminisation, reduced fertility, hatchability and viability of offspring and altered sexual
behavior (Colborn and Clement, 1992). Although in most cases the causative agent/s are not
known, researchers have linked these effects to endocrine disrupting chemicals. Many
chemicals have been identified in the environment that can act as potential endocrine
disrupters. However, exactly how these chemicals interact with each other to counteract or
synergise endogenous pathways within a biological system and whether the levels of these
chemicals are high enough to exert any biological changes is not known. It does appear,
however, that more gross malformations are occurring in animals 'lower' down the
phylogenetic tree with birds, reptiles, amphibians and fish showing the most pronounced
effects.
In 1980, Lake Apopka, Florida, was badly polluted after a chemical spill with trichloroethane
(DDT), and subsequently with its degradation metabolites DDD and DDE which are known
to have oestrogenic, anti-androgenic, or endocrine disrupting effects (Bitman and Cecil, 1970;
Bitman et ai, 1968). The lake suffered a decline in the number of juvenile alligators due to
reproductive disorders induced by these chemicals (Guillette et al., 1994). Male alligators had
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abnormal germ cells within the testis and abnormally small phalli indicating that normal male
sexual development had been permanently modified by exposure to high doses of the
polluting chemicals.
Abnormal reproductive tracts have been found in many species of fish. Fish living in water
downstream from kraft pulp mills (e.g. white sucker) showed signs of delayed maturation,
smaller gonads, lack of secondary sex characteristics, reduced serum testosterone and a
dysfunctional hypothalmic-pituitary-gonadal axis (Munkittrick et al., 1991). The effects of
polychlorinated biphenols (PCBs) have been investigated in Atlantic cod as dietary exposure
to these compounds disrupts testicular spermatogenesis (Toppari et al., 1996). In England,
rainbow trout downstream of sewage treatment outflows display an increased incidence of
hermaphroditism. These male fish produce large quantities of the egg protein vitellogenin
which is normally only produced by female fish in response to oestrogen (Jobling and
Sumpter, 1993; Purdom et al., 1994). In a bioassay to assess vitellogenin production on
exposure to xenoestrogens, a class of alkylphenol-polyethoxylates, a major group of
surfactants found in sewage were shown to be oestrogenic to fish (Jobling et al., 1996).
The Florida Panther, an endangered species of which there are only about 35 individuals,
exhibits a wide array of reproductive abnormalities (Facemire et al., 1995). The males have a
low ejaculate volume, low sperm concentrations (>90% of sperm are morphologically
abnormal) and exhibiting poor sperm motility. The incidence of cryptorchidism has increased
since 1975; all but one of the nine cubs born since 1985 are cryptorchid. These abnormalities
are thought to be due to the contamination of mothers with endocrine disrupting chemicals
(Facemire et al., 1995) but others have argued that these abnormalities could be a consequence
of in-breeding.
In most cases there is no definitive proof that the changes observed in wildlife have occurred
as a direct consequence of exposure to 'environmental oestrogens'. However, the changes
reported in human reproductive health and the similarities reported in some animal species
only serves to heighten awareness that there could be a problem. In species where the
causative agent is known, the adverse effects on the reproductive tract have been induced only
after exposure to high levels of the environmental contaminant. Therefore effects observed in
wildlife must be interpreted with caution, and care must be taken not to extrapolate the causes
directly with the changes observed in human reproductive health.
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Many of the reported malformations described in both humans and wildlife are evident at birth
and probably stem from changes induced during development. It may be possible that high
levels of oestrogenic and/or anti-androgenic chemicals may interfere with the normal patterns
of sexual differentiation and subsequent development of the gonads and accessory organs. It
is therefore important to identify whether exposure to such chemicals, at doses comparable to
those found in the environment, can act to interfere with normal sexual development. The
current understanding of the sites of oestrogen and androgen action within the male
reproductive tract is reviewed in section 1.6.
1.2.5 Diethylstilbestrol and Abnormalities in the Reproductive Tract of Males
The synthetic oestrogen, diethylstilbestrol (DES), was prescribed to pregnant women from the
late 1940s to the early 1970s as a preventative measure to stop miscarriage and pregnancy
complications (Palmund et al., 1993). The results of a double-blind placebo-controlled study
on the therapeutic value of DES demonstrated that it was not efficacious for the medical
conditions for which it was being used (Dieckmann et al., 1953). DES was associated with an
increased rate of abortion, neonatal deaths and premature births (Brackbill and Berendes,
1978). The use of DES during pregnancy was banned in the early 1970s after it was
discovered that a very rare form of vaginal cancer (clear cell adenocarcinoma of the vagina)
had increased in incidence in young women whose mothers had taken DES (Herbst et al.,
1974). Millions of women across USA and Europe were exposed to DES and in addition it
was used as an anabolic agent in livestock and was transferred into dairy products.
The sons of mothers exposed to DES during pregnancy also showed abnormalities in the
structure and function of reproductive organs (Arai et al., 1983; Stillman, 1982). These
included an increased incidence of hypospadias, epididymal cysts, hypoplastic testes,
cryptorchidism, microphallus and abnormal semen parameters (Gill et al., 1977; Gill et al.,
1979; Henderson et al., 1976). Several studies have recorded significantly lower sperm
concentrations in DES exposed men (83 million per ml in DES exposed men as opposed to
123 million per ml in placebo exposed men) (Gill et al., 1979) and other studies published
similar findings (Stillman, 1982). However most DES exposed men are fertile and have
sperm counts within the defined normal range (> 20 million per ml) (Wilcox et al., 1995).
There is however a significantly higher number of DES exposed men who have semen
analysis scores which are rated 'severley pathological' (23% versus 5%) (Gill et al., 1977).
There is some evidence to suggest that DES induced a small increase in the incidence of
testicular cancer (Vessey, 1989) which reached significance after meta-analysis (Toppari et al.,
1996). Men who were exposed to DES before 1 1 weeks of gestation (i.e. when the genital
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tract is just forming) had double the risk of developing genital anomalies compared to men
exposed to this chemical later in gestation (Wilcox et al., 1995). This demonstrates the
sensitivity of the fetus to exogenous chemicals during organogenesis and the importance of
the timing of exposure.
1.2.6 Oestrogenic Chemicals Identified In The Environment
The industrialisation of the Western world over the last century has led to revolutions in
manufacturing processes. Industry has developed thousands of compounds, produced new
materials and products that have become part of everyday life. Industrial manufacturers are
capable of producing thousands of tonnes of chemicals every year. Some of these products
are involved in the production of pesticides, plastics, detergents, petrol and many other
household commodities. When these compounds were initially manufactured they were not
considered to have potentially harmful effects on man. Therefore the release of tonnes of such
chemicals into the environment every year was of no real concern. The major change in this
thinking probably occurred during the 1960s when it became clear that some organochlorine
pesticides were having detrimental effects on wildlife. Thirty years later, concern has been
raised again due to the possibility that synthetic chemicals in the environment may be having
an adverse effect on human reproductive health.
An increasing number of synthetic chemicals have been identified as hormonal mimics either
in vitro or in vivo. Currently, the major classes of these compounds include some members of
the following groups: organochlorine pesticides, polychlorinated biphenols, alkyl- and bis-
phenolic compounds and phthalate esters. However, only a small fraction of chemicals within
the environment have been tested and it is not possible to predict accurately whether a
compound is oestrogenic or not from its chemical structure, therefore this list will probably
continue to increase for the foreseeable future.
Organochlorine pesticides include methoxychlor, kepone (chlorodecane), dieldrin and 1,1,1-
trichloro-2,2-bis (p-chlorophenyl) ethane, better known as DDT. The use of DDT was banned
in developed countries in the 1960s but it is still widely used in developing countries.
However, DDT is a persistent chemical in the environment with a half-life of > 60 years. It is
also lipophilic and accumulates in body fat. There are several isomers of DDT, of which o,p
DDT has the most potent oestrogenic activity as determined by both oestrogen receptor
binding (Kelce et al., 1995) and uterotrophic activity in vivo (Gellert et al., 1972). However,
the major metabolite of DDT found in the body is /?,/?'DDE which has potent anti-androgen
effects both in vitro and in vivo (Kelce et al., 1995). Other compounds such as methoxychlor
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and chlordecone are also oestrogenic and administration of either compound to neonatal
female rats induces accelerated vaginal opening and infertility (due to persistent oestrus in
adulthood) (Colborn and Clement, 1992).
Industrial chemicals such as polychlorinated-biphenols (PCBs) are also widespread and
persistent in the environment. There are over 200 congeners of PCBs, some of which possess
oestrogenic activity while some others have anti-oestrogenic activity (Turner and Sharpe,
1997). Another group of industrial chemicals, the alkylphenol polyethoxylates (APEOs) are
widely used as surfactants in many household products such as plastics, detergents, petrol
additives, paints, cosmetics and condom spermicides. Up to 60% of these chemicals enter the
aquatic environment. During sewage treatment, microbes break down APEOs, and
degradation products are produced, some of which have oestrogenic activity (octylphenol and
nonylphenol) (Turner and Sharpe, 1997). Similarly, bisphenol A, another component of
polycarbonate plastics, acrylic resins, xeroxing chemicals and the lacquer coating of food cans
has been shown to be oestrogenic. Finally, another group of chemicals, the phthalates which
are used as plasticizers in the production of plastics and resins are among some of the most
ubiquitous synthetic environmental chemicals. The majority of phthalate esters are not
oestrogenic but butyl benzyl phthalate and di-n-butyl phthalate are oestrogenic in vitro
(Turner and Sharpe, 1997).
All the synthetic environmental oestrogens described to date are weak oestrogens. They are at
least 1000 times less potent than oestradiol (Arnold et al., 1996). This suggests biological
effects would only occur after exposure to very high levels. But this situation is complicated
by the fact that these chemicals may be capable of causing additive, synergistic or antagonistic
effects. However, a recent study examined the sons of farmers and gardeners for genital tract
abnormalities, since some of the heavily used chemicals within these occupations have been
shown to be oestrogenic and possess other hormone-disrupting effects (Weidner et al., 1998).
The results indicated a significant increase in the risk of cryptorchidism but not hypospadias
in the sons of mothers (but not fathers) working in these occupations (Weidner et al., 1998).
This suggests that occupational exposure to some of these chemicals may be high enough to
induce an increase in congenital abnormalities.
There is another source of oestrogens which occur naturally in the environment, termed
phytoestrogens (plant oestrogens) that are likely to be a more significant source of human
oestrogen exposure than synthetic oestrogens. Phytoestrogens are consumed largely via the
diet and are present in substantial levels in soya, grains, vegetables, and fruits. Phytoestrogens
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can be grouped into 3 main subsets: isoflavones (e.g. genistein, daidzein), coumestans/lignans
(e.g. coumesterol) and mycoestrogens (e.g. zearanalone) (Kaldas and Hughes, 1989). Unlike
many of the synthetic compounds, phytoestrogens do not bioaccumulate in body fat and are
readily metabolised. This is one source of oestrogen which has undoubtedly increased in the
developed world in recent years particularly through the addition of soy-based proteins to
many convenience foods. There are contradictory views regarding the potential benefits and
risks of increasing our consumption of phytoestrogens. One argument suggests that a high
phytoestrogen diet, as is prevalent in Japan, may give some protection against breast, colon
and prostate cancer (Messina et al., 1994). However, a high dietary intake of phytoestrogens
has been shown to cause reproductive abnormalities in sheep (Kaldas and Hughes, 1989) and
can prolong the follicular phase of the menstrual cycle in humans (Cassidy et al., 1994). Due
to the increasing use of phytoestrogens in the Western diet (and also in baby foods and
formula feeds) it is important to determine whether an increased dietary consumption of these
chemicals has any effect (positive or negative) on reproductive health.
1.3 Anatomy of the Male Reproductive System
The male reproductive tract consists of two testes, each of which is attached to a highly coiled
epididymis that ends in a straight vas deferens (see Figure 1.1). The vas deferens loops
around the bladder and merges with the ducts of the seminal vesicles and then enters the
prostate gland and joins the urethra which extends along the length of the penis (Curtis and
Barnes, 1989).
1.3.1 The Testis
The testis is an ovoid structure encapsulating the seminiferous tubules which contain the
developing germ cells. The testicular capsule (tunica albuginea) is a fibrous layer which covers
the testis (Setchell et al., 1994). It is composed of several layers of fibroblasts, collagen and
smooth muscle cells. These muscle cells are capable of rhythmic contractions and may aid
sperm transport out of the testis. The testicular capsule is also regarded as important for
maintaining interstitial pressure within the testis and is important in controlling blood flow
into the testis (Setchell et al., 1994).
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Figure 1.1 Diagram of the Testis and Excurrent Duct System
Illustration of the anatomy of the testis, rete testis, efferent ducts, the regions of the epididymis
and the vas deferens and their proximity to each other. Adapted from (Robaire and Hermo,
1988).
The majority of adult testicular volume comprises seminiferous tubules which consist mostly
of germ cells and the only somatic component, the Sertoli cells. The seminiferous tubules are
coiled loops which have both ends attached to the rete testis. In the rat there are approximately
30 tubules per testis (Setchell et ai, 1994). A layer of peritubular myoid cells surrounds the
basement membrane of each seminiferous tubule and these cells are also able to contract,
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which may aid sperm transport. The regions between seminiferous tubules contain interstitial
cells, nerves, blood and lymph vessels. The interstitial cells comprise Leydig cells (hormone
secreting cells), as well as immune cells (mast cells and macrophages).
1.3.2 Spermatogenesis
In order to understand how sperm counts could be affected by exogenous chemicals it is
important to have a basic understanding of how the process of spermatogenesis is
constructed. It is only by understanding how sperm are produced and what processes
determine the efficiency of spermatogenesis that insight can be gained into the processes that
could be vulnerable to disruption by oestrogenic chemicals.
1.3.2.1 The Organisation of Spermatogenesis
Spermatogenesis is a complex process which transforms a round germ cell into a flagellated
spermatozoon. There are morphologically and spatially defined stages that each developing
germ cell passes through and these comprise the spermatogenic cycle.
The developing germ cells are enclosed within the seminiferous tubules of the testis. At the
base of the tubules lie the stem cells (spermatogonia; termed A0 in the rat and Ad in humans)
and the Sertoli cells. A schematic diagram of a cross section through a Sertoli cell is shown in
Figure 1.2. The cytoplasm of the Sertoli cell extends in towards the lumen of the
seminiferous tubule. These cells are essential to spermatogenesis as their extended cytoplasm
engulfs the developing germ cells and supplies them with nutrients and hormones.
In Figure 1.2, immature germ cells (spermatogonia) can be observed at the base of the
seminiferous tubule and as they differentiate the germ cells move towards the lumen where
they are released upon completion of spermatogenesis. At any one time, the Sertoli cell has to
support several different germ cell types at different stages of development. Due to the
defined time required for the maturation of one germ cell type into another there are patterns
of germ cell complements which are always viewed in cross-section together. These germ cell
complements are called stages. There are XTV stages identified in rat spermatogenesis and
these are collectively referred to as the spermatogenic cycle (Sharpe, 1994). As each stage is
composed of germ cells at various developmental stages, a single germ cell passes through the
spermatogenic cycle 4.5 times. A single passage through the cycle takes -12.5 days and the
duration of rat spermatogenesis is between 51 and 53 days (Sharpe, 1994).















Peritubular myoid cell layer
Interstitium
Figure 1.2 Diagram of a Cross section through a Sertoli Cell
Illustrates both the anatomical arrangement of the seminiferous tubule and the close
association between the Sertoli cell of the Seminiferous tubule and the developing germ cells.
Adapted from (Sharpe, 1994).
At the initiation of a spermatogenic cycle the spermatogonia divide, one of the daughter cells
repopulates the stem cell population while the other undergoes a series of mitotic divisions. In
rat spermatogenesis there are six mitotic divisions and the cells pass successively through
A,, A2, A3, A4 and an intermediate stage to become B spermatogonia. The daughter cells of the
final mitotic division enter meiosis and are termed preleptotene spermatocytes. These cells
pass through the Sertoli cell tight junctions and enter the adluminal compartment. They are no
longer able to gain independent access to nutrients and hormones derived from either the
blood stream or interstitial fluid and become dependent on the Sertoli cell to support them
throughout spermatogenesis (Sharpe, 1994).
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The process of meiosis involves DNA synthesis (preleptotene spermatocytes), RNA synthesis
(pachytene spermatocytes) and, upon completion of meiosis, a reduction division to produce 4
haploid round spermatids. The differentiation of the haploid cells into spermatozoa occurs
during the process of spermiogenesis. Spermiogenesis has been separated into 19
morphologically defined steps. During this process the nucleus compacts its DNA which
thus becomes transcriptionally inactive. The nucleus becomes overlain with an enzyme filled
sack called the acrosome which, at fertilization, aids sperm penetration of the vestiments
surrounding the oocyte. The developing spermatids lose most of their cytoplasm and
organelles during spermiogenesis and develop a flagellum which is rich in mitochondria and
will allow the cell to be motile after ejaculation (Sharpe, 1994).
1.3.2.2 What Determines Sperm Numbers
There are a few factors which are important in determining the overall sperm count. For
examples, the number of Sertoli cells, the number of germ cell mitoses and rate of
degeneration; these will be discussed briefly below.
1.3.2.2.1 The Relationship Between Sertoli Cells and Sperm Production
The number of Sertoli cells within the testis is essential in determining both testicular size and
daily sperm production in the adult animal (Russell and Peterson, 1984). As each Sertoli cell
can only support a defined number of germ cells through spermatogenesis at one time, the
number of Sertoli cells determines the maximum achievable sperm production for each testis.
The germ cells comprise most of the testicular volume and the quantity of germ cells is limited
by the number of Sertoli cells, therefore, indirectly, Sertoli cells determine adult testis size
(Sharpe, 1998). So, what determines the number of Sertoli cells?
The number of Sertoli cells is determined prior to the onset of spermatogenesis. Sertoli cells
divide when they are immature/undifferentiated in fetal/neonatal life and, in some species, in
early puberty (Sharpe, 1994). In the rat, Sertoli cell multiplication occurs from embryonic day
19 through until day 15 postnatal (Orth, 1984; Orth, 1982) while in humans, Sertoli cell
proliferation occurs in neonatal and probably in the pre-pubertal period but not thereafter
(Cortes etai, 1987). The most important factor which can increase the rate and duration of
Sertoli cell division is the gonadotrophic hormone FSH (Orth, 1982). The neonatal
suppression of FSH in rats (i.e. during the period of Sertoli cell replication) leads to a
permanent reduction in Sertoli cell numbers (Sharpe, 1994), (Sharpe et al., 1998a). Oestrogen
is a powerful suppressor of FSH secretion in males, particularly neonatally (Arai et al., 1983),
(Sharpe et al., 1998a) and neonatal administration of high doses of the potent synthetic
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oestrogen DES can permanently lower Sertoli cell numbers though this may result, in part,
from direct effects of DES on the Sertoli cells (Sharpe et al., 1998a). In contrast, the
administration of moderate levels of oestradiol to neonatal rats does not induce an alteration in
Sertoli cell numbers (Cook et al., 1998). These studies suggest that oestrogens/oestrogenic
compounds can inhibit Sertoli cell replication but possibly only at high concentrations. This
suggests that oestrogenic chemicals could potentially influence the multiplication of Sertoli
cells, however since these chemicals are weak oestrogens it seems unlikely that humans would
consume enough of these compounds to induce a biological effect.
Whether or not xenoestrogens in the environment or other environmental/lifestyle changes
could cause a reduced sperm output by this mechanism is not known but this is the basic tenet
of the hypothesis put forward in 1993 to suggest a mechanism behind the changes reported in
the literature (Sharpe and Skakkebaek, 1993). Using the rat as a model, various xenoestrogens
were administered during the period of Sertoli cell replication and induced small (8-12%) but
significant reductions in testis size and daily sperm production in adult rats (Sharpe et al.,
1995), although these findings have proved difficult to repeat (Sharpe et al., 1998b).
1.3.2.2.2 The Efficiency of Spermatogenesis
Another factor which could influence the sperm output of an animal is the efficiency of
spermatogenesis. This varies greatly between species. For example, the average number of
elongate spermatids per Sertoli cell is 10.3 ±1.6 in rats in comparison with only 3.9±0.5 for
human Sertoli cells (Sharpe, 1994). Similarly, when the daily sperm production (DSP) per
gram of testis is compared, humans produce only 4.4 xl06/g whereas the rat is capable of
producing 24 xl06/g. Humans have the most inefficient spermatogenesis of any mammal so
far described and this is often linked to the manner in which the spermatogenic cycle is
arranged within the seminiferous tubule. Rats have a segmental arrangement along the
seminiferous tubule which means that all of the Sertoli cells in a cross section have germ cell
complements at the same spermatogenic stage. Humans however, have a helical arrangement
of stages which means that Sertoli cells in a single cross section may be in contact with germ
cells at several different stages of the spermatogenic cycle which may lead to a suboptimal
microenvironment for the developing germ cells (Sharpe, 1994). Why this helical
arrangement evolved is unknown. The lower DSP/g may also stem from the number of
mitotic divisions. In humans there may be as few as 3 divisions compared to 6 in the rat (see
Figure 1.3) which would halve the number of germ cells entering meiosis in comparison to the
rat.











































Figure 1.3 Illustration of the Differences between Rat and Human Spermatogenesis
These differences may account for the inefficiency of human spermatogenesis when
compared to the rat. Adapted from (Sharpe, 1994).
Each preleptotene spermatocyte which enters meiosis should give rise to four haploid round
spermatids but this ratio is never attained as meiosis is a major point in the spermatogenic
cycle at which germ cell degeneration occurs and this happens at an increased frequency in
humans (Sharpe, 1994). The most common stage for germ cell degeneration to occur in all
mammals is during Metaphase II of meiosis. In rats there is a 4-6% shortfall in the expected
number of spermatids after meiosis but in humans, this value is closer to 40% and appears to
rise with age (Johnson, 1986) (Johnson et ai, 1990). Faulty meiotic divisions have been
suggested as one cause which may account both for the high level of germ cell loss and for
the high numbers of abnormal spermatozoa found within the normal human ejaculate (Sharpe,
1994), (Skakkebaek et al., 1973). Germ cell degeneration can also occur during the mitotic
divisions of spermatogonia and during nuclear condensation of spermatids, however loss at
these stages is minor by comparison to losses at meiosis (Sharpe, 1994). Alterations in the
level of FSH may also be important in determining the number of spermatogonia entering
meiosis (see Figure 3). In primates, including humans, FSH is a factor involved in stimulating
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spermatogonial cell division. The administration of FSH to adult cynomologous monkeys
(Weinbauer and Nieschlag, 1991) increases the number of B spermatogonia, spermatocytes
and spermatids over the treatment period. This effect was induced by an FSH induced
increase in Ap spermatogonia (Shaipe, 1994). These data suggest that the Sertoli cell is not at
maximum capacity, thus, theoretically the administration of FSH could improve the efficiency
of spermatogenesis and a reduction could cause it to fall. However, there is little evidence that
suppression of FSH in normal men causes any major decline in sperm counts if adequate
testosterone levels are maintained (Bremner et al., 1981).
From the above description, human spermatogenesis is very inefficient in comparison to most
mammals. There appear to be several stages in the spermatogenic process which are
susceptible to germ cell degeneration. In the adult testis the germ cells are responsible for
most of the testicular volume so a large loss in germ cells would be expected to be associated
with a reduction in testis weight. Whether exposure to oestrogenic chemicals could increase
the rate of germ cell degeneration or decrease the rate of mitotic divisions and hence the
number of B spermatogonia is unknown but exposure to DES and some environmental
compounds has been demonstrated to decrease testicular weight and DSP in rats after
gestational/neonatal exposure (Sharpe et al., 1995). This decline was presumed to occur due
to a reduction in FSH which induced a reduction in Sertoli cell numbers, however no studies
have been performed to exclude germ cell degeneration or decreasing numbers of B
spermatogonia as possible mechanisms for these decreases.
1.3.3 The Rete Testis
The terminal regions of the seminiferous tubules which open into the rete testis are termed
transitional zones or tubuli recti (see Figure 1.4). This region of the epithelium contains no
germ cells and is lined by cells resembling Sertoli cells (Roosen-Runge, 1961). The distal end
of this region is an extension of the rete proper and in the human up to six seminiferous
tubules can join with a single tubulus rectus (Roosen-Runge and Holstein, 1978).
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Figure 1.4 Diagram of a Testis-Rete Testis Junction
Illustrating the terminal segment (tubulus rectus) of a seminiferous tubule and the sharp
change in morphology to the rete testis. Adapted from (Setchell et al., 1994).
Under light microscopy the terminal segment has no lumen unless the testicular pressure is
raised by efferent duct ligation (Osman and Ploen, 1978). Normally the tall columnar cells
occlude the lumen due to their long cytoplasmic processes which some investigators have
described as 'plug-like' structures and suggest these function as a valve to prevent fluid reflux
back into the seminiferous tubule (Perey et al., 1961; Roosen-Runge, 1961). Another
function of the long cytoplasmic processes of these 'Sertoli cells' could be either resorption
or secretion (Waites and Setchell, 1990).
The rete testis is often described as a labyrinth-like structure due to its network of
interconnecting channels. The epithelium lining the rete changes from columnar in early
postnatal life to cuboidal/squamous in the adult rete testis (Fisher et al., 1997), (Dym, 1976).
The location of the rete testis differs between species. In primates and rats the rete is situated
under the tunica albuginea where it connects with the efferent ducts of the epididymis
(Roosen-Runge, 1961) whereas in sheep the rete forms a cavity in the centre of the testis.
Based on its anatomical position this structure can be described as having three parts,
intratesticular, intratunical and extratesticular (Roosen-Runge, 1961). Of these regions, the
intratesticular region is the largest.
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The ultrastructural characteristics of the adult rat rete testis epithelium have been examined by
electron microscopy (Leeson, 1962). The epithelium lining the central cavity of the rete
appears squamous whereas the regions connecting with the tubuli recti and efferent ducts are
cuboidal (Leeson, 1962). The cuboidal cell contains a multilobed nucleus which is situated
towards the basement membrane rather than the lumen. The epithelial cell membranes of the
rete testis have many specialised features, adjoining lateral membranes show complex
interdigitating connections which are often associated with desmosomes. The role of these
complex junctions is not known. The basal membrane of the epithelial cells is smooth and
parallel to the basement membrane. The apical membrane shows numerous slender microvilli,
pseudopodial projections associated with cytoplasmic vesicles and occasional cilia (Leeson,
1962). Whether these cilia are functional is doubtful (as no centrioles have been identified)
but they may function as chemoreceptors (Leeson, 1962). The presence of microvilli,
cytoplasmic vesicles and numerous mitochondria indicates that the epithelium is metabolically
active and probably involved in fluid transport (Leeson, 1962). To support this, Morales and
colleagues observed numerous small invaginations on apical, basal and lateral cell membranes
corresponding to either the formation or fusion of pinocytotic vesicles (Morales et al., 1984).
The rete testis is embedded in highly vascular, loose fibro-connective tissue that lies close to
the testicular artery and is covered by the mediastinal venous plexus (Free and Jaffe, 1972).
The connective tissue of the rat rete testis consists of elongate fibroblasts. A "looseness"
becomes increasingly evident around days 22-27 postnatal which probably reflects an increase
in hydration (Nykanen, 1980). The rete testis epithelium is firmly attached to the basement
membrane which may be to prevent compression and or obliteration of the lumen during
changes in testicular pressure (Leeson, 1962).
1.3.4 The Efferent Ducts
The efferent ducts are a series of ductules connecting the rete testis to the epididymis. The
number of efferent ducts varies between species; only five or six have been reported in
humans (Jonte and Holstein, 1987; Saitoh et al., 1990) and between two and nine have been
isolated in the rat (Cooper and Jackson, 1972) (Dym, 1976) (Gutroff et al., 1992). The
efferent ducts become increasingly coiled as they near the epididymis forming the bulbous
coni vasculosi which connects to the initial segment of the epididymis (Setchell et al., 1994).
The efferent ducts of the rat converge into a single tubule which continues as the initial
segment of the epididymis (MacMillan, 1953) though some investigators believe that two
separate branches of efferent ducts join with the epididymis (Cooper and Jackson, 1972). The
lining of the efferent duct epithelium is largely composed of two cell types, ciliated and
nonciliated cells, but some investigators have also reported intraepithelial lymphocytes and
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basal cells (Ramos and Dym, 1977; Setchell et al., 1994). These cell types have a low
capacity for protein synthesis but have a well developed endocytotic apparatus that is active in
fluid resorption (Ramos and Dym, 1977). Beneath the epithelium is a basal lamina which lies
adjacent to a layer of periductular connective tissue which contains fibrocytes, abundant
collagen fibres and a layer of smooth muscle cells (Ramos and Dym, 1977).
1.3.4.1 Ciliated Cells
The apical surface of the cell has many cilia and a few microvilli. The cilia contain the typical 9
+ 2 arrangement of microtubules and terminate in a basal body. The well developed ciliary
roots frequently reach to the perinuclear zone far beyond the apical cytoplasm (Ramos and
Dym, 1977). These cells have large ovoid or spherical nuclei which are located in the middle
or apical regions of the cells (Ramos and Dym, 1977). The nuclei contain electron lucent
euchromatin with prominent nucleoli (Ramos and Dym, 1977). The cell cytoplasm contains
numerous round or short rod-shaped mitochondria which are most concentrated around the
supra- and perinuclear areas of the cells (Ramos and Dym, 1977). The cytoplasm contains
numerous microfilaments, free ribosomes and polyribosomes; however, neither the rough nor
smooth endoplasmic recticulum are well developed (Ramos and Dym, 1977). There is some
rough endoplasmic recticulum and Golgi apparatus in the supranuclear and apical regions of
the cells (Ramos and Dym, 1977). The function of the cilia is not clear. Initially they were
thought to propel the sperm through the duct but the cilia on opposing sides of the epithelium
beat in opposite directions therefore they probably induce a constant current in the fluid
causing it to mix (Ilio and Hess, 1994).
1.3.4.2 The Nonciliated Cells (Apical or Principal Cells)
The surface of the apical cell is covered in microvilli of a similar height. Canaliculi extend
down into the cytoplasm between the microvilli and in some cells appear continuous at their
ends with coated vesicles called tubular coated pits (Hermo et al., 1988; Ramos and Dym,
1977). The nonciliated cells have a dense nucleus which contains heterochromatin and is
situated near the basal lamina (Ramos and Dym, 1977). The nucleus is smaller and has
numerous deep infoldings of the nuclear envelope compared to the ciliated cell. The cell
cytoplasm contains fewer mitochondria than the ciliated cell but similarly the endoplasmic
recticulum is not well developed (Ramos and Dym, 1977). The most notable entities within
the cytoplasm of the nonciliated cell are the many micropinocytotic vesicles, membrane bound
dense bodies and numerous vacuoles it contains (Ramos and Dym, 1977). These
characteristics provide strong evidence for this cell having a role in endocytosis.
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1.3.4.3 Nonciliated Cells and Endocytosis
Even the early light microscopic studies into the function of the efferent ducts suggested a role
in endocytosis (Mason and Shaver, 1952; Van Wagenen, 1925). This suggestion was
supported by electron microscopy studies which employed the use of electron dense tracers to
examine the fate of substances within the lumens of the efferent ducts (Goyal and Hrudka,
1980; Hermo et al., 1988; Ladman, 1967; Yokoyama and Chang, 1971). Changes in the
composition of luminal fluid between the start of the efferent ducts and the beginning of the
initial segment of the epididymis have been detected using micropuncture techniques (Levine
and Marsh, 1971) (Jenkins et al., 1980; Turner, 1984), providing further evidence that there is
a dynamic flux of fluids, proteins and ions across the efferent duct epithelium.
Illustrating the process of endocytosis within the nonciliated cell of the efferent duct
epithelium as determined after the injection of electron dense tracers. Adapted from (Hermo et
al., 1988).
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The apical region of the nonciliated cell cytoplasm contains many specialised vesicles and
coated tubules which are important in endocytosis (see Figure 1.5). Two types of endocytosis
have been described, adsorptive and fluid phase, depending whether or not the molecule binds
to the apical plasma membrane. If the molecule does bind via a specific or non-specific
receptor and is then internalised by pinocytosis this is classed as adsorptive endocytosis.
When a molecule is suspended in fluid and does not bind to the surface membrane, but is still
internalised via pinocytotic vesicles, this process is termed fluid phase (or bulk) endocytosis
(Morales et al., 1984). Experimentally, tracers such as cationic ferritin (CF) which bind
electrostatically to anionic groups at the cell surface have been used to examine adsorptive
endocytosis, and horseradish peroxidase (HRP) is extensively used as a marker to
demonstrate fluid phase endocytosis The pathway through the cell is identical whether the
substance is internalised by adsorptive or fluid phase endocytosis and is shown
diagrammatically in Figure 5. Tubular coated pits (TCP) are connected to the apical plasma
membrane. Beneath these are apical tubules (AT) which show a partial coat (Hermo et al.,
1988). Using CF both TCP and AT were shown to exhibit similar patterns of labeling. The
amount of tracer found within both these structures peaked after 25 and 60 minutes
suggesting that the tracer was being recycled within the cell as only one injection of tracer was
given. TCP were labeled after 30 seconds, before any tracer was identified in AT, indicating
that tracer enters the TCPs first (Hermo et al., 1988). Molecules enter sequentially, TCP, AT,
endosomes, multivesicular bodies and secondary lysosomes. It is thought that AT bud off
from TCP and a portion (30%) of these fuse to form endosomes and then recycle back to the
cell surface while the other 70% transform into endosomes, multivesicular bodies and
secondary lysosomes (See Figure 5) (Hermo et al., 1988). AT have been found in other
epithelia involved in endocytosis and membrane recycling, e.g. the proximal convoluted tubule
of the kidney (Graham and Kamovsky, 1966).
1.3.5 The Epididymis and Vas Deferens
The epididymis is a single highly convoluted duct that extends from the anterior to the
posterior pole of the testis and is held closely to the testicular capsule by connective tissue.
The epididymis is grossly divided into 3 regions, the caput, corpus and cauda (head, body and
tail respectively), but other investigators have made more detailed divisions based on
morphological and histological observations which have separated the epididymis into
between 6 and 12 regions. There are many different cell types within the epididymis some of
which are region specific and the roles of which are not clearly understood. The major cell
type within the epididymal epithelium is the principal cell, which has stereocilia on its apical
brush border. This cell type is found throughout the epididymal duct. The other cell types
Chapter 1 Literature Review 25
include basal cells, clear cells, apical cells and halo cells. Functionally the caput region of the
epididymis is important for maturational changes to the spermatozoa and the distal regions are
thought to be important for storing mature sperm in a quiescent state. At the distal region of
this duct the epididymis straightens out and continues as the vas deferens.
The initial segment of the epididymis continues from the efferent ducts. The principal cells in
this region are taller than in other epididymal regions with tall microvilli which form a brush
border. Only the initial segment contains narrow cells, so called as they have an ill-defined
narrow base contacting the basement membrane, but these cells give rise to clear cells which
are found in the rest of the epididymis. Both the columnar and narrow cells derive from a
common undifferentiated stem cell (Clermont and Flannery, 1970). Principal cells and basal
cells are derived from a columnar cell and the specific cell types are evident after postnatal day
28 (Sun and Flickinger, 1979). The principal cells found in the remainder of the epididymis
are shorter but have a larger apical surface in contact with the lumen and with the basement
membrane via foot-like processes (Robaire and Hermo, 1988). These cells show specialised
adaptations for endocytosis with coated pits comprising a clathrin-like lattice coat within the
apical membrane. There are also numerous large uncoated vesicles and apical tubules. The
lateral plasma membranes are smooth and show no interdigitations with neighbouring cells.
Clear cells have only been identified in the rodent epididymis and have a higher endocytotic
activity than principal cells (Robaire and Hermo, 1988). Basal cells have been identified in all
species studied. These cells can be small, round or elongated in appearance with a large
nucleus and little cytoplasm. They are often situated between two principal cells and have a
large area of contact with the basement membrane. Basal cells have few cytoplasmic features
suggesting they are not very metabolically active and their role is unknown. Throughout the
epididymal epithelium there are halo cells, often referred to as lymphocytes (Robaire and
Hermo, 1988). These cells migrate into the epididymis during postnatal development. Similar
cells are also found surrounding seminiferous tubules and share many features with
monocytes from peripheral blood.
The functions of the epididymis are generally cited as the transit of spermatozoa to the vas
deferens, the acquisition of sperm motility, sperm maturation and storage in the cauda
epididymis. Transit time through the epididymis in mammals is approximately 10 days.
Sperm transit is aided by neuronal input which induces contraction of the periductular myoid
cells (Robaire and Hermo, 1988). The length of time that sperm are stored in the cauda
epididymis is variable and depends on ejaculatory frequency (Robaire and Hermo, 1988).
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Sperm also acquire the ability to fertilize during transit through the epididymis but it is unclear
how much sperm maturation is driven by the epididymal epithelium and how much maturation
is a sperm driven process.
The epididymis is regarded as being androgen dependent through the results of numerous
castration and testosterone replacement studies (Brooks, 1979; Karkun et al., 1974; Robaire et
al., 1985). It has been shown to atrophy when the testis is removed. Testosterone treatment
only partially maintains epididymal weight as approximately 40% of the weight is due to the
presence of the spermatozoa and testicular fluid secretion (both interstitial and seminiferous
tubule fluid) (Brooks, 1979; Karkun et al., 1974; Robaire et al., 1985).
The vas deferens connects the epididymis to the urethra. The epithelium lining the vas
deferens is complex and has been shown to perform both secretory and absorptive functions.
In humans, at least four different cell types have been identified: principal, pencil,
mitochondrion-rich and basal cells (Setchell et al., 1994). The epithelium of the human vas
deferens is surrounded by a thick muscle layer which is composed of three coats, an inner
longitudinal layer, a circular or oblique layer and an outer longitudinal layer. In the rat vas
deferens there is a progressive decrease in the complexity of the epithelial and muscle layers
as the organ becomes more distal to the epididymis.
1.3.6 The Accessory Glands
The accessory glands comprise the prostate, seminal vesicles, ampulla and the bulbourethral
gland (Cowpers Gland). The prostate gland is a lobular organ which is present in all
mammalian species. It is defined as a compound tubuloalveolar gland and can be identified as
either disseminate or discrete. If the glandular acini remain within the lamina propria without
penetrating the urethral muscle it is defined as disseminate but when the gland forms a definite
body outside the urethral muscle it is termed discrete (Setchell et al.. 1994). The rat prostate
comprises the ventral prostate (a bilobed structure next to the urethra) and a dorsolateral lobe.
The coagulating gland is an additional lobe of the prostate which is also known as the anterior
prostate. The lobes of the prostate drain into the urethra through multiple ducts. The seminal
vesicles are a pair of glands which lie next to the prostate. They are not present in all animals
but do exist in both man and rats. The glands are composed of compact tissue arranged in
multiple lobes which contain a system of secretory ducts. It is lined with a pseudostratified
epithelium which has a row of round basal cells and a row of larger columnar cells. The
remainder of the gland comprises two layers of connective tissue with a layer of smooth
muscle sandwiched between (Setchell et al., 1994).The ampulla is a spindle-shaped thickening
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at the terminal region of the ductus deferens. It is not present in all animals but is present in
man. Bulbuorethral glands (Cowpers glands) are multilobular, compound tubuloalveolar
glands which are present in most mammals. They are located near the bulb of the penis and
are connected to the urethra by a duct. The alveoli of the ducts are lined with mucous-like
cells and the ducts by a single layer of cuboidal/squamous cells (Setchell et al., 1994).
1.4 Fluids of the Male Reproductive System
All of the cells within the testis, epididymal duct system and accessory organs are bathed in a
tissue specific fluid creating specific environments for the immature and maturing
spermatozoa. This fluid varies in composition in the different regions of the male
reproductive tract and provides a continuously changing environment for the developing germ
cells in the testis and for their maturation in the epididymis.
1.4.1 Interstitial Fluid of the Testis
The outside of the seminiferous tubules and the surrounding interstitial tissue are bathed by
interstitial fluid (IF). Within the testis the capillaries have a high vascular permeability with no
apparent restriction to the passage of proteins into IF (Setchell et al., 1994) and the protein
concentration of IF is similar to blood plasma. The volume of IF is reduced in prepubertal rats
after hypophysectomy and oestradiol treatment (Widmark et al., 1987).
Interstitial fluid is collected by making an incision in an isolated testis and letting the fluid drip
into a container (Setchell et al., 1994). The drip technique demonstrated almost 10 times
higher levels of androgen binding protein (ABP) compared with testicular venous blood
(Turner et al., 1984) and about 100 times as much arginine vassopressin (AVP) (Pomerantz et
al., 1988). This technique, found IF high in potassium and testosterone in comparison to
blood plasma but other techniques, such as using an ion-sensitive microelectrode to measure
ion concentrations directly in the testis of an anaesthestised rat, found no difference in
potassium concentrations between IF and plasma (Setchell et al., 1994). Measurements of the
concentrations of ions and proteins in IF will vary widely depending on the method used to
both collect samples and measure a parameter.
1.4.2 Seminiferous Tubule Fluid (STF)
The Sertoli cells of the testis secrete seminiferous tubule fluid (STF). This secretion is
probably a constitutive function of the Sertoli cell but it is only evident after the development
of Sertoli cell junctions and the formation of a lumen within the seminiferous tubules (Shaipe,
1994). These changes within the seminiferous tubule occur around puberty and prior to the
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onset of the first meiotic division during the first wave of spermatogenesis. It is at this time
that the Sertoli cells cease replicating and undergo several maturational changes. One of these
changes involves the formation of tight junctions between adjacent Sertoli cells which is often
referred to as the blood-testis-barrier. This barrier serves at least two functions. First, it
allows the formation of an adluminal compartment within the seminiferous tubule allowing the
maintenance of a separate, controlled environment around the meiotic and post meiotic germ
cells. Secondly, as postmeoitic cells are haploid, they would be detected as 'foreign' by the
body's immune system, the barrier prevents the entry of immune cells (i.e. macrophages)
which could detect haploid-specific antigens. In rats, a barrier to the entry of macromolecules
was noted in the majority of tubules on postnatal days 15 and 16 and was completely formed
in all tubules prior to postnatal day 18 attaining adult characteristics by day 22 postnatal
(Russell et al., 1989).
The appearance of the Sertoli cell barrier occurs at around the same time as lumen formation
within the seminiferous tubule. Sertoli cells can secrete STF both apically and basally,
although the bulk is secreted apically (Setchell et al., 1978), (Setchell, 1978). The barrier
channels the secreted STF and presumably causes a rise in hydrostatic pressure due to the
increased fluid secretion and induces lumen formation. STF flows down the seminiferous
tubules driven by the fluid pressure caused by secretion and/or the contraction of the
peritubular myoid cells (Clermont, 1958). In rats, some developing seminiferous cords show
lumen formation as early as postnatal day 10 and lumen diameter increases slowly until day
30 and then rapidly until day 70 (Jegou et al., 1983; Russell et al., 1989; Setchell, 1970).
Efferent duct ligation has been used to detect STF production in neonatal animals (Jegou et
al., 1982). By this technique, STF was not detected prior to day 15 postnatal and rose rapidly
after day 20 coincident with the prepubertal rise in serum FSH. Rats at 25 days of age were
administered a subcutaneous injection of either FSH, LH, testosterone propionate, hCG
(human chorionic gonadotrophin) or prolactin at the time of efferent duct ligation. A
significant rise in STF was only observed after FSH treatment in neonatal animals (Jegou et
al., 1982). Around puberty, the high increase in testosterone production appears to make
many testicular functions more responsive to testosterone and less responsive to FSH. In the
adult rat, the production of STF is thought to be controlled by testosterone levels and the
presence of elongate spermatids (Sharpe, 1994). Efferent duct ligation was used in adult rats
to examine STF production before and after hypophysectomy (Jegou et al., 1983). Forty
eight hours after hypophysectomy there was a significant (26%) fall in STF production, and
by 16-44 days, STF production was at 15% of control animals. Another set of animals were
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treated four days after hypophsectomy for 3 days with either LH, FSH, testosterone
propionate, or FSH plus testosterone propionate (Jegou et al., 1983). STF production was
restored in rats treated with LH, testosterone propionate or testosterone propionate
administered with FSH (Jegou et al., 1983). When these treatments were administered to
intact rats only LH significantly increased STF production (testosterone propionate failed to
reach significance). These results suggest that in the adult rat STF production is regulated by
testosterone secreted by the Leydig cells in response to stimulation by LH (Jegou et al.,
1983).
The rate of STF secretion (as measured by electrophysiology) is 21pl/hour/testis in adult rats
(Setchell, 1970). The rate of fluid secretion can be reduced by cooling the testis or removing
glucose and potassium from the bathing medium (Setchell et al., 1994). The formation of
STF has been proposed to occur by several mechanisms. Setchell (1969), proposed that
solutes are pumped by Sertoli cells from the interstitial fluid into the intercellular spaces above
the occluding junctions of the seminiferous epithelium. This would cause a hypertonic fluid
in the intercellular spaces and fluid would be drawn in to restore osmolarity. Fluid would then
flow along the intercellular spaces into the seminiferous tubule lumen (Setchell, 1969). This
hypothesis remains unproven. Another mechanism of STF formation was put forward by
Waites and Gladwell (Waites and Gladwell, 1982). Their hypothesis was based on the
identification of Na+/K+-ATPase pumps within the basal membrane of the Sertoli cell.
Sodium ions were proposed to diffuse into the Sertoli cell and were pumped back into the
interstitium and exchanged for a K+ which would diffuse into the lumen. Bicarbonate ions are
also thought to be involved as carbonic anhydrase inhibition decreases the secretion of STF.
The movement of ions would induce the formation of an osmotic gradient and water would be
drawn into the seminiferous tubules. Sertoli cells cultured in vitro have been shown to
secrete over 100 proteins into STF but less than 30 have been identified (Bardin et al., 1994).
These can be classed as transport binding proteins (androgen binding protein, sulphated
gycoprotein-2, transferrin, ceruloplasmin), proteases (cyclic protein-2, plasminogen activator)
hormones (inhibin B, activin) and energy metabolites (lactate, pyruvate and a-keto acids).
Androgen binding protein (ABP) is a heterodimeric glycoprotein with a molecular weight of
85-90 KDa. It is comprised of two subunits H (47 KDa) and L (41 KDa), which have been
shown to be present in the isolated native molecule in a ratio of 3:1 (Larrea et al., 1981). ABP
has a high affinity for both testosterone and dihydrotestosterone and it is regarded as a carrier
protein for these steroids. ABP is secreted bidirectionally but 67% is secreted apically into
the lumen of the seminiferous tubules and transported through the rete testis, efferent ducts
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and into the epididymis (Bardin et al., 1994) Immunocytochemical methods demonstrate that
ABP is endocytosed in the efferent ducts and the proximal region of the epididymis (Bardin et
al., 1994).
After the initiation of spermatogenesis, STF bathes the developing germ cells and transports
the released spermatozoa to the epididymis. STF forms the basis of the fluid which bathes the
spermatozoa throughout their maturation and passage through the rete testis, efferent ducts,
epididymis and vas deferens. The composition of this fluid is constantly modified by these
various regions of the excurrent duct system (presumably to provide an optimal environment
for maturation and storage). It is important to understand the composition of this fluid as it is
may give us some insight into what are the important factors required for germ cell
development. Also, by comparing fluids from different regions of the excurrent duct system
the ions, proteins, or hormones that have been resorbed or secreted in a particular region can
be determined. This will aid understanding of the functions of these tissues and the process
of sperm maturation. The alterations in ion and protein composition between the fluids of the
seminiferous tubules, rete testis and cauda epididymis are compared in Section 1.4.5.
1.4.3 Rete Testis Fluid (RTF)
Rete testis fluid (RTF) has a different ionic and protein composition from that of STF
(Setchell et al., 1994). RTF is much easier to sample than STF and can be collected using
catheters either chronically implanted in large animals (rams, bulls, boars) or acutely in small
animals (rats, rabbits, wallabies) (Setchell et al., 1994). The fluid is a suspension of immature
spermatozoa at a concentration of -30 million/ml in rats (Setchell et al., 1994). The ionic
composition is different from blood plasma, testicular interstitial fluid and STF (see Tables 1
and 2) and it contains more chloride and less bicarbonate than any of the other fluids. Rete
testis fluid contains very little protein (~lmg/ml) suggesting that it may be resorbed by the
epithelial cells of the rete testis (Hinton and Keefer, 1983). The level of androgen binding
protein is similar to that of STF, however the level of transferrin is about one third of the level
in STF but this is still almost 75 times the level detected in blood plasma (Sylvester and
Griswold, 1984; Turner et al., 1984). Serum albumin comprises between 11-17% of RTF
protein (Skinner et al., 1987). The level of testosterone gradually decreases between
interstitial fluid (150 ±27 ng/ml), STF (91 ±14ng/ml) and RTF (33 ±3ng/ml) but the level of
the metabolite DHT is higher in RTF (Comhaire and Vermeulen, 1976) (Turner et al., 1984).
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1.4.3.1 Endocytosis in the Rete Testis of the Rat
Determining whether the rete testis epithelium is capable of endocytosis and/or exocytosis
would aid understanding of how the differences in the fluid composition between STF and
RTF was achieved. The endocytotic functions of the epithelial cells has been determined by
examining ultrastructural changes using electron microscopy after the injection of electron
dense tracers. Using CF and HRP Morales et al.( 1984) demonstrated that both fluid phase
and absorptive endocytotic pathways are active in the rete testis epithelium. Binding of CF
was observed at the apical plasma membrane and in underlying vesicles 1-5 minutes after
injection. Within 1-2 hours some tracers were internalised into lysosomes while other tracers
were transported through the cells and found in intercellular spaces or at the base of the cells
(Morales et al., 1984).
1.4.4 Efferent Duct Fluid
RTF passes through the efferent ducts into the epididymis. This creates the initial source of
epididymal luminal fluid. The efferent ducts are known to be the major site of fluid resorption
in the excurrent ducts. Winet (1980) proposed a mathematical model which predicts that the
flow of fluid through the efferent ducts is based on a cilio-peristaltic model. The main
contributor inducing fluid movement is peristaltic action while the cilia induce reflux and
reduce the flow rate (Winet, 1980). The mechanism of fluid resorption within the efferent
ducts has often been inferred from studies carried out on the caput epididymis as this region
is easier to cannulate. Whether the same mechanisms of fluid resorption are working at both
these sites remains to be determined but there are proteins which are expressed in the efferent
ducts that are involved in fluid uptake which are not present in the epididymis, e.g. Aquaporin-
1 (Brown et al., 1993). In the caput epididymis, fluid resorption is energy-dependent and can
be modified by hormones (Setchell et al., 1994).
Efferent duct fluid can be examined by in vivo micropuncture and microperfusion. These
techniques are used to compare the fluid composition between the rete testis and epididymis to
determine the changes which occur on transit through the efferent ducts. Between the rete
testis and the end of the efferent ducts in the rat, spermatozoa are concentrated by a factor of
25 fold from 2.24 xl04/gl to 6.00 x 105/jnl, indicating that 96.2% of the fluid entering the
efferent ducts is reabsorbed (Clulow et al., 1994). Microperfusion studies have demonstrated
that the rate of fluid resorption is dependent on luminal flow rate (Clulow et al., 1996). The
principal solutes in luminal fluid are Na + (137-144mM), CI" (113-130mM) and, K+(13.5 ±
2.4 mM) (Clulow et al., 1994; Man et al., 1997). Osmotic pressure did not vary along the
ducts or differ significantly from blood plasma (301-307 mosmol/kg) (Clulow et al., 1994) or
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rete testis fluid (311.2 ±1.7) (Man et al., 1997). This demonstrates that the efferent ducts
reabsorb the majority of the testicular output of water and inorganic electrolytes, and most of
the protein. It is the epididymis, rather than the efferent ducts which is responsible for the
accumulation of specific organic compounds such as inositol (Clulow et al., 1994).
1.4.4.1 Ion and Water Transport
One of the major functions reported for the efferent ducts is fluid resorption. The exact
mechanisms involved in fluid resorption are not clearly understood. Two main proposals have
been suggested to explain fluid resorption. One is that it occurs secondary to ion transport via
the action of the Na/K-ATPase. An ATP-dependent Na7K+ pump has been immunolocalised
to the rat testis, efferent ducts and epididymis (Ilio and Hess, 1992). The staining pattern was
found to be most intense in the basolateral region of the cells but there was no
immunostaining reported on the apical plasma membranes. Studies that have used a specific
inhibitor of the Na-pump (ouabain) decreased fluid resorption by 50%. This suggests that
this an important mechanism, but not the only route involved in fluid resorption from the
efferent ducts. Castration has also been shown to inhibit Na+ and water transport but this
effect was reversed after the administration of testosterone. This suggests the process is
steroid dependent. The other hypothesis is that fluid is taken into the cells by endocytosis
which would allow water to enter the cell along with ions and other macromolecules. Water
could be used by the cell in reactions with carbonic anhydrase or in other processes, while the
remainder exits the cell by an unknown mechanism (Hamilton, 1975). In 1993, a water
channel protein, CHannel forming Integral membrane Protein of 28 KDa (CHIP28),
subsequently renamed Aquaporin-1, was localised to the efferent duct epithelium (Brown et
al., 1993). This channel may also prove to be important in fluid resorption across the efferent
duct epithelium.
Various studies have used different techniques to explore the function of the efferent ducts by
determining what enzymes and receptors they express. The efferent ducts have been found to
be rich in carbonic anhydrase, Na+/K+-ATPase and various steroid receptors. Carbonic
anhydrase has been localised to the efferent ducts of the rat and bull (Cohen et al., 1976;
Goyal et al., 1980). The secretion of hydrogen ions causes the pH of a solution to be
lowered as occurs in the stomach; conversely in the pancreas the secretion of bicarbonate
causes the fluid to become more alkaline (Ilio and Hess, 1994). The pH of the fluid within the
efferent ducts changes as it passes through to the epididymis. In fact, between the rete testis
and the caput epididymis the pH of efferent duct luminal fluid becomes substantially more
acidic (lowering from pH 7.2 - 6.4) suggesting that carbonic anhydrase is one component
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used to induce luminal acidification within the efferent ducts by the production of hydrogen
ions (Levine and Marsh, 1971).
1.4.4.2 Does the Renin-Angiotensin System (RAS) regulate fluid and electrolyte
balance in the efferent ducts?
There have been many reports that components of the renin-angiotensin system (RAS) are
present in different regions of the male reproductive tract. This system will be briefly
reviewed along with the evidence supporting its role in male reproduction and with particular
attention to evidence surrounding its involvement in efferent duct fluid resoiption.
The renin-angiotensin pathway is active in the kidney and regulates water and electrolyte
balance. One of the major players in this system is aldosterone which is a mineralocorticoid
secreted by the zona glomerulosa of the adrenal cortex. Aldosterone acts on the distal
convoluted tubule of the nephron when blood pressure is low and induces the juxtaglomerular
cells of the kidney to secrete renin. Renin is an enzyme which converts angiotensinogen (a
component of the a2-globulin fraction of plasma proteins) to the decapeptide angiotensin I in
the circulation. A second enzyme, angiotensin converting enzyme, cleaves two amino acids
from the carboxy terminus of angiotensin I to produce angiotensin II, an active octapeptide
hormone (Vinson et al., 1995). Angiotensin II causes constriction of the efferent arterioles
that lead away from the glomerulus and increase blood pressure. Angiotensin II can also
stimulate the production of aldosterone from the adrenal gland. Aldosterone increases the
resorption of water and Na+ by the distal convoluted tubules and collecting tubules. The
resoiption of Na+ into the peritubular blood induces the movement of CI" and HC03 to
maintain the electrostatic balance. High levels of K+ in extracellular fluid have also been
shown to induce aldosterone secretion by the adrenals (Tortora and Anagnostakos, 1990).
The efferent ducts have been studied to determine whether fluid and electrolyte resorption is
controlled by adrenal mineralocorticoids (Man et al., 1997). Testicular fluid output and fluid
flow from the efferent ducts were determined in rats ten days after adrenalectomy ±
aldosterone administration or in sham operated controls. Fluid output was also assessed in
rats given the aldosterone antagonist spironolactone for ten days. In sham operated rats
testicular fluid output was 36.0 ±7.8 pl/h and fluid flow from the efferent ducts was 1.23
±0.12 gl/h. This resulted in a fluid resorption of 94.8% of the testicular output by the efferent
ducts. None of the treatments altered the rate of testicular output or the rate of fluid resorption
nor did they alter the osmolality or electrolyte concentrations. Like the homologous proximal
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tubule of the kidney, fluid resorption in the efferent ducts is independent of adrenal
mineralocorticoid control (Man et al., 1997).
Exactly what role/s the components of the renin-angiotensin system play in male reproductive
physiology is unclear. Renin (prorenin) mRNA has been isolated from rat and mouse testes
and localised to the Leydig cells in rats and humans (Vinson, et al., 1997). Angiotensin
Converting Enzyme (ACE) has been localised to the testis and efferent ducts which are
considered sites of angiotensin I synthesis (Holbrugger et al., 1982). The ACE isozyme in the
testis is found in Leydig cells and developing spermatozoa and has also been located in the
epididymis (Vinson et al., 1997). Ligand binding studies and autoradiographic studies have
revealed Angiotensin II receptors in Leydig cells and evidence indicates that angiotensin II
may be involved in regulating androgen secretion as it inhibits cAMP and testosterone
responses to human hCG (Vinson et al., 1997). In females, angiotensin II has been shown to
stimulate ovarian oestrogen production (Speth and Husain, 1988) and treatment with an
angiotensin II antagonist (saralasin) can inhibit ovulation in perfused rat ovaries (Peterson et
al., 1993). Functional receptors for Angiotensin II have been localised to the epididymis and
spermatozoa (rat and human) but their role within the male reproductive system is not clear
(Grove and Speth, 1989). Some authors have suggested that they may be important factors in
the regulation of sperm motility (Vinson et al., 1995), spermiogenesis and the contraction of
the epididymal smooth muscle cells (Ilio and Hess, 1994), while others suggest they are
involved in electrolyte and fluid flux across the epithelium (Vinson et al., 1997; Wong and
Uchenda, 1990).
1.4.5 Epididymal Fluid
Many studies have shown that there are large differences in the concentrations of inorganic
and organic compounds between epididymal luminal fluid and blood, supporting the
hypothesis of a functional blood-epididymal barrier (Crabo and Gustafsson, 1964). The
luminal compartment is composed of water, ions, small organic molecules, proteins,
glycoproteins and spermatozoa. The composition of this fluid is constantly changing as it
travels through the excurrent duct system. Specific proteins have been shown to be
endocytosed from the epididymal lumen. ABP has been localised to the cytoplasm of
principal cells within the efferent ducts and proximal segment of the caput epididymis
(Attramadal et al., 1981; Pelliniemi et al., 1981). Other proteins such as a-2 macroglobulin
and transferrin are internalised by receptor-mediated endocytosis (Robaire and Hermo, 1988).
Many ions and small molecules have also been shown to be secreted by the cells of the
epididymal epithelium. Potassium and phosphate are secreted, as are carnitine, inositol and a-
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glycerylphosphorylcholoine. Micropuncture studies have demonstrated that the level of
sodium decreases between the efferent ducts and caput epididymis. Similarly, the level of
chloride falls between the caput and cauda whereas the concentration of potassium increases
in the luminal fluid in all regions of the epididymis (Jenkins et al., 1980). Ion transport
across the epididymal epithelium is thought to be dependent on the presence of testosterone as
is the synthesis and secretion of epididymal glycoproteins (Wong and Yeung, 1978).
Micropuncture has also been used to measure the pH of the luminal fluid and showed that
there was a gradual luminal acidification on passage through the epididymis (Levine and
Marsh, 1971). The pH of seminiferous tubule fluid was found to be pH 7.31 and this was
reduced to 6.48 in the distal caput epididymis (Levine and Marsh, 1971). Luminal
acidification indicates the existence of ion channel proteins in the epididymal epithelial
membranes. Two apical proteins, Na/H exchanger and H+-ATPase have been implicated in
luminal acidification. The immunoexpression of these two proteins in the efferent ducts of
control and neonatally oestrogen treated animals will be addressed in Chapter 6.
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1.4.6 Comparison of Fluid Compositions in Compartments of the Male Reproductive
Tract
The following tables illustrate how the ionic composition (Table 1.1) and the concentration of
low molecular weight organic compounds (Table 1.2) changes along the reproductive tract in
STF, RTF and fluid sampled from the cauda epididymis.
Table 1.1 The Ionic Composition(mM) of Fluids of the Rat Male Reproductive
System
Na+ k+ Caz+ Mg"+ ci hpo42 hco3
stf 108 50 0.44 1.2 120 <0.1 20
±7 ±5 ±0.02 ±0.18 ±5
rtf 143 14 0.81 0.39 140 <0.1 21
±4 ±1 ±0.09 ±0.09 ±2
Cauda 26 47 0.18 1.1 24 13 6.7
(15-37) (43-55) (0.11-0.25) (0.9-1.3) (20-27) (9.5-
16)
Data from (Setchell et al., 1994). The values are shown are means with either ± the standard
error margin or with the range of values shown in parentheses.
Table 1.1 illustrates the increasing concentration of both Na+ and Ca2+ from STF to RTF
whereas the concentrations of K+ and Mg2+ decrease. The levels of CI", HP042", HC03"
remain unchanged between these two fluids. Fluid analysed form the cauda epididymis
shows large reductions in Na+, CI" and Ca2+ while F1P042" and HCOf are increased. Both K+
and Mg2+ show levels similar to those recorded for STF.
Table 1.2 The Concentration of Low Molecular Weight Organic Compounds and
Total Protein(mg/ml) in Fluids of the Rat Reproductive System





STF <1 1.8 <1 <0.1 <0.1 6
RTF <0.1 2.5 <1 <0.1 <0.1
Cauda 31 54 32 20 32
Data from (Setchell et al., 1994)
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The concentration of low molecular weight organic compounds also varies throughout the
fluids of the reproductive system (Table 1.2). The level of inositol is greatly increased
between STF and the fluid of the cauda epididymis as are carnitine, glycerophosphocholine,
phosphocholine and total protein levels. Understanding how these changes in ions and
proteins are controlled would aid understanding of both epididymal function and the process
of sperm maturation.
1.5 Physiological Control of the Male Reproductive System
The physiological control of reproduction is maintained at many different levels. The
reproductive system is part of the endocrine system and has control centres within the
hypothalamus and pituitary gland (hypothalamo-pituitary axis) which includes a classical
negative feedback system. There are also local control loops involving paracrine and autocrine
signals which maintain organ/cell homeostasis, especially within the testis. The major
hormones that control reproduction are Gonadotrophin Releasing Hormone (GnRH),
Luteinising Hormone (LH), Follicle Stimulating Hormone (FSH), testosterone and inhibin.
GnRH is secreted from the terminals of hypothalamic GnRH neurons and interacts with
specific GnRH receptors in the gonadotroph cells of the pituitary. The gonadotrophs release
two hormones, FSH and LH, which are both important in regulating gonadal function. LH
acts via specific receptors on the interstitial Leydig cells of the testis to stimulate production of
the steroid, testosterone. FSH acts on specific receptors on Sertoli cells and there is some
debate as to whether spermatogonia also have specific receptors for FSH (Baccetti et al.,
1998; Rannikko et al., 1996). One of the products induced after FSH stimulation of the
Sertoli cell is inhibin B (Byrd et al., 1998).
The importance of the gonadotropic hormones is evident after the administration of a GnRH
antagonist. Spermatogenesis is suppressed when the release of LH and FSH is inhibited.
This suggests also that non-gonadotrophic hormones are unlikely to be able to maintain
spermatogenesis in mammals (Weinbauer and Nieschlag, 1993). However, there are receptors
for other pituitary hormones within the testis. Receptors have been identified for prolactin
(PRL), growth hormone (GH), thyroid stimulating hormone (TSH) and ACTH. Both PRL
and GH can increase the number of LH binding sites on Leydig cells. The mechanisms of
action of testosterone and FSH on spermatogenesis are not known.
Testosterone is synthesised by the Leydig cells from cholesterol or acetyl coenzyme A and it
diffuses into the interstitial fluid and blood stream. As the blood circulates the increased level
of testosterone is detected at the level of the hypothalamus which inhibits the secretion of
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GnRH from the hypothalamus and subsequently reduces LH release from the pituitary. The
levels of LH secreted into the blood stream will also be detected by the hypothalamus and
influence the level of GnRH released by the hypothalamus. Once the level of testosterone
falls beneath a certain level the release of GnRH by the hypothalamus is no longer inhibited.
In a similar way, the other gonadotrophin, FSH is also controlled by a negative feedback loop.
FSH acts via specific receptors on Sertoli cells within the seminiferous tubules of the testis
resulting in increased secretion of inhibin B which is important in the negative feedback
regulation of FSH at the pituitary level. Increased levels of inhibin in the circulation are
responsible for decreasing the level of FSH released by the anterior pituitary. This feedback



















Figure 6 Demonstrating the Levels of Physiological Control Within the Reproductive
Axis
Modified from (Tortora and Anagnostakos, 1990).
1.5.1 The Hypothalamus
The physiological control of reproduction is influenced by the central nervous system (CNS),
particularly by the secretions of the hypothalamus. The hypothalamus is a small region at the
base of the brain and lies immediately above the pituitary gland. The third ventricle separates
the hypothalamus into two symmetrical halves. The hypothalamus contains many small areas
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with dense aggregations of neurons called hypothalamic nuclei (Johnson and Everitt, 1995).
These nuclei are involved in the hypothalamic regulation of many diverse functions such as
sexual behaviour, thermoregulation, ingestive behaviour and integration of autonomic activity
(Johnson and Everitt, 1995). The centres involved in the control of reproduction are the
supraoptic, paraventricular, arcuate, ventromedial and suprachiasmatic nuclei. These
hypothalamic regions have either a direct neural or an indirect vascular link to the pituitary
gland. The posterior pituitary secretes hormones (vasopressin and oxytocin) directly into the
systemic circulation from axon terminals arising from large magnocellular neurons (Riskind
and Martin, 1989). The cell bodies of these neurons arise in the supraoptic and paraventricular
nuclei and their axons project directly into the posterior pituitary. In contrast, the
hypothalamus communicates with the anterior pituitary via a vascular connection. The
hypothalamus secretes releasing (and release inhibiting) hormones into a specialized portal
system via the axon terminals of small parvocellular neurons. These neurons terminate in the
precapillary space of the median eminence (infundibulum) (Riskind and Martin, 1989). The
portal system arises at the base of the median eminence in a vascular band that is continuous
with the pituitary stalk (Riskind and Martin, 1989). Hypothalamic releasing hormones are
secreted into this closed portal system to reach the anterior pituitary.
1.5.1.1 The Hypothalamic Hypophysiotrophic Hormones
The hypothalamus secretes many hormones important in endocrine control (e.g. thyroid-
releasing hormone, corticotrophin-releasing hormone) but the major hormone which controls
reproduction is Gonadotrophin Releasing Hormone (GnRH). GnRH is secreted by the
parvocellular neurosecretory cells of the hypothalamus into the portal system of the pituitary.
It then interacts with GnRH receptors on the surface of the gonadotroph cell to stimulate
gonadotropin synthesis and release and stimulate target gene expression. GnRH is a
decapeptide with a short half-life of between 5 and 7 minutes (Lincoln, 1989). The protein is
not synthesized in its mature form but as a precursor molecule 92 amino acids long. This
protein comprises a signal sequence which joins directly with the active hormone. GnRH
(and subsequently LH) are secreted in pulses at the rate of about one an hour thus they are
termed circhoral pulses. The pulse generator resides in the arcuate nucleus of the mediobasal
hypothalamus (Johnson and Everitt, 1995). This pulsatile release is essential for the secretion
of FSH and LH. Continual stimulation with GnRH would result in continuous occupancy of
the GnRH receptor sites which would lead to their desensitization and internalisation by the
gonadotroph leading to the down regulation of gonadotrophin secretion (Johnson and Everitt.
1995).
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1.5.2 The Pituitary Gland
The pituitary lies outside the brain directly beneath the hypothalamus. It sits in the
hypophyseal fossa of the sphenoid bone overlain by a fold of dura mater (diaphragma sellae)
which has a central opening through which the pituitary stalk runs. The pituitary gland has
three lobes, the anterior lobe (adenohypophysis), the posteior lobe (neurohypophysis) and the
intermediate lobe which is a small division of the anterior pituitary. The anterior pituitary is
the region that houses gonadotroph cells which respond to GnRH, therefore this region will
be discussed further.
1.5.2.1 The Anterior Pituitary
The anterior pituitary comprises glandular epithelial cells which synthesize and package
hormones into secretory vesicles that are then released into nearby fenestrated capillaries
(Page, 1988). The pituitary is composed of several different cell types which are specialised
for the secretion of different hormones: lactotrophs (secrete prolactin), thyrotrophs (secrete
thyroid stimulating hormone), gonadotrophs (secrete Follicle Stimulating Hormone (FSH)
and Luteinsing Hormone (LH), somatotrophs (secrete growth hormone) and corticotrophs
(secrete adrenocorticotropic hormone (ACTH) and melanocyte stimulating hormone). The
gonadotrophs are the major players controlling the reproductive axis and secrete their
hormones in response to GnRH pulses from the hypothalamus. The majority of the
gonadotrophs synthesize both LH and FSH whilst about 20% of the cells secrete either FSH
or LH but not both. The hormones are glycoproteins composed of an a and p subunit. The a
chain is identical between TSH, LH, hCG and FSH, but the p chain is hormone specific. Once
secreted into the systemic circulation the gonadotrophins act at their target organs, the gonads,
to induce biological responses, including the production of sex steroids. In the male, LH acts
on Leydig cells within the interstitium of the testes to induce the production of testosterone.
Testosterone performs many biological functions within the testis and excurrent duct system
and also acts as a feedback molecule to regulate the secretion of GnRH and LH as shown in
Figure 1.6. Levels of FSH can also be partially altered by testosterone levels but a more
complete suppression is induced by the Sertoli cell product inhibin B (Pierik et al., 1998).
1.5.3 The Testicular Feedback Hormones Inhibin B: a useful marker of
spermatogenesis?
Inhibins are polypeptide glycoproteins which are related to the TGF-p family and have been
implicated in the control of spermatogenesis by exerting negative feedback on FSH secretion
(Byrd et al., 1998) or perhaps via paracrine effects within the testis. Inhibin is composed of
an a-subunit which is linked by disulphide bridges to one of two highly homologous p-
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subunits (A and B). This determines the formation of either inhibin A (a-PA) or inhibin B (a-
PB). The p-subunits show some homology with the TGF-p superfamily (Halvorson and
DeCherney, 1996).
In humans in the immediate neonatal period there is an increase in hypothalamic-pituitary
function which results in a transient increase in gonadotrophin levels and gonadal steroid
production. These levels decline over the next few years (Halvorson and DeCherney, 1996).
The trend is mirrored by the level of inhibin B. In male infants, serum levels of inhibin B
(inhibin A levels are not measurable) are in the adult male range and decrease again until
puberty (Anderson et al., 1998). Inhibin levels subsequently rise progressively, roughly
corresponding to the stage of puberty and increases in sex steroid production (Halvorson and
DeCherney, 1996). A similar trend in production of inhibin B has recently been observed in
the rat (Sharpe et al., 1999). The neonatal increase in inhibin B in rats and humans coincides
with the period of Sertoli cell replication. Decreasing the number of Sertoli cells via
administration of a GnRH antagonist causes corresponding reductions in both inhibin B and
FSH (Sharpe et al., 1999).
Prior to puberty in humans, Sertoli cells produce both the alpha and beta subunits of inhibin.
A recent study has described that during puberty the expression of the p-B subunit changes
to germ cells whilst Sertoli cells retain the expression of the a-subunit (Anderson et al.,
1998). This might suggest that both Sertoli cells and germ cells (pachetyne spermatocytes to
early spermatids) contribute to inhibin B secretion. These studies require further confirmation
but subject to this, in the future, inhibin B could become a useful marker of the activity of the
seminiferous tubules and the efficiency of spermatogenesis (Anderson et al., 1998; Pierik et
al., 1998).
1.5.4 Testosterone
Testosterone is essential for the maintenance of spermatogenesis but how it carries out this
role is not understood. In the testis, testosterone is synthesized and secreted by Leydig cells.
Once synthesized via the steroidogenic pathway it rapidly leaves the cell and enters the
interstitial fluid (Cooke et al., 1972). From here, testosterone can enter either the seminiferous
tubules or the circulation. The amount of testosterone leaving via the bloodstream is
dependent on blood flow (Galil and Setchell, 1987). The concentration of testosterone within
the testis is far higher than the levels within the circulation. The most acurate measurement of
intratesticular testosterone levels can be achieved by measuring the level of testosterone in
testicular venous blood and this level is reduced by 50% as blood passes up the spermatic
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cord through the pampiniform plexus (Maddocks and Sharpe, 1989). By the time the blood
has reached the level of the posterior vena cava the testosterone levels have been reduced by
more than 90% (Maddocks and Sharpe, 1989). The concentration of testosterone in the
spermatic vein is about 250 times more concentrated than levels detected in peripheral venous
serum (Maddocks and Setchell, 1989). Other androgens are also synthesised by the testis and
can also enter the circulation (e.g. androstanediol, androstenedione, dehydroepiandrosterone,
and dihydrotestosterone). The combined concentration of all these other androgens is less
than 15% of the total concentration of testosterone in the spermatic vein and the contribution
of steroids in the blood stream from other steroid producing sources, such as the adrenal
account for less than 5% of the total serum testosterone. Of the testosterone in the circulation,
98% is bound to serum proteins such as sex hormone binding globulin (SHBG), leaving only
2% free.
The potent androgen 5-a dihydrotestosterone (DHT) is also synthesised in the testis and
other regions of the excurrent duct system. DHT is formed from testosterone by the enzyme
5-a reductase. It is 10 times more potent than testosterone and has a 2-fold greater affinity for
the AR as it forms more stable complex on binding, has a low plasma concentration and binds
tightly to plasma proteins. (Grino et al., 1990). Testosterone acts by binding to intracellular
androgen receptors which are present in Leydig cells, peritubular myoid cells and Sertoli cells
of the adult testis. Studies localising AR have shown that expression within the Sertoli cell is
not constant throughout the spermatogenic cycle and AR expression increases in Sertoli cells
during puberty implying that the role of AR in Sertoli cells is more important after puberty
than neonatally (Sharpe, 1994). Similarly, the level of the FSH receptor varies between
different spermatogenic stages but binding studies and mRNA analysis studies give
contradictory results as to which stages display the highest expression and as to whether FSH
receptors are present on spermatogonia (Kliesch et al., 1992).
The production of STF is under the control of testosterone in the adult rat whereas
prepubertally it is under the control of FSH (Au et al., 1986; Free et al., 1980; Jegou et al.,
1982; Jegou et al., 1983). Similar changes are probably true for the secretion of androgen
binding protein and the control of Sertoli cell functions. The Sertoli cell becomes increasingly
less responsive to FSH during puberty and into adulthood (Sharpe, 1994). During the
spermatogenic process, testosterone appears to play a major role in the development or
progression of cells at stages VII-VIII of the spermatogenic cycle of the rat as germ cells at
these stages show increased rates of degeneration when testosterone is removed (Dym and
Madhaw Raj, 1977; Flickinger, 1977; Russell et al., 1981). The cyclical changes in Sertoli
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cells observed during the spermatogenic process are probably manifested by testosterone
acting indirectly (i.e. via the Sertoli cells) on the appropriate germ cell complements (Sharpe,
1994).
1.6 Fetal / Neonatal Development of the Testis and Associated Duct
Systems
The testis develops along the ventral cranial portion of the mesonephros (Byskov and Hoyer,
1994). The initial stage of gonad formation occurs when the primordial germ cells migrate
from the endodermal yolk sac through the hindgut to the coelomic epithelium and the
underlying mesenchyme of the mesonephros. At this time, cells of mesonephric origin are
released and migrate to the coelomic epithelium. This induces the establishment of cell
lineages to support the migrating germ cells (Byskov and Hoyer, 1994).
1.6.1 The Mesonephros
The mesonephros is part of the developing nephric structures. There are three nephric
structures which arise consecutively during mammalian fetal development, these are termed the
pro-, meso, and metanephros (Byskov and Hoyer, 1994). All of these structures arise from
the nephrogenic cord. The pronephros never functions as a kidney in mammals but serves as
an inducer for the development of the meso- and metanephros (Du Bois, 1969). The
nephrons of the mesonephros develop from the nephrogenic cord and form a connection with
the pronephric duct or Wolffian duct. In humans, the mesonephros does act as a kidney
with functional glomeruli but in the mouse the glomeruli are not functional (Grinsted and
Aagesen, 1984). The developing gonads remain connected to the mesonephros through cell
streams attached to the adjacent duct systems (Wolffian and Mtillerian). These cell streams
develop into the rete testis or rete ovarii (Byskov and Hoyer, 1994). Connection with the
mesonephros is required for normal gonad development, as when ovaries are removed from
the mesonephros their differentiation and germ cell development are inhibited (Byskov, 1974).
1.6.2 Coelomic Epithelium
The sexually indifferent gonad consists of coelomic epithelium (germinal epithelium)
underneath which lies mesenchymal tissue. Early in gonadal development the coelomic
epithelium is invaded by capillaries and nervous tissue (Pelliniemi, 1975). In males, it is
delimited by a basal lamina which separates the developing testicular cords. Also the
epithelium and the outermost testicular cords are separated by mesenchymal tissue which
becomes the tunica albuginea (Byskov and Hoyer, 1994). An early event in testicular
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differentiation is the development of a close association between germ cells and somatic cells
(Sertoli cells) leading to the formation of testicular cords. The presumptive Sertoli cells
express the gene Sry and initiate testicular differentiation. The Y chromosome contains a
region containing the testis determining gene Sry (Swain and Lovell-Badge, 1999). In mouse
development Sry is expressed in the genital ridge in males at day 10.5-1 lpc to initiate testis
development. Expression of Sry occurs in a wave from anterior to posterior where it is
thought to trigger the formation of Sertoli cells. Sertoli cells in turn then direct the
differentiation of the other cell types in the testis (Swain and Lovell-Badge, 1999). Sry is
probably involved in the switching on of Miillerian Inhibiting Substance (MIS, also termed
Anti-Mtillerian Hormone (AMH)) by fetal Sertoli cells which then orchestrate male
development. On day 17.5 post coitum the fetal rat testis consists of cords that are simple
arches perpendicular to the axis of the testis connecting to the rete testis (Byskov and Hoyer,
1994). The connection with the rete testis ensures communication with the mesonephric cells
and cells migrate in and contribute to the Sertoli cell, peritubular myoid and Leydig cell
populations. After testicular cord formation the testis rounds up and there is only a thin
attachment with the mesonephric tissue (Byskov and Hoyer, 1994).
After the genu cells (prespermatogonia) have been enclosed in the testicular cords they enter
rounds of mitosis. This creates clusters of cells connected via cytoplasmic bridges which
divide in synchrony. The developing Sertoli cells originate from the coelomic epithelium but
mesonephric cells are also known to contribute to this cell population (Byskov, 1986). Sertoli
cells divide during fetal and neonatal life but this ceases before the onset of spermatogenesis
(Clermont and Perey, 1957; Nagy, 1972). As the testis develops, the prespermatogonia move
from a central to a peripheral location within the seminiferous cords and the Sertoli cell shape
becomes more irregular with cytoplasmic extensions. The Sertoli cells develop desmosomes,
then incomplete tight junctions and small gap junctions (Byskov and Hoyer, 1994). The
steroidogenic capacity of the fetal testis is not well mapped temporally. Androgen secretion
has been detected in fetal guinea pig testes prior to the differentiation of Leydig cells (Byskov
and Hoyer, 1994). Sertoli cells are known to be responsible for the secretion of MIS which
induces the regression of the female anlage, the Miillerian duct (Lovell-Badge, 1992). The
initial secretion of MIS may be switched on by Sry (Lovell-Badge, 1992).
Testicular cord formation precedes Leydig cell differentiation and the Sertoli cell is thought to
drive the formation of the fetal Leydig cell population. Leydig cells divide slowly in fetal life
but a new generation ('adult Leydig cells') differentiate rapidly during puberty (Vergouwen et
al., 1991). The fetal and adult populations of Leydig cells display different characteristics.
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Fetal Leydig cells are found in clumps which are not observed after day 10 in the neonatal rat
and testosterone secretion by the fetal testis is closely correlated with the cytodifferentiation
and an increase in volume and number of the Leydig cells (Picon, 1976; Roosen-Runge and
Anderson, 1959). Leydig cells contain many active steroidogenic enzymes and are capable of
synthesising both androgens and oestrogens.
1.6.3 Formation and Differentiation of the Genital Ducts
The undifferentiated gonad is the same structure in either sex and follows one of two distinct
developmental pathways. However, two sets of internal ducts develop in both sexes as distinct
and separate structures termed, Mtillerian and Wolffain ducts. The two duct systems lie side-
by-side and differentiation depends on gonadal sex. In females, maintenance of the Miillerian
duct is required for normal reproductive tract development (fallopian tube, oviduct, uterus and
upper vagina) while in males, testosterone is required for the stabilisation and development of
the Wolffian duct into the epididymis, vas deferens and seminal vesicles. Prior to the onset of
virilsation the female (Mtillerian) duct has to regress. Sertoli cells secrete MIS which induces
the regression of this duct. In females neither of these hormones are produced. The lack of
MIS prevents regression of the Mullerian duct and the lack of testosterone prevents the
stabilization of the Wolffian duct and therefore it regresses. Female development is often
referred to as the default pathway.
1.6.4 The Undifferentiated Ducts
As mentioned above two ductal systems arise independently. The Wolffian duct develops
from the excretory duct of the mesonephros and is recognisable before gonad formation
whilst the Mullerian (paramesonephric) duct develops along the back of the Wolffian duct in a
cranial-caudal direction at the time the gonad forms (Dohr and Tarmann, 1984). Both of these
duct systems are straight tubules lined with a simple epithelium with cells ranging from
squamous to cylindrical and their differentiation is dependent on epithelial-mesenchyme
interactions. The mesenchyme is probably the target of hormones and growth factors which
then drive the morphogenesis of the epithelium (Cunha et al., 1981).
1.6.4.1 Differentiation of the Wolffian Duct and Urogenital Sinus
The cranial portion of the Wolffian duct develops into the epididymis, the central portion
becomes the vas deferens and the caudal region forms the seminal vesicles (Byskov and
Hoyer, 1994). The rete testis is connected to the Wolffian duct via mesonephric tubules
which develop into the efferent ducts and join the epididymis. The differentiating epididymis
grows in length and becomes highly convoluted. The epithelium is columnar and has many
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apical microvilli. In humans the epithelium is actively secretory during the third trimester of
pregnancy (Zondek and Zondek, 1965). The developing duct becomes surrounded by a layer
of mesenchyme which develops into a layer of smooth muscle cells. This clearly
differentiates the epididymis from the vas deferens as the latter develops a thick layer of
trilaminar muscle (Byskov and Hoyer, 1994).
It is well cited in the literature that testosterone is responsible for the stabilisation of the
Wolffian duct and subsequent development of the excurrent ducts, and that DHT is reponsible
for prostate growth and the masculinization of the external genitalia. Recent evidence
regarding the times and sites of expression of the enzyme 5a-reductase suggest this
interpretation is an over simplification. It is true that during the initial stages of sex
differentiation the synthesis of DHT from testosterone by 5a-reductase does not occur in the
Wolffian duct of embryonic rats, rabbits, guinea pigs or humans, but high levels of 5a-
reductase are observed at later periods (Tsuji et al., 1994).
5a-reductase is undetectable during the stabilisation of the Wolffian duct but it is elevated at
the times when the duct is differentiating into the epididymis, vas deferens and seminal
vesicles (Wilson and Lasnitzki, 1971), (Siiteri and Wilson, 1974). The structures that develop
from the urogenital sinus are known to be dependent on DHT since patients with 5a-
reductase deficiency show poor prostatic development and feminized external genitalia but the
Wolffian duct derivatives develop normally (Wilson, 1992). However, in serum free organ
culture growth and branching morphogenesis of the neonatal mouse seminal vesicle (Wolffian
derived) is dependent on DHT not testosterone (Shima et al., 1990). Furthermore, growth of
the cranial regions of the Wolffian duct can be induced by either DHT or testosterone in vitro
(Tsuji et al., 1991) and in vivo (Schultz and Wilson, 1974). At day 14.5 post coitum (pc) the
different regions of the male reproductive tract are producing various levels of functional 5-a
reductase. The level of functional 5a-reductase was inferred from the concentration of 3H 5-a-
reduced steroids produced from 3H testosterone over the 48h culture period (Tsuji et al.,
1994). After the culture period the fetal testis showed little 5a-reductase activity. The cranial
region of the Wolffian duct (prospective epididymis) had very low 5a-reductase activity
supporting the involvement of testosterone in epididymal development. The level of 5a-
reductase activity gradually increased in a cranial to caudal direction with the developing
Wolffian duct. The region which develops into the seminal vesicles had a higher 5a-reductase
activity than did the developing urogenital sinus at day 14.5 - 16.5 pc.
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Exactly how testosterone and dihydrotestosterone induce the differentiation of the male
reproductive tract is unclear but it undoubtedly involves strong mesenchyme / epithelial cell
interactions. Some studies have shown that prostaglandin E, is able to masculinize the genital
duct of a fetal mouse in in vitro organ cultures and also that Wolffian duct differentiation
could be inhibited by the addition of an antibody against this prostaglandin (Gupta, 1989;
Gupta and Bentlejewski, 1992). This suggests that one mediator of testosterone action could
be prostaglandin E2. The secretion of paracrine factors from the mesenchyme around the
developing seminal vesicles and prostate, such as keratinocyte growth factor, play an important
role in seminal vesicle development and in the growth of both normal and neoplastic prostate
epithelial cells (Tsuji et al., 1994).
1.7 Steroids and the Male Reproductive System
Androgens and oestrogens act within the same tissues of the male reproductive system and
often within the same cells. Oestrogen action is the main concern of this thesis and will be
emphasised here, but the ratio of androgens: oestrogens is likely to be important in oestrogen
action within the male reproductive system, so the sites of androgen action will also be
reviewed (Section 1.7.4).
In order to determine the physiological role of oestrogen in male reproduction it would be
logical to establish where oestrogens act. This can be assessed by determining where radio¬
labeled oestrogen binds, where oestrogen receptors are localised or by determining the
consequences of disrupting the genes involved in either oestrogen synthesis or action. This
section will examine the literature concerning where oestrogens act in the male and the
consequences of abnormal oestrogen action.
1.7.1 Oestrogen Receptor Expression In the Male
Oestrogens and other steroid hormones act by diffusing into the cell cytoplasm and
interacting with specific protein receptors which then dimerise and translocate into the
nucleus. Once in the nucleus, the steroid receptors bind to target DNA and activate or repress
gene transcription. Prior to the identification and sequencing of the oestroegn receptor (ERa)
there were no antibodies available, therefore studies used indirect methods of detection such as
steroid autoradiography to determine where oestrogen (or DES) bound or measurement of the
binding coefficients of oestrogen binding proteins collected from the cytosol after sucrose
gradient density centrifugation. There were a number of conflicting reports within the
literature as to where oestrogen acted in the male reproductive tract. Some studies suggested
that only the efferent ducts expressed ERs while others reported ERs throughout the male
Chapter 1 Literature Review 48
reproductive tract. These controversies were clarified in 1996 when a novel form of the
oestrogen receptor (ER(3) was cloned (Kuiper et al., 1996). This explained why
immunocytochemical studies which only detected ERa produced different results from steroid
autoradiography with labeled oestrogen which detected all oestrogen binding sites. The
historical data regarding oestrogen binding will be reviewed here. The new data regarding
ERp will be introduced in Chapter 3.
The majority of studies have been performed in the mouse and a few studies have examined
fetal expression. Stumpf et al, (1980) injected tritiated DES into pregnant mice on day 16 of
gestation and examined binding in the fetus by autoradiography (Stumpf et al., 1980). They
reported that binding was concentrated in the cell nuclei of certain hypothalamic and extra-
hypothalamic nuclei of the brain, the anterior pituitary, laryngeal mesenchyme, the
mesenchyme surrounding both the Miillerian and Wolffian ducts, the urogenital sinus, rectum,
mammary gland, gubemaculum testis and the skin (Stumpf et al., 1980). Cooke et al. (1991)
examined ER expression in the male fetal mouse reproductive tract from day 16 of gestation
to 10 days postnatal. They found that all fetal reproductive organs expressed mesenchymal
ER (efferent ducts, urogenital sinus, Wolffian duct and epididymis, vas deferens, seminal
vesicles, coagulating glands, prostate and bulbuorethral glands) (Cooke et al., 1991b). The
efferent ducts were the first site of expression in the developing male tract, with epithelial ER
expression present on fetal day 16 and thereafter. The epididymis did not express ER until
fetal day 19. There appeared to be a gradient in epididymal ER expression as the epithelial
cells of the efferent ducts contained 3 times as many silver grains as the more distal regions of
the epididymis (Cooke et al., 1991b). By postnatal day 6 the epithelium of the seminal vesicle
and coagulating gland both expressed ER but the epithelia of the vas deferens, prostate and
bulbourethral glands were never ER positive (Cooke et al., 1991b).
An immunocytochemical study was performed on fetal male mice in 1992 (Greco et al.,
1992). At fetal day 13, ER was detected in both the epithelial and mesenchymal cells of the
Wolffian duct. By day 15, the testis was clearly differentiated and staining was present within
the testicular cords and interstitium. The staining within the fetal duct system was identical to
that on day 13 but was judged to be more intense. On fetal day 17, Leydig cells and possibly
peritubular myoid cells showed positive staining but cells within the seminiferous cords
showed little staining (Greco et al., 1992). Another imunocytochemical study examined
expression of ERa from late fetal life through to adulthood in the rat (Fisher et al., 1997). In
the fetal, neonatal and adult rat testis, only Leydig cells were immunopositive. No
immunostaining was observed within the seminiferous cords/tubules. ERa was found in the
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mesenchyme surrounding the mesonephric tubules but postnatally it was expressed within the
epithelium of the rete testis with the most intense staining occurring in the efferent ducts
(Fisher et al., 1997). Except for sporadic staining within the epididymis during neonatal life
the epididymal duct was negative for ERa (Fisher et al., 1997). A study conducted in adult
macaques determined that the efferent ducts contained a similar amount of ER per mg DNA
as did the oestrogen-treated endometrium and oviducts (West and Brenner, 1990). In adult
goats the only site of ER expression detected by immunocytochemistry was the nonciliated
cells of the efferent ducts (Goyal et al., 1997).
The sites of oestrogen action within the epididymis have also been explored by
autoradiography after the administration of tritiated oestradiol (Schleicher et al., 1984). This
study found the highest number of grains in the efferent ducts, initial and caput segments of
the epididymis. In the epididymis there was a higher labeling of clear cell nuclei with
oestradiol than with DHT, suggesting that oestradiol may be important in modulating clear cell
function (Schleicher et al., 1984).
These studies demonstrate the conflicting opinions about sites of oestrogen action within the
male reproductive system. The majority of studies do however agree that the efferent ducts of
the epididymis are the major site of oestrogen action within the male reproductive tract.
1.7.1.1 Oestrogen Receptor Mutations
Early in the 1990s, functional ERs were considered essential for embryonic survival as they
were regarded as essential for implantation and no naturally occurring mutations in the ER
had ever been clinically described. In 1993, however, an oestrogen receptor minus mutant
mouse (ERKO) was described (Lubahn et al., 1993). Both sexes were viable and
phenotypically normal (Lubahn et al., 1993) but they were both sterile (Korach, 1994)
suggesting that oestrogen is essential for normal fertility. Further examination of the male
mice showed ERKO mice had a higher mean testis weight but 3 times lower daily sperm
production and with a higher number of abnormal sperm in cauda epididymal fluid than in
either heterozygotes or wild type mice (Lubahn et al., 1996). In young adult mice (3-5
months) spermatogenesis was occurring in some seminiferous tubules while others were fluid
filled with dilated lumens and a disorganised seminiferous epithelium; still others had only
Sertoli cells present (Eddy et al., 1996). The seminiferous tubule lumens were dilated by day
20 as was the rete testis which was also abnormally extended into the testis (Eddy et al.,
1996).
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A transgenic mouse has also been created which overexpresses estrogen receptor-a (Davis et
al., 1994). This mouse displayed normal differentiation of sexual organs of both sexes and
there were no major fertility problems observed in male mice (Davis et al., 1994). Transgenic
female mice overexpressing ERa displayed prolonged gestation which led to a loss of litters
due to difficulties in parturition (Davis et al., 1994).
A year after the ERKO mouse had been reported the first clinical report of a patient with a
mutated ER was published (Smith et al., 1994). The man was 28 years old, very tall and had
incomplete epiphyseal closure and reduced bone density (3.1 SD below age matched mean).
He underwent puberty normally but his fertility status is unknown. He had elevated serum
oestradiol and oestrone levels but normal serum testosterone. He also had an impaired
glucose tolerance with hyperinsulinaemia (Smith et al., 1994). Oestrogen is essential for both
the development and maintenance of optimal bone mass in both sexes and this effect is
mediated by ERa (Kusec et al., 1998). Oestrogen has been shown to have effects on the
chondrocytes involved in longitudinal growth in epiphyseal growth centres (Kusec et al.,
1998).
1.7.2 Aromatase Expression in the Male Reproductive tract
Another method for assessing the importance of oestrogen in male reproductive physiology is
to examine the sites of aromatase expression. Aromatase is the P450 enzyme responsible for
the conversion of certain androgens into oestrogens. There are very few studies that have
characterized the expression of aromatase within the male reproductive tract. Within the testis,
Sertoli cells of immature males produce oestrogen and aromatase expression is highly
responsive to FSH before puberty (Rosselli and Skinner, 1992). Leydig cells are regarded as
the source of aromatase in the adult testis (Dorrington et al., 1978). Within the epididymis,
aromatase was localised to the clear cells of the corpus and caput epididymis (Janulis et al.,
1996b). The most interesting location of aromatase is in developing spermatozoa both in the
testis and the epididymis. Within the seminiferous tubules, round and elongating spermatids
have been shown by in situ hybridisation and immunoctyochemistry to express aromatase
(Nitta et al., 1993) (Janulis et al., 1996a). As sperm transit through the epididymis the level of
aromatase decreases (Janulis et al., 1998). This suggests that spermatozoa are a source of
oestrogen during their transit through the excurrent duct system. This oestrogen could
interact with ER within the epithelia to alter their maturational environment.
A couple of clinical reports have been described for men with mutations in aromatase. The
clinical phenotype is very similar to the patient described above with a mutation in the ERa
Chapter 1 Literature Review 51
gene. Both cases showed decreased bone density, incomplete epiphyseal closure and
increased serum FSH. One patient had macro-orchidism while the other was oligospermic
(but his other siblings were also oligospermic) (Morishima et al., 1995; Qin et al., 1996).
1.7.3 Animal Models - the effects of synthetic oestrogen exposure
The effects of potent oestrogens such as DES, oestradiol benzoate and ethinyl oestradiol have
been studied in animal models. The effects observed appear to depend on the dose, time and
duration of exposure. Oestrogen could act at several levels within the male reproductive tract.
Oestrogen affects specific neuronal regions in the brain that are important for sexual
behaviour, they modulate gonadotrophin secretion from the pituitary gland, or they can
directly affect the reproductive tract. Oestrogen receptors are present in all of these sites but
there are also reports in the literature suggesting that steroids can interact with cell surface
receptors to induce changes that do not require RNA synthesis (Sadler and Mailer, 1982).
Whether all of these interactions are occurring in the developing gonadal system is not clear.
Administration of sex steroids during perinatal life can have permanent or long lasting effects
in the central and peripheral mechanisms controlling reproduction. Masculinization of the
brain occurs in early neonatal life and is dependent on testicular secretions (Arai et al, 1983).
Removal of the testis results in "feminine males" which secrete gonadotrophins in a cyclical
pattern and display feminine sexual behaviour. In contrast, the female brain can be
masculinized by the neonatal administration of oestrogen or androgen (which is thought to be
aromatised to oestrogen) (Arai et al., 1983). This is known to occur in the sexually dimorphic
nuclei of the preoptic area which is markedly larger in females but can be altered by perinatal
steroid manipulation (Arai et al., 1983). Sexual dimorphism has also been identified in the
hypothalamic arcuate nucleus and the medial amygdaloid nucleus. These changes induce
altered sexual behaviour which in some studies is the cause of infertility.
In rodents detrimental effects on the reproductive tract can be induced with either pre- or early
postnatal injections of oestrogens. Studies have examined the administration of DES to time
mated pregnant mice over days 9-16 gestation (lOOgg/kg maternal body weight) as this covers
the development of the reproductive tract (McLachlan and Newbold, 1975). The fertility of the
male offspring was assessed at 7 months of age, 6/10 males housed separately with two fertile
females failed to impregnate the mice. At 9-10 months the reproductive structures were
assessed post mortem. Testicular abnormalities were recorded in 15/24 animals with six of
these having at least one intra-abdominal testis. DES also appeared to induce the appearance
of multinucleate giant cells within the seminiferous epithelium of scrotal testes. Eight mice
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had epididymal cysts and six of these had testicular lesions. The accessory glands also
displayed several abnormalities such as distension, inflammation and ulcers (McLachlan and
Newbold, 1975).
The major effects induced in animals after DES exposure are abnormal testes with disordered
spermatogenesis, an increased incidence of cryptorchidism, poor semen quality and infertility
(McLachlan, 1981). Oestrogen administration during development appears to interfere with
normal development as males show delayed or incomplete regression of the Miillerian duct
(McLachlan, 1981); this has been verified by in vitro organ culture experiments (Newbold et
al., 1984). Oestrogen receptors have been identified in the Miillerian ducts at the time of
regression (Greco et al., 1993).
Postnatal treatment of rats with p-oestradiol-3-benzoate or clomiphene citrate from birth
delayed the formation of the blood-testis-barrier which is normally formed between 16-19
days until day 24 postnatal (Vitale et al., 1973). When testicular histology was assessed at
days 30 and 60 both compounds induced the appearance of large lumens within the
seminiferous tubules with many exfoliated germ cells present in the luminal fluid. The
authors judged the effects of oestradiol benzoate to be more severe than those induced after
the administration of clomiphene citrate (Vitale et al., 1973). Testicular abnormalities were
also noted in rats which were given a single injection of oestradiol benzoate on postnatal day 5
(Kind et al., 1963). Rats received an injection of either 120, 30 or 10 pg. When treated rats
were housed with fertile females only the rats which had received the lOgg dose sired any
litters (ll/13males) (Kind et al., 1963). When assessed in adulthood, the rats which were
administered 120pg oestradiol benzoate had testis weights which were reduced by more than
50% and the seminiferous tubules demonstrated almost a complete loss of the seminiferous
epithelium except for a group of large tubules in the central region where the seminiferous
epithelium was preserved, but immature germ cells were present in the lumen. The lower
doses of oestradiol benzoate did not induce testicular atrophy and testicular morphology
appeared normal (Kind et al., 1963).
Many studies investigating neonatal oestrogen exposure report bilateral or unilateral
cryptorchidism which may be related to the underdevelopment or lack of the gubernaculum
testis which is thought to aid testicular descent into the scrotum (Arai et al., 1983). Aside
from cryptorchidism, testicular abnormalities are often described including those already
mentioned and interstitial cell hyperplasia and tumours, Sertoli cell hyperplasia and Sertoli cell
carcinoma in situ (Arai et al., 1983). Lesions have also been reported within the epididymis.
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Dunn and Green (1963) reported lesions of the epididymis in more than half the male mice
sampled at 13-16 months after a single injection of 0.1ml of a 2% DES suspension on the day
of birth. Both single and multiple cysts on both epididymides were noted (Dunn and Green,
1963). Warner et al., (1979) reported that epididymal cysts occurred in 70% of mice treated
from days 1-5 postnatal with 50gg oestradiol (Warner et al., 1979). Similar findings have
been frequently observed after DES exposure (Arai et al., 1983). Cyst formation is thought to
be related to the persistence of the Mtillerian duct structures as there is a close association
with increases in cyst formation after exposure to DES (McLachlan, 1981).
1.7.4 Androgens and the Reproductive System
The expression of androgen receptors within the rat fetal testis has been determined by
immunocytochemistry (Majdic et al., 1995). On fetal day 16.5 AR was present in the
mesenchyme surrounding the Wolffian duct but was negative around the Miillerian duct. A
day later, staining was evident within the epithelium of the Wolffian duct. Within the testis
staining was confined to cells of the interstitium and in particular, to the peritubular myoid
cells. These cells did not co-localise with cells expressing 3(3-hydroxysteroid dehydrogenase
and so were not considered to be Leydig cells (Majdic et al., 1995). Sertoli cell staining only
became evident a week after birth (Majdic et al., 1995). An earlier study had used tritiated
DHT to examine AR binding sites by autoradiography during fetal and early postnatal life of
the male mouse (Cooke et al., 1991a). They found that the mesonephric tubules, Wolffian
duct, urogenital sinus and their derivatives all had AR in mesenchymal/stromal cells. The first
site of epithelial androgen receptor expression was the efferent ducts from fetal day 16
onwards. The expression of AR occurred in a cranial - caudal direction and the vas deferens
showed epithelial AR expression on fetal day 19 (Cooke et al., 1991a).
In adult rats, AR expression was immunolocalised to Leydig cells and peritubular myoid cells
of the interstitium (Bremner et al., 1994). Within the seminiferous tubules the Sertoli cells
displayed a stage-dependent pattern of expression. Nuclear staining increased throughout
stages II-VII and declined during stage VIII and was barely detectable within stages IX-XIII
(Bremner et al., 1994). In the adult ram epididymis, AR have been immunolocalised to the
principal cells of the epididymis. The region between the central caput and the proximal
corpus shows the most intense AR staining and is therefore determined to be the most
androgen-dependent (Tekpetey et al., 1989).
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1.7.4.1 Expression of 5a-Reductase
As the androgen receptor can bind either testosterone or DHT it is important to know the sites
of synthesis for the enzyme 4-ene steroid 5a-reductase (5a-reductase) as it catalyses the
formation of this hormone from testosterone.
There are two forms of 5a-reductase (Type 1 and 2). Type 2 5a-reductase is found in most
male reproductive tissues and has 10-15 times higher affinity for testosterone than does type
1. Type 2 has been located to the testis, epididymis and vas deferens, while type 1 was shown
to be more abundant in the seminal vesicles and ventral prostate (Normington and Russell,
1992). Both mRNAs follow a gradient of expression with enzyme levels being higher in the
initial segment of the epididymis and decreasing towards the cauda. This gradient is set up
and maintained during fetal and early neonatal life (Tsuji et al., 1994). Most 5a-reductase
activity in the epididymis is due to Type 2 activity in view of its acidic pH optimum and its
activity at low substrate concentrations (Normington and Russell, 1992). Gene defects in 5a-
reductase type 2 lead to pseudohermaphroditism in humans. These 46, XY males have male
internal urogenital ducts as testosterone acts to stabilize the Wolffian duct but have female
external genitalia as DHT is required for the formation of the male external genitalia
(Andersson et al., 1991). Inactivating mutations of the AR gene results in various degrees of
defective sexual differentiation. At the most severe the complete lack of androgen action
prevents the development of both the Wolffian duct and the external genitalia so the child
appears female but is infertile. As the presence of a testis induces the secretion of MIS the
female ductal system also regresses. The testes generally remain abdominally and are usually
removed due to the fear of malignancy (MacLean et al., 1995).
1.8 Conclusions
With the reported increases in disorders of male reproductive health and analogous changes in
wildlife it seems plausible to consider that some environmental factor(s) might be having a
detrimental effect on reproductive tract development. There are stark similarities between the
changes observed to be increasing in humans and those induced in the sons of mothers
exposed to the potent non-steroidal oestrogen DES in utero. This suggests that substances
that can act like an oestrogen may be involved in the increasing incidence of abnormalities.
Similarly, as many of the conditions are present at birth or have links with events occurring in
utero or neonatally, it suggests that the causative agents may be acting at these sensitive time
points. The role of oestrogen in male reproductive physiology is not understood nor is its
role in fetal development. These basic questions regarding the physiological role(s) of
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oestrogens have to be answered to understand how exogenous oestrogens may disrupt normal
male reproductive tract development.
The experimental work undertaken in this thesis focuses mainly on the efferent ducts of the
male reproductive tract as they have been highlighted as a major target of oestrogen action.
The level of ERa within the efferent ducts is higher than that of the oestrogenised litems and
the discovery of another ER isoform (ER|3) will identify other sites of oestrogen action which
had not been previously considered. The efferent ducts have been shown to be abnormal in
ERKO mice which are also infertile suggesting that oestrogen may be important for normal
fertility. The major function of the efferent ducts is in fluid resorption, therefore it is
important to discover whether any steps of this process are regulated or can be disrupted by
oestrogens.
The experimental chapters of this thesis will be presented as follows; chapter 3 addresses the
sites of oestrogen receptor-p immunoexpression in the marmoset monkey thus fully reviewing
the sites of oestrogen action within the male reproductive tract. Chapter 4 focuses on a
possible mechanism of fluid resorption within the efferent ducts by immunolocalising
Aquaporin-1 from fetal/neonatal life to adulthood in both the rat and marmoset monkey. The
remainder of the experimental chapters focus on the effects of oestrogen and 'environmental
oestrogens' on the male reproductive tract. Chapter 5 examines the consequences of neonatal
oestrogen treatment on the histology of the rete testis. Chapter 6 focuses on the effects
induced in the efferent ducts by examining AQP-1 immunolocalisation, protein levels,
epithelial cell height and general histology. Chapter 7 focuses more specifically on the
epididymis and localisation of potentially oestrogen regulated ion channel proteins. This
chapter first assesses the possibility that CFTR may be modulated by oestrogen. Secondly,
this chapter compares the localisation of two ion channels (Na/H exchanger and H+-ATPase)
before and after neonatal oestrogen exposure to determine whether any markers of epididymal
function have been altered. Finally, Chapter 8 summarises the main findings and conclusions
of the experimental work and suggests several avenues which might lead to further the present
understanding of oestrogen action within the male reproductive system.
Chapter 2 Materials and Methods
2.1 Animals and Animal Welfare
The animals used in these studies were maintained and treated in accordance with Government
guidelines as stated in the Animals Scientific Procedures Act, 1986. Most of the animals used
in these studies were male Wistar rats which were bred and maintained at the MRC
Reproductive Biology Unit animal facility. All rats were maintained under standard
conditions of 12 hour light / 12 hour dark cycle and in an ambient temperature of 21°C.
Male animals from late fetal life through to adulthood were assessed at various time points.
As treatment regimens were implemented from early neonatal life the female pups were
removed from the litters after birth and cross fostered. The male pups were housed with their
mothers until death or weaning on day 22 days. After this time the male pups were housed
together and fed food and water ad libitium. Animals that were not undergoing any further
procedures were killed by CO, inhalation followed by cervical dislocation in accordance with
Schedule 1. Very young neonatal animals (i.e. younger than 18 days) were killed by CO,
inhalation followed by decapitation. Similarly, all fetuses were decapitated after removal from
the mother.
This study also used tissue obtained from marmoset monkeys. All of this tissue was acquired
from tissue stored within the department which arose from other studies. The author is
thankful to Dr Hamish Fraser for the use of this tissue.
2.2 Treatment Regimes and Test Compounds
These studies examine the effects of administering potent oestrogens (DES, ethinyl
oestradiol) and many weakly oestrogenic environmental chemicals. These treatment regimes
involved subcutaneous administration on alternate days from days 2-12 postnatal (inclusive)
or every day until day 18 or weaning. At times this produced a hectic injection schedule so
the help of Drs Richard Sharpe and Katie Turner is duly noted.
2.2.1 Diethylstilboestrol (DES)
DES is a well known potent synthetic oestrogen which is known to mimic the action of
oestrogen in vivo. This compound was used as the principal positive control treatment to
assess the effects of high dose oestrogen. Cohorts of animals were set up and administered
DES (Sigma, Poole, Dorset, UK) at doses of lOpg, lgg or 0.1 pg in 20pL of corn oil. The
neonatal rats were subjected to sub-cutaneous injections on alternate days from day 2-12
inclusive (i.e. six injections).
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2.2.2 Ethinyl Oestradiol (EE)
The treatment regime for EE (Sigma) was identical to that for DES except that only one dose
(10gg/20gL corn oil) was administered to neonatal rats using the same injection schedule.
2.2.3 Gonadotrophin Releasing Hormone Antagonist (GnRHa)
GnRHa was administered to separate any specific actions of the oestrogenic compounds from
those which occur through oestrogens acting in a negative feedback loop to reduce the amount
of gonadotrophins released from the pituitary. The administration of GnRHa effectively
abolishes gonadotrophin secretion and any effects observed in these animals which also
occurred in animals treated with oestrogen could therefore be a consequence of the reduced
gonadotrophin levels rather than of any specific, directs effect of oestrogen administration.
GnRHa was to some degree used as a negative control treatment.
GnRHa (Antarelix, Europeptides. Argenteuil, France) was administered via subcutaneous
injection at lOgg/kg in 20gL 5% mannitol on postnatal days 2 and 5. The dose administered
was based on previous studies which had demonstrated complete suppression of FSH levels
beyond day 18(Sharpe et al., 1998; Sharpe et al., 1999).
2.2.4 Bisphenol A
Bisphenol A (Aldrich Chemicals Limited, Dorset, UK) was administered at a dose of 0.5mg in
20 pL corn oil on postnatal days 2-18 (inclusive). This dose was based on the maximum
solubility obtained by dissolving this chemical in oil.
2.2.5 Octylphenol
Octylphenol was administered at a dose of 2mg/20gL corn oil administered on days 2-18
inclusive. Again, this dose was chosen due to the maximum solubility of this compound in
oil.
2.2.6 Methyl-parabens
Methyl-parabens was a gift from Dr J. Ashby (Zeneca CTL, Cheshire, UK), and was injected
at a dose of ~2mg/kg/day in 2ml/kg corn oil on days 2-18 inclusive; animals that were killed
on day 18 were sampled 4 hours after they received their final injection. The dose was based
on recent studies which assessed its effects in vivo on rat uterine weight (Routledge et al.,
1998).
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2.2.7 Genistein
Genistein, which is one of the isoflavenoid phytoestrogens found in soya, was administered
between days 2-18 inclusive at a dose of ~4mg/kg/day in 2mL/kg vehicle (phosphate buffered
saline (PBS) + 2.5mg/mL gelatin. Genistein was initially dissolved in 0.4M KOH and
diluted 1:20 with PBS producing a dosing concentration of 800gg/mF. The mothers of rats
treated neonatally with genistein and their respective controls (treated with the appropriate
vehicle) were fed on a casein-based soy-free diet (B.S.&S., Edinburgh, Scotland). Rats were
killed on days 10 and 18, while they were undergoing treatment. Rats were killed 4 hours
after their daily injection. The dose of genistein administered was based on figures reported
by Setchell et al. (Setchell et al., 1997) which showed this was the total isoflavenoid intake by
human 4-month old infants fed on 100% soy formula milk diet (Setchell et al., 1997).
2.2.8 Tamoxifen
Tamoxifen (Sigma) was administered at a dose of ~2mg/kg in 20pl corn oil on days 2-16
inclusive. This dose was based on previous studies which reported significant effects of this
dose on male reproductive development.
2.3 Methods for Tissue Fixation, Processing and Staining
2.3.1 Tissue Fixation for Frozen Sections
A cohort of 25 day old animals were treated to be used in studies performed in the Renal Unit,
Harvard Medical School. This laboratory only had access to a cryotome therefore a different
fixation protocol was employed. The testis with the epididymis attached was removed and
fixed in 4% paraformaldehyde in 0.1M sodium phosphate buffer for 6 hours and washed for
30mins in 0.2M ammonium chloride to quench the aldehyde and stop the fixation process.
The tissue was stored in 0.1M sodium phosphate containing 0.02% sodium azide and stored
at 4°C.
2.3.2 Tissue Preparation for Frozen Sections
The tissue was rinsed and incubated in PBS containing 30% sucrose for several hours/
overnight until the tissue was saturated and sank to the bottom of the vial. Sucrose penetration
of the tissue acts as a cryopreservative and helps prevent ice crystals forming once the tissue is
frozen. The epididymis was removed from the testis and mounted onto a cutting chuck. The
tissue was covered in OTC compound 4583 (Tissue-Tek, Miles, Inc.) and slowly frozen to -
30°C in a Reichert-Jung Fridgocut 2800 cryostat. Cryosections (5pm) were cut with high
profile disposable knives. Tissue sections were mounted onto Fisher Superfrost Plus
microscope slides (Fisher Scientific, Fos Angeles, CA, USA). These tissue sections were
stored at -20°C until used for immunostaining.
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2.3.3 Tissue fixation for Paraffin Embedding
In animals which were less than 25 days old the testis and epididymis were removed together
and placed in Bouin's' fixative (500ml 40% v/v formaldehyde, 100ml acetic acid and 2 litres
saturated picric acid) for 5 hours and then transferred into 70% ethanol until processed into
paraffin wax. Animals older than 25 days were perfusion fixed via the dorsal aorta. This
procedure was performed by Dr Sharpe and is described in Millar et al., (Millar et al., 1994).
The rats were anaesthetised with halothane prior to perfusion. Once anaesthetised, the
abdominal cavity was exposed and a catheter inserted into the dorsal aorta. Normal saline was
perfused for approximately 3 min until the testicular blood vessels cleared completely. Filtered
Bouin's' fluid was then perfused for 45 min. The testis and epididymis were removed
together. The cranial region of the testis which contains the rete testis was cut off whilst still
attached to the epididymis. The corpus and cauda portions of the epididymis were removed
and the remaining piece of testis attached to the caput epididymis was postfixed for a further
5h before being transferred into 70% ethanol.
Prior to being processed, the tissue was orientated to ensure that tissue cross sections through
the testis, rete testis and efferent ducts could be achieved. In animals 18 days and older this
meant cutting off the cranial region of the testis attached to the caput epididymis and removing
the corpus and cauda epididymis. The cranial portion of testis was then bisected along the
plane of the epididymis to cut the rete testis and efferent ducts into two equal halves.
2.3.4 Tissue Processing and Sectioning for Paraffin Blocks
Tissue was dehydrated through a series of graded alcohols before being saturated by paraffin
wax. This process was performed using a 17.5h automated cycle on a Leica TP-1050
processor (Leica UK Limited, Milton Keynes, UK). The tissue was then embedded with the
cut surfaces facing up so that the rete testis and efferent duct region could be sectioned. Glass
microscope slides to be used for immunocytochemistry were dipped twice in a 4% v/v
solution of 3-aminopropyl triethoxysilane (TESPA, Sigma) in acetone (BDH), washed in
acetone and rinsed in double distilled water and dried overnight. The TESPA coating
increased the adherence of the tissue to the slide. Slides used for in situ hybridisation were
purchased to ensure they were RNase free and coated with poly-L- lysine, again to promote
tissue adherence to the slide. Paraffin sections were cut (5pm) using a hand-operated
microtome (Jung RM2035; Leica) with disposable blades. Sections were floated onto a heated
water bath (containing distilled water for immunocytochemistry sections or RNase free water
for sections to be used for in situ hybridisation) at approximately 50°C. The sections were
transferred onto slides and dried overnight before use.
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2.3.5 Haematoxylin and Eosin (H&E) Staining
The composition of the components involved in haematoxylin and eosin staining will be
described here. The theory behind this staining regime and the protocol will be described in
Chapter 5 (Section 5.2). These stains were routinely prepared by Sheila Mcpherson in the
Histology department.
Harris's haematoxylin is prepared by dissolving 2.5g of haematoxylin in absolute alcohol
which is added to alum which has previously been dissolved in 500ml warm distilled water
(Bancroft and Stevens, 1996). This mixture is boiled and either mercuric oxide (1.25g) or
sodium iodate (0.5g) is carefully added. The stain is then rapidly cooled by plunging the
flask into a sink containing cold water and chipped ice. Once cold 20mls of glacial acetic acid
is added. Eosin Y is prepared by preparing a 1% solution with distilled water and 0.5ml of
acetic acid is added to 1L (Bancroft and Stevens, 1996).
2.4 Immunocytochemistry
Immunocytochemistry is a method used to localise a specific protein within a cell using a
specific antibody raised to the protein in question. This is a useful technique as it allows a
protein to be localised to a specific cell type and often a specific cellular location. The
procedure involves building up a sandwich of antibodies to increase the available binding sites
for the avidin/biotin based linking system. This amplifies the signal obtained on addition of
the horse-radish peroxidase based detection system
2.4.1 Immunoctyochemisty Protocol for Paraffin Sections
2.4.1.1 Procedure for detection with Diaminobenzidene (DAB)
Slide mounted tissue sections were deparaffinised in Histolclear (National Diagnostics, Fleet
Business Park, Hull, UK) for 5-10 min and rehydrated by washes in decreasing
concentrations of ethanol. The slides were then washed for 30 min in 270ml methanol
containing 30ml of 30% hydrogen peroxide. The slides were washed twice in tris buffered
saline (TBS; pH 7.4) for 5 min prior to the addition of a serum blocking solution which was
diluted 1:5 in TBS and incubated for 30 min at room temperature (i.e. normal swine serum;
Scottish Antibody Production Unit, Carluke, Scotland; SAPU). The primary antibody specific
for the protein of interest was then applied at the working dilution (e.g. Aquaporin-1 used at
1:500 dilution). The antibody was diluted with the serum based blocking solution. The
negative control slides were either incubated with pre-immune serum or control serum specific
to the species the antibody was raised in (i.e. a polyclonal rabbit antibody negative control
would be normal rabbit serum of an equal protein concentration). The tissue was either
incubated overnight at 4°C or left at room temperature for 2 h.
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Prior to the addition of the secondary antibody the slides were washed twice with TBS to
remove any unbound antibody. The secondary antibody was applied to link to the primary
and therefore had to be raised against the species used to raise the primary antibody (i.e. a
rabbit polyclonal primary must be linked with a linking antibody raised against rabbit IgG).
Therefore swine-anti-rabbit biotinylated (SARB; DAKO Ltd., Cambridge, UK) was incubated
for 30 min at room temperature. After a further two washes in TBS an avidin-biotin/ hrp
linking system (DAKO) was applied for 30 min. The avidin-biotin complexes bind to the
biotinylated sites on the secondary antibody. After two final rinses with TBS the
diaminobenzidene substrate was added (10ml TBS, 3.3gl 30% H202, 5mg DAB). This reacts
with the horse-radish peroxidase to induce a brown precipitate at the site of antibody
localisation. The reaction was stopped by immersing the slides in distilled water. The slides
were moderately counterstained with heamatoxylin, dehydrated and cleared in xylene before
being mounted using Pertex mounting medium (Cell Path, Hemel Hempstead, UK) and
coverslipped.
2.4.2 Immunfluorescence Protocol for Frozen Sections
Tissue sections were removed from -20°C storage and brought to room temperature. The
sections were drawn around with a diamond pencil and then encircled in a ring of wax to
ensure the slides did not dry out. Any excess OTC outwith this ring was scraped away with a
disposable razor. The slides were washed twice for 5min in PBS to dissolve the OTC and
non-specific binding sites were blocked by incubating the tissue for 20 min in 1% BSA/PBS
solution. The primary antibodies were applied to separate tissue sections and left in a moist
chamber at room temperature for 2 h. The slides were rinsed twice for 5 min in PBS before
the addition of the secondary antibody which was linked to either FITC or CY3. The slides
were incubated for a further hour. The slides were then rinsed in PBS 2x5mins before being
mounted using Vextasheild H-100 mounting medium (Vector Labs, Burlington, California).
Control experiments with no primary antibody were routinely performed and always gave
negative staining.
2.5 Image Analysis
2.5.1 Digital Photomicroscopy (Paraffin Sections)
Tissue sections were examined using an Olympus Provis microscope (Olympus Optical,
London, UK) and images were captured using a digital Kodak DCS420 camera (Eastman
Kodak, Rochester, NY). Captured images were stored on a 8100 PowerPC computer (Apple
Macintosh, Apple Computer. Cupertino, CA) and images were compiled using Photoshop 3.0
(Adobe Systems Inc., Mountain View, CA) before being printed using a Kodak XLS 8600 PS
printer (Eastman Kodak).
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2.5.2 Fluorescent Photomicroscopy (Frozen Sections)
The slides were examined using a Nikon FXA fluorescence microscope (Nikon, Surrey, UK).
Profiles of tubules within the epididymis were captured using a digital Optronix 3-bit colour
CCD camera and IP Lab Spectrum Software (Scanalytics, Vianna, Va.) running on a Power
Macintosh 8500. Images were compiled using Photoshop 3.0 (Adobe Systems Inc.,
Mountain View, CA) and printed using a Kodak XLS 8600 PS printer (Eastman Kodak,
Rochester, NY).
2.5.3 Traditional Film Photomicroscopy
Black and white photomicrographs (Tmax 400 film) were taken of the immunofluorescent
frozen sections to allow measurement and analysis. Images were shot using a Nikon FXA
fluorescence microscope fitted with a Kodak film camera.
2.5.3.1 Development and Printing of Black and White Film
The Tmax film was removed from the canister in a dark room with no illumination and rolled
onto a spool and placed in a light proof box. Tmax developer (Eastman Kodak Company)
was diluted 1:5 with water and incubated with the film. The exact time depending on the
temperature of the water. The developer was removed and the film washed under running
water for 1 min. Any further developing was stopped by immersing in stop bath (16ml/L;
Indicator Stop Bath, Eastman Kodak). After rinsing under running water for 1 min rapid fixer
(Kodak) was added for 6 min. The fixer was prepared by adding 946ml of solution A to 1.9L
warm water (27°C) and agitated before adding 104ml of Solution B and then add 850ml of
water and left to cool. The film was then left under running water for 3-5 min before the
addition of perm wash (47ml in 2L water; BKA Brandess-KAIC-AETNA Group, Inc,IL
60001). The film was washed for 1 min in distilled water and left to dry. The
photomicrographs were then printed using images projected on to a 45 MTX Besseler
enlarger. The exposure time was determined and the images printed using an automated
Radioprint DD3700 Agfa Gavaert.
2.6 Protein Extraction from Efferent Ducts
Protein was extracted from adult rat kidneys and efferent ducts and from postnatal animals at
day 18 for both control and DES (lOpg) treated rats. Protein extraction was carried out on the
pooled efferent ducts from 5 adult males. Samples were shredded with a hand-held
homogeniser in 300gL chilled PBS containing 50gL protease inhibitor cocktail (Complete
protease inhibitor cocktail, Boehringer Mannheim, East Sussex, UK). Protein extraction for
the day 18 animals was as described above except that, efferent ducts were pooled from 6
treated and 6 control animals and the homogenisation volume was halved. The efferent ducts
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are embedded in adipose tissue, so to remove this and any tissue debris, the samples were
spun in a centrifuge at 3000 x g for 10 min at 4°C. The supernatant from below the fat layer
was decanted and stored at -20°C.
2.6.1 Estimation of Protein Concentration
Due to the limited volumes of protein obtained from the efferent duct extractions a microtitre
plate protein assay was optimised to determine the protein concentrations of samples. A
standard curve of BSA was prepared by serial dilution ranging from 2mg/ml to 0.0156mg/ml.
The total volume in each microtitre well was 150 pL, comprising 25gL of sample and 125gL
of BioRad protein assay reagent (Bio-Rad Laboratories, Heme! Hemstead, UK). This reagent
detects the concentration of protein based on a dye colour change in response to protein
binding (Bradford, 1976). The reagent was diluted 1:5 with deionised distilled water and
filtered. Each of the unknown protein samples were added in a sample volume of 25 pL and
at least two different dilutions (i.e. 1:10 and 1:50). After the addition of the BioRad reagent
the plate was swirled gently and after 5-60 min the plate was read in a Labsystems
Multiskan® Mcc/340 plate reader and the optical density measured at 620nm. A standard
curve was drawn and the protein concentrations of the samples manually determined from the
graph.
2.7 One Dimensional Gel SDS-PAGE
One dimensional gel SDS-PAGE was performed based on the technique described by
Laemmli (1970) (Laemmli, 1970). A Protean electrophoresis system with a 300xi power unit
(Bio-Rad Laboratories) was used to perform the electrophoresis. Prior to and during use, the
apparatus was cooled to 10°C using a chiller/ heater circulator unit (Betta-Tech Controls,
Newport Pagnell, Bucks, UK). Protein samples were separated on 12% w/v acrylamide gels.
Each gel was composed of a total of 32ml (14ml 30% acrylamide, 8ml 1.5M Tris-HCl (pH
8.8) and 9.6 ml distilled water). Gels were degassed and polyimerised by the addition of
300pl 1% ammonium persulphate and 9pl TEMED (Sigma). Once cast, the gel was overlain
with water-saturated-isobutanol (Aldrich Chemical Co.) until set. This was removed and the
gel washed with distilled water. The gel was then ready for use or overlain with 0.375M Tris-
HCl and stored overnight at 4°C. After storage the gel was left to come to room temperature
while the stacking gel was prepared (consisting of 1.3 ml 30% acrylamide, 2.5 ml 0.5M Tris-
HCl, 6.2 ml double distilled water) and polymerised by the addition of 10gl TEMED (Sigma)
and 50pl 1% ammonium persulphate. A fifteen well comb was inserted into the gel and it was
left to polymerise.
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Prior to the addition of the protein samples they were mixed with an equal volume of SDS
sample buffer containing 1.5% w/v Tris dissolved in double distilled water and HC1 used to
adjust the pH to 6.75. To this was added 4% w/v SDS, 2% w/v dithiothreitol (DTT) and
0.05% w/v bromophenol blue and the final volume made to 20ml with double distilled water.
After the addition of the sample buffer the samples were boiled for 5mins and centrifuged for
2 min at lOOOxg and loaded into the stacking gel. One lane was reserved for molecular weight
markers (phosphorlase b, 97 kDa; albumin, 67 kDa; carbonic anhydrase, 43 kDa; trypsin
inhibitor, 20.1 kDa; a-lactalbumin, 14.4 kDa; Pharmacia, Milton Keynes, UK). The gel was
enclosed in a tank containing an electrolyte buffer (0.3% w/v Tris base, 1.44% w/v glycine and
0.15% w/v SDS (all from Sigma) in double distilled water. Electrophoresis was performed at
35mA until the samples had cleared the stacking gel and raised to 38mA for 3.5 h. After
electrophoresis the gel was electroblotted for Western blot analysis.
2.8 Western Blot Analysis
This technique detects a specific protein resolved using SDS-PAGE. The technique uses the
specificity of antibody/ligand interactions to bind to the protein of interest. As SDS breaks
disulphide bonds and induces alterations in the tertiary structure of the protein, antibodies
raised to conformational epitopes may not be successful in this method. Two detection
methods were employed as the first (NBT detection) was not successful in producing a
specific band.
2.8.1 Nitroblue Tetrozolium (NBT) detection
Protein samples which were separated using 1-D SDS-PAGE were electroblotted by semi-dry
transfer (Novablot apparatus; LKB Pharmacia, Uppsala, Sweden) onto a PVDF membrane
(Immobilon-P Millipore, Watford, UK) based on the technique described by Towbin et al.,
(1979) (Towbin et al., 1979). The transfer buffer consisted of 0.06% w/v Tris base, 0.288%
w/v glycine, 0.02% w/v SDS and 20% w/v methanol (BDH, Merk Ltd., Leicestershire, UK).
The gel was blotted for 90 min at a current which was calculated by determining the area of
the gel and multiplying it by the constant 0.8. This generally worked out at between 160-180
mA. After blotting onto nitrocellulose, the lane containing the molecular weight markers was
removed and stained with coomassie blue (0.1% w/v coomassie blue in 50% methanol and
7.5% w/v acetic acid) for at least 30 min. The strip was destained (50% methanol:5% acetic
acid v/v) until the staining of the MW markers was optimal.
The remainder of the membrane was blocked for 2 h at room temperature in TBS-Tween
(Tris-buffered saline pH 7.4, containing 50mM Tris-HCl, 150mM NaCl and 0.05% v/v
Tween 20) containing 5% normal sheep serum (SAPU). The membranes were incubated
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overnight at 4°C with the primary polyclonal antibody to Aquaporin-1 which was diluted
1:5000 with blocking buffer. The control blot was incubated with the same dilution of pre-
immune serum. The blots were rinsed 3 times for 10 min in TBS-Tween prior to the addition
of the secondary antibody. Sheep-anti-rabbit IgG (SAR; Serotec, Oxford, London) was
diluted 1:500 in TBS and incubated for 45 min at room temperature. A further three lOmin
washes with TBS-Tween were performed before the addition of 1:2000 dilution (in TBS) of
rabbit alkaline phosphatase anti-alkaline phosphatase conjugate (Serotec) for 45 min. The
blots were given two final washes in TBS-Tween, one in TBS and a further 2 min rinse in
equilibrating buffer (lOOmM Tris, pH 9.5, lOOmM NaCl and 50mM MgCl2). The
membranes were developed immediately in 25ml equilibrating buffer to which 0.3mg/ml
nitroblue tetrozolium (NBT), 0.175mg/ml 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) and
0.24mg/ml levamisole (all from Sigma) were added. Developing was performed in the dark
and the reaction was stopped by immersing the blot in distilled water. This detection method
gave a large number of non-specific bands which masked any positive identification of the
Aquaporin-1 protein so a more sensitive detection method was employed as described below.
2.8.2 ECL Detection
The 1-D gel was electroblotted as described in Section 2.8.1. The blots were then left to block
overnight at 4°C in 5% normal swine serum (NSS; SAPU) in TBS-Tween. The primary
antibody (rabbit polyclonal raised to aquaporin-1; diluted to 1:5000 in TBS) was incubated at
room temperature for 2h and the control blot was incubated in pre-immune serum (1:5000).
The MW marker strips were removed and washed in NSS-TBS-Tween. Membranes were
then washed for 40 min in large volumes of TBS-Tween with several changes of buffer prior
to the addition of the secondary antibody. Blots were incubated for 1 hour in swine-anti-
rabbit peroxidase (1:5000 in TBS) containing 5% NSS and then washed for a further 40 min
in TBS-Tween. The MW markers were incubated with streptavidin peroxidase! 1:3000 in
TBS-NSS) for 1 h. The blots were then ready to be developed in a dark room. ECL
(Amersham Life Science, Buckinghamshire, UK) detection was performed as per the
manufacturers guidelines Hyperfilm (Amersham) was placed over the blots for the desired
time and the film was developed and fixed. A specific band appeared at 29 KDa signalling the
detection of AQP-1.
2.9 Ribonucleic Acid (RNA) Extraction
RNA extraction was performed using a commercially available product, Tri-Reagent™
(Sigma) which follows the method described by Chomczynski, (1993) (Chomczynski, 1993).
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Tissues were dissected from rats (testis, caput, corpus, cauda epididymis, prostate, kidney,
adrenals, heart, lung, liver, intestine and the efferent ducts which were carefully dissected free
from surrounding adipose tissue) and pieces were placed into 10-15ml of chilled Tri-Reagent
and homogenised on ice until the tissue was completely dissociated and then left on ice. Prior
to the addition of 4 ml chloroform (Sigma) the mixture was left at room temperature for at
least 5 min. Vigorous mixing on the addition of chloroform induced the formation of an
emulsion. After standing at room temperature for 15 min the mixture was centrifuged at
10,000 x g at 4°C for 20 min. The upper aqueous phase was decanted to a new vial and an
equal volume of isopropanol (stored at -20°C) was added. This induced the precipitation of
RNA which was left to stand at room temperature for 10 min and centrifuged as above. The
resulting RNA pellet was washed with 75% ethanol, air dried then dissolved in water and
stored at -70°C. The purity and concentration of the RNA sample was determined by reading
the optical density (OD) at 260 and 280nm. The ratio for each sample was calculated to give
an estimation of the purity of the RNA, a ratio of 2.0 was taken to be pure. The concentration
of the sample was calculated from the 260nm reading. An OD of 1.0 is equivalent to an RNA
concentration of 40ug RNA/ml.
2.10 Oligonucleotide Primers
Oligonucleotide primers for CFTR were chosen by Dr Philippa Saunders and sent to
Genosys (Genosys Biotechnologies (Europe) Ltd., Cambs, UK) for synthesis. Primers were
chosen using the following guidelines. Primers should ideally have a 50% G+C content and
have an annealing temperature within the range 56-62°C. The primer and the expected PCR
product should be within the coding regions but avoiding conserved regions. Ideally primers
should be picked on different exons so that the RNA-specific PCR product is a different size
from any bands arising through contaminating DNA. The length of the primer determines
both the specificity and the annealing temperature. A primer of 18-24 nucleotide bases is
sequence specific as long as the annealing temperature is set within a few degrees of the
dissociation temperature for the template/primer duplex. Using primers of minimal length (18
bases) ensures a melting temperature of around 54°C or higher and a high probability of
sequence specificity. The 3' end of the primer is critical for successful PCR. If a conserved
amino acid can be used and serve as the first three bases in the primer, it allows a perfect base
pairing between the template and the 3' end. All primer sequences were checked through
GenBank to ensure that they did not match to any other known sequences.
2.10.1 Concentration of Primers
The concentration of primer required for a lOOgl PCR reaction is 0.05|j.M. To calculate the
volume of primer required the OD at 260nm was checked by adding 4pl primer to 796pl
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distilled water. The OD was multiplied by 4000. The molecular weight of the primer was
calculated and divided by 20. This value was divided by the value obtained by multiplying
OD by 4000 to give the volume (pi) of primer required to give 0.05gM in lOOgl. Prior to the
use of specific primers, a cDNA pool from the tissue of interest must be synthesised to
provide a template to which the specific primers can bind.
2.11 cDNA Library Synthesis
This procedure was performed using reagents from Boehringer Mannheim. cDNA was
synthesised using random hexanucleotides, which bind to RNA at any complementary site
then performing RT-PCR to amplify pools of cDNA. RNA (2.5gg) from a variety of tissue
were used as a template for DNA synthesis. This was incubated together with 2ul of random
primer and added sterile water to bring the total volume to 9pl. This mixture was heated at
70°C for 10 min and centrifuged briefly before the addition of 4pl reverse transcriptase buffer,
2pl 0.1M DTT and, lpl each of lOmM dATP, dCTP, dGTP, dTTP. This was heated to 42°C
for two mins before lpl of reverse transcriptase was added and mixed by pipetting. This was
incubated at 25°C for lOmin followed by 50 mins at 42°C. The reaction was stopped by
adding 4pl 50mM EDTA. 2pl of this cDNA pool was used as a template for PCR with
specific primers.
2.12 PCR Amplification Using Specific Primers
The cDNA library can be probed with specific primers to determine whether a specific RNA
message is present within the tissue from which the cDNA pool was synthesised. Thermal
cycling, using the polymerase chain reaction (PCR), allows the rapid synthesis of millions of
copies of a specific section of DNA. RNA polymerase (Taq Polymerase; Perkin Elmer, Ltd.,
Cheshire, UK) catalyses the synthesis of the DNA strand which lies between the 3' and
5'primer pair, which will be of known size. A supply of reaction buffer, dNTPs, and the
optimised concentration of magnesium chloride are required for successful PCR. The PCR
mixture is overlain with mineral oil to prevent evaporation and placed in a thermal cycler for
25-35 cycles.
To check that the size of the PCR product was correct lOgl was run out on a 1.5% agarose gel
(75ml mini-gel contains; 1.13g agarose (Boehringer Mannheim), 75ml Ix TBE buffer
(0.089M Tris base, 0.089M boric acid and lOmM EDTA)). The agarose was melted and 2ul
of ethidium bromide added (Sigma) to allow UV visualisation of the PCR bands. The PCR
product was mixed with 5gl of OJ ('orange juice'; 0.25% orange G (Sigma), 15% w/v ficoll
and 0.5M EDTA at pH 7.0). The samples were electrophoresed by running in lx TBE at
100V for 1 h alongside pGEM DNA markers (range 36-2645 base pairs, Promega). The gel
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was viewed under UV light and photographed. A single band of the correct size should be
visible in each sample.
2.13 Cloning of PCR Product into Plasmid Vector
The cloning of PCR products synthesised using Taq polymerase can be performed using the
TOPA TA Cloning® Kit Dual Promoter (Invitrogen BV, Holland). The cloning reaction was
performed by adding 2gl of PCR product to 1 pi of pCR-topo vector and 2pl sterile water.
This was mixed gently and incubated for 5 min at room temperature then briefly centrifuged
and placed on ice. The vector containing the PCR product was introduced into competent
cells; this kit uses One Shot™ competent E. coli . The transformation reaction was
performed by adding 2gl of 0.5M p-mercaptoethanol to a vial of competent cells and mixed by
stirring gently with a pipette tip prior to the addition of 2gl of the cloning reaction. This was
incubated for 30min before the cells are heat shocked at 42°C for 30 sec. The cells were then
cooled on ice for 2mins and 250gl of SOC medium added and mixed. The tube was left in a
shaker at 37°C for at least 30 mins and then placed on ice. The E.coli were then spread on
agar plates containing ampicillin (Penbritin Injection, Beecham Research) which had been
previously spread with 40pl of 40mg/ml X-gal and 40gl of lOOmM IPTG. The plates were left
overnight at 37°C.
2.13.1 Analysis of Positive Clones - Direct Lysis PCR
This technique is a quick way to check that the transformed cells have an insert of the correct
size. Only white colonies should be analysed. A white colony was placed in 50gl plasmid
lysis buffer and heated at 95°C for 5min. After being centrifuged at 13,000 rpm for 5min, 5pl
of the supernatant was used as a template for PCR using the vector promoter sites T7 and SP6
as template primers. The size of the insert was checked by running the PCR product on a
1.5% agarose gel as described in section 2.12.
2.13.2 Plasmid Preparation and Glycerol Stocks
2.13.2.1 Glycerol Stocks
Plasmid stocks were prepared by picking a colony off the agar plate and growing it overnight
at 37°C in 10ml LB (Luria Bertani) broth containing 50gg/ml ampicillin. Prior to plasmid
preparation, 700 pi of bacterial stock was added to 300pl of 50% glycerol and frozen to
provide a future stock of E.coli from which fresh plasmid could be grown.
2.13.2.2 Plasmid Preparation
Plasmid DNA was isolated from remainder of the culture using the alkaline lysis method in
Wizrad™ DNA purification system (Promega). The culture is centrifuged for 15 min at 1,600
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x g and the pellet was re-suspended in 'Resuspension solution' (50mM Tris-HCl pH 7.5,
lOmM EDTA and lOOpg/ml RNase). The tubes were inverted after addition of 300gl of the
cell lysis solution (0.2M NaOH and 1% SDS) and the solution neutralised in 300pl of
neutralisation buffer (1.32M potassium acetate and 6.4% glacial acetic acid (pH 4.8). The
mixture was centrifuged for 5min at 12,000 x g resulting in the sedimentation of bacterial
genomic DNA. One ml ofDNA purification resin was then applied to the plasmid suspension
before it was passed through a miniprep column. The column only retards plasmid DNA.
The column was washed (200mM NaCl, 20mM Tris/HCl, pH 7.5, 5mM EDTA and 47.5%
v/v ethanol) and the plasmid eluted from the column by the addition of lOOgl of hot (~70°C)
water.
2.13.3 Plasmid DNA Purity and Concentration
The purity of plasmid DNA was determined by running lgl of plasmid on a 0.8% agarose
gel. Samples were separated in parallel with pGem DNA markers. Under UV light, pure
plasmid DNA appears as two bands, one for circular DNA and the other representing
supercoiled DNA. Supercoiled DNA is more compact and therefore runs more rapidly
through the gel. The approximate concentration was determined by running a plasmid sample
of known concentration (200ng; pBR322, Promega) on the gel and comparing the intensity of
the band.
2.14 In situ hybridisation
Two different detection methods were employed to try and localise specific RNA species to
the cells of a specific tissue. Abundant mRNAs can generally be detected without the use of
radioactivity. This method was employed unsuccessfully for the detection of CFTR and so
radioactive detection was also attempted.
2.14.1 Non-Radioactive In Situ Hybridisation
2.14.1.1 Probe Preparation
Plasmid DNA containing a specific insert for CFTR was prepared as described in sections
2.10- 2.12. The plasmid was linearised (lpg DNA, reaction buffer (10-50mM Tris-HCl, 5-
lOmM MgCl,, 50-100 mM NaCl and ImM dithiothreitol; Boeringher Mannheim), 10U
restriction enzyme (Boerhinger Mannheim) and pure water was added to make up to a volume
of 40pl followed by incubation for 1 -2 h at 37°C. The restriction enzyme used depends on
the plasmid vector being digested and the direction of synthesis of the riboprobe. To check
whether the enzyme had cut the plasmid properly, 3gl of the reaction was run on a 0.8%
agarose gel alongside an uncut sample of plasmid. Digested DNA was extracted with Tris-
buffered phenol:chloroform:isoamylalcohol 25:24:1 v/v (pH 8.0), and then precipitated with
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l/10th volume 3M sodium acetate (pH 5.5) and 2.5 volumes absolute ethanol overnight at -
20°C. The linearised DNA was pelleted, dried and resuspended in 10gl pure water.
2.14.1.2 Preparation of Digoxigenin Labelled Riboprobes
Riboprobe synthesis was performed using lpg of linearised plasmid DNA. This was added
to the following reaction: lOmM DTT (Promega), ImM each of rATP, rCTP, rGTP
(Boehringer Mannheim), transcription buffer (lx transcription buffer containing 40mM Tris-
HC1 (pH 7.9), 6mM MgCl2, 2mM spermidine and lOmM NaCl and 0.35mM Dig-labelled
UTP (Boehringer Mannheim) with 20U RNase inhibitor (Promega) and the appropriate RNA
polymerase (either T3 or SP6; Boehringer Mannheim). This was incubated for approximately
2 h at 37°C prior to running out 2gl of the reaction on a 0.8% agarose gel to detect the
presence of two bands corresponding to 28 and 18 S RNA. Enzymes and salts were removed
by two rounds of phenol/chloroform extraction. The RNA was precipitated with sodium
acetate and ethanol overnight at -70°C and recovered by centrifugation. The RNA was
suspended in 50gl sterile water and further purified by passage through an RNA spin column
(Nu-clean R50, IBI).
2.14.1.3 Pre-treatment and Hybridisation of Tissue
Slide mounted paraffin tissue sections were cleared in Histoclear for 10 min and rehydrated
by passing through an alcohol series of decreasing concentration. Tissue was placed in 0.2M
HC1 for 20 min and then washed twice with distilled water. The tissue was incubated in
2gg/ml Proteinase K (Sigma) in buffer (20mM Tris-HCl pH 7.4, and 50mM EDTA) at 37°C
for 40 min to remove excess protein from the tissue section which aids the hybridisation of
the riboprobe. Proteinase K was inactivated by incubating the slides at 4°C in 0.2% glycine
for 20 min and then washed in 0.1M triethanolamine TEA pH 8.0 (Sigma). The slides were
acetylated to reduce any ionic charges produced by protein digestion by the addition of 0.25%
acetic anhydride (Sigma) in TEA buffer. The slides were given a final wash in 6x STE (lx
STE contains 150mM NaCl, 2.5mM Tris and 0.25mM EDTA) before being incubated for 2-4
h in prehybridisation buffer containing 6x STE, lx Denhardt's solution (50x Denhardt's: 5g
BSA, 5g polyvinylpyrolidine and 5g ficoll in 500ml solution), 125gg salmon sperm DNA
(Sigma), 125|ig/ml yeast transfer RNA (Sigma) and 50% deionised formamide for 2-4 h in a
humidified chamber at 35°C. The probe was added to the hybridisation buffer which had the
same composition as prehybridisation buffer except for the addition of 10% v/v dextran
sulphate. The probe was added at a concentration of 2gl with 40|il of buffer being allowed for
each slide which was then coverslipped with Gel Bond film (Flowgen Instraments Ltd.). This
was hybridised overnight at 35°C in a humidified chamber.
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The slides were washed twice for 5 min in 4x SSC to wash off any anhybridised probe before
being incubated in RNase A at a concentration of 20pg/ml in buffer for 30 min at 37°C.
Slides were rinsed in 2x SSC (5 min) at room temperature followed by 30 min incubation in
0.1 x SSC/30% v/v formamide at 30-40°C.
2.14.1.4 In Situ Hybridisation - Development of Signal
Slides were washed in TBS (2x 5 min washes) before they were blocked with normal sheep
serum (1:5 dilution with TBS) for 30 min. The slides were rinsed with TBS prior to the
addition of the linking antibody (anti-DIG conjugated to alkaline phosphatase Fab fragments
raised in sheep; Boehringer Mannheim) used at 1:300 in TBS and incubated for 2 h. Excess
antibody was rinsed with TBS washes (2x 15 min). The development was performed as
described in section 2.8.1. The sections were incubated with this solution in the dark at room
temperature until staining was optimal (generally overnight) prior to being washed in water.
The slides were then dehydrated and coverslippecl.
2.14.2 Radioactive in situ Hybridisation
2.14.2.1 Preparation 3=S-Labelled Riboprobes
Plasmids were cut as described in Section 2.13.1.1. The riboprobe was synthesized by the
addition of 3.5pl sterile water, 5pl of 5x transcription buffer, lgl of RNasin, lpl lOOmMDTT
and lgl of each of the following lOmM rATP, rCTP and rGTP and 0.5gl of lOOmM UTP.
Together with 5gl of the linearised plasmid , 5pl 35S UTP and lpl of RNA polymerase SP6 or
T7, the sample was incubated at 37°C for 1 h and a further lpl of RNA polymerase was
added. After a further hour lgl Dnase was added and the solution was passed down a DEPC-
100 column (Chroma Spin-100) to remove unincorporated nucleotides. The radioactivity level
was determined by adding lpl of the probe to 4ml scintillation fluid and reading it in a (3-
counter. The volume of probe required to coat each slide with 106cpm probe was then
determined.
2.14.2.2 Pretreatment and Hybridisation of Tissue
This was performed as described in Section 2.13.1.3.
2.14.2.3 Development of In Situ Hybridisation
Once the slides were given their final wash they were dehydrated in graded ethanols
containing ammonium acetate and left for an hour to air dry. The slides were then dipped in
emulsion (NBT-2 autoradiography emulsion, Kodak) at 45°C and placed in a light- proof
humid box and left for several hours at room temperature prior to the addition of a desiccant.
The slides were exposed for two weeks at 4°C before being developed. Slides were developed
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by being incubated in filtered developer (Kodak D-19 developer diluted into 5L, Kodak), and
then cooled to 14°C for 4 mins. Before being fixed in Kodak GBX fixer and replenished for
10 min, the slides were washed in distilled water. Once developed the slides were washed in
water and then counterstained as described in Section 2.4.1.1.
Chapter 3 Oestrogen Receptor-Beta
Immunoexpression in the Male Marmoset
Reproductive Tract
3.1 Introduction
The human oestrogen receptor (ER) was cloned in 1986 and was classed as a member of the
steroid receptor gene superfamily which includes the other sex steroid receptors along with
the thyroid hormone receptor, glucocorticoid receptor and retinoic acid receptor (Green et al.,
1986). The contradictory evidence in the literature concerning the sites of expression of the
oestrogen receptor (reviewed in section 1.7.1) should perhaps have alerted scientists to the
possibility that more than one form of oestrogen binding protein existed. However, it was not
until 1996 that a second isoform of ER was detected and cloned from rat prostate and ovary
(Kuiper et al., 1996). This second form was named oestrogen receptor-beta (ER(3) and the
older isoform was renamed ER-alpha (ERa). The isolation of this second isoform has
opened a new field in scientific research and has broadened the understanding of both the
possible roles of oestrogen and the molecular dynamics of oestrogen receptor activation. The
work in this chapter aimed to determine the sites of immunoexpression of ERp within the male
marmoset testis and epididymis and to compare these with the expression of ERa and the
androgen receptor (AR). This introduction summarises what has been discovered about ERp
over the past 3 years since its identification.
ERp has currently been cloned in the rat (Kuiper et al., 1996), mouse (Tremblay et al., 1997),
human (Enmark et al., 1997) and sheep (Walther et al., 1999). The human gene has been
mapped to chromosome 14q22-24 while the murine gene resides in the central region of
chromosome 12 (Enmark et al., 1997), (Tremblay et al., 1997). Sequence comparisons have
determined that ERp is highly homologous to ERa (Kuiper et al., 1996), and has a similar
arrangement of the functional domains characteristic to members of the steroid receptor
superfamily. The N-terminal region contains the transactivation domain which can interact
with transcriptional components, and this region shares the least homology with ERa. The
DNA binding domain is highly conserved (there is 95-97% homology between the two
isoforms) and contains two zinc fingers which are required for inducing receptor dimerization
and DNA binding (Kuiper et al., 1996). Finally, the C-terminus contains the ligand binding
domain which is essential for nuclear translocation, ligand-dependent transactivation, receptor
dimerization and interactions with co-repressors and activators (Chang and Prins, 1999).
Within the DNA binding domain there are two domains (P-box and D-box which bind to
oestrogen response elements (ERE) of oestrogen responsive genes) that are identical between
ERa and P; thus predicting that ERp will bind to the same EREs that have already been
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identified for ERa (Kuiper et al., 1996). The amino acid sequence of the ligand binding
domain of ERp shares only 55-60% homology with ERa (Kuiper et al., 1996), (Mosselman et
al., 1996), (Tremblay et al., 1997). Variation within the ligand binding domain may suggest
that the two isoforms of ER have different affinities for ligand.
Ligand binding affinities to various oestrogen metabolites and oestrogenic compounds have
been assessed using recombinant ERa or ERp. Both receptor isoforms bound 17p-oestradiol
with high affinity but the dissociation constant for ERp was generally half that of ERa
(Kuiper et al., 1996), (Kuiper et al., 1997), (Tremblay et al., 1997). ERp has been shown to
bind many xenoestrogens (polychlorinated biphenols (PCBs), dichlorodiphenyl-
trichloroethane (DDT) and metabolites, alkylphenols and Bisphenol A) with an affinity that is
generally 1000 times lower than that for 17(S-oestradiol (Kuipier et al., 1998). However,
phytoestrogens (genistein, coumestrol and zearlenone) were found to have a 10-fold higher
affinity for ERp than ERa (Kuiper et al., 1997; Kuipier et al., 1998) as did Bisphenol-A and
methoxychlor (Kuiper et al., 1997). The xenoestrogens used in this assay were able to induce
reporter gene expression at a consensus ERE using a human ERp expression plasmid
(Kuipier et al., 1998). This may suggest that tissues with a high ERp or combined ERa and
ERp expression may be more vulnerable to potential effects of environmental chemicals
(Chang and Prins, 1999).
After ligand binding, steroid receptor proteins link to another steroid receptor forming a dimer
which then translocates to the nucleus. It is known that some steroid receptors are capable of
dimerizing with other members of the steroid family to form heterodimers. Experiments have
been performed to determine whether ERp forms homodimers or is capable of interacting with
ERa to form heterodimers. Studies using human and mouse ERp have shown that ERp is
capable of forming heterodimers with ERa in vitro and in COS-7 cells (Pettersson et al.,
1997), (Ogawa et al., 1998). The formation of heterodimers suggests the potential for three
oestrogen-mediated signals in cells (ERa/ERa, ERp/ERp and ERa/ERp) which express both
isoforms of ER which may therefore induce the transcription of three unique sets of genes.
The cloning of ERp has led to the publication of a number of papers suggesting the existence
of multiple forms of this protein. Petersen and co-authors isolated four variants (ERp 1-4;
with ERpi being the originally cloned receptor). ERp2 had an in-frame insertion of 54
nucleotides which corresponded to an additional 18 amino acids being inserted into the ligand
binding domain (Petersen et al., 1998), (Hanstein et al., 1999). ERp2 was expressed at similar
levels to ER-pi in the ovary, prostate, pituitary and muscle but ER-P2 had a lower affinity for
oestradiol than did either ERa or pi (Petersen et al., 1998). Two further variants (ERp4,5)
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were identical to ER-pl and ER-(32 respectively except that they had a deletion of 117bp. These
bases encompassed the coding region of the second zinc finger of the DNA binding domain.
All 4 variants were translated into functional proteins (Petersen et al., 1998). Another study
isolated 5 isoforms of ERp from a human cDNA testis library. All five isoforms were shown
to diverge at a common position within the predicted helix 10 of the ligand binding domain,
which the authors predict is consistent with different exon usage (Moore et al., 1998).
There has also been some debate regarding the true transcriptional start site for the ERp gene
as one study found that the N-terminus contained an additional open reading frame, both in-
frame and upstream of the published ERp clones (Bhat et al., 1998). This long form of the
receptor is more active than the 'truncated' variant at activating ERE-based reporter genes,
which might suggest that the extended N-terminus amino acids have a role in modulating
oestrogen responsive gene expression, at least in vitro (Bhat et al., 1998). An extended N-
terminus was also reported by Ogawa and co-authors (1998), they suggested that an
additional 53 amino acids were present in the extended N-terminus and that this variant was
capable of forming heterodimers with ERa (Ogawa et al., 1998).
ERp expression has been determined in a number of tissues within the reproductive systems
of both sexes, the brain, urinary system, cardiovascular system and bone using various
methods from RT-PCR, in situ hybridisation, RNase protection assays, Northern blots and
immunocytochemistry (see Chang and Prins, 1999). As bone growth was affected in humans
with inactivating mutations of aromatase and ERa, the sites of ERp expression in this tissue
will be important for determining the complete role of oestrogen in bone physiology.
Immunocytochemistry using two different antisera demonstrated ERp staining in tissue
samples collected from four female prepubertal patients. Staining was located in hypertrophic
epiphyseal chondrocytes suggesting that ERp (as well as ERa) plays a role in longitudinal
bone growth (Nilsson et al., 1999). When the experimental research of this thesis was started
in 1996, the sites of expression of ER-p within the male reproductive tract were not known,
aside from the bands detected in prostate and testis which were illustrated on the Northern blot
published by Kuiper (1996). This chapter examines the immunolocalisation of ERp within
the testis and epididymis of the marmoset monkey from perinatal life until adulthood.
3.2 Experimental Procedures
3.2.1 Tissue collection
Marmoset tissues were collected with the testis and epididymis attached. Donor animals were
classed as neonates, infants, prepubertal or adults (aged 1 day to 8 weeks, 18-24, 54-62, 92-
112 weeks, respectively; n= 2-4 per group). Tissues were collected from control animals by
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Dr Hamish Fraser and were from another experiment. The tissue was fixed in Bouins fluid
and processed into paraffin blocks (as described in section 2.3.4).
3.2.2 Antibody Production
The antibody used in this study was synthesised under the direction of Dr Phillipa Saunders.
A peptide raised to the hinge domain of ERf5 (CAGKAKRSGGHAPRVREL) was
synthesised by Affitini Reagents (Exeter, UK). This peptide was injected into sheep;
immunisations and recovery of antisera were all carried out by Diagnostics Scotland, Carluke,
Lanarkshire, UK. The serum was then affinity purified by Dr Saunders using the following
protocol. The polyclonal antiserum was purified against the unconjugated form of the
immunising peptide as follows: the antiserum was mixed with 2x volume of sodium acetate
(60 mM; pH 4) and stirred vigorously during the addition of 0.75ml caprylic acid (Sigma, St
Louis Missouri) per 10ml of antiserum. The resulting cloudy solution was centrifuged at
3000g for 30 min at 4°C, the supernatant was filtered through Whatman No. 1 paper and
dialysed extensively against phosphate buffered saline (PBS; pH 7.4). The antibody was
used at a dilution of 1:500 and antiserum pre-absorbed with the immunising peptide was used
as a negative control.
3.2.3 Immunoctyochemistry on paraffin tissue sections
Immunocytochemistry was performed as described in Section 2.4.1 except an antigen retrieval
step was introduced after the methanol/hydrogen peroxide wash. The slides were pressure
cooked in glycine buffer (50mM; pH3.5 + 0.01% EDTA) for 5 min and left to stand for
20min. The heat treatment and the pH of the buffer used appear important in antigen retrieval.
This protocol was optimised by Mr M Millar. The marmoset tissue was also blocked in
0.01% avidin in PBS for 30 min before being incubated in 0.001% biotin for 30 min. This
step was performed to quench any endogenous biotin activity within the marmoset testis. The
primary antibody was then added. The negative control was pre-absorbed antibody which was
prepared 24h before use. The peptide used to immunise the sheep was added to the antibody
at 10 times the protein concentration of the antibody. The protocol was then followed as
described in Section 2.4.1. The secondary antibody was a rabbit anti-sheep biotinylated
(Serotec).
3.2.4 Androgen Receptor Immunocytochemistry
Immunocytochemistry was performed using a commercial rabbit polyclonal antibody
(Novocastra). The protocol used was as described in Section 2.4.1, except that an antigen
retrieval process was performed after the methanol block. Slides were pressure cooked for 5
min in 0.01M citrate buffer (pH 6.0) and left to stand for 20 min. Instead of incubating the
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primary antibody overnight, it was left at room temperature for 2 hours. The antibody was
used at a dilution of 1:20.
3.2.5 Oestrogen Receptor a Immunocytochemistry
Immunocytochemistry was performed using a commercial monoclonal antibody (Novocastra)
which had previously been validated (Fisher et al., 1997). The slides were immunostained
using NBT (nitroblue tetrazolium) which form a dark blue precipitate at sites of antibody
localisation or DAB (diaminobenzidine) which forms a brown precipitate. The
immunostaining procedure is essentially similar to that described in Chapter 2 (section 2.4.1)
except that there was no methanol block. The slides underwent an antigen retrieval step as
described in Section 3.2.4. The primary antibody was used at a dilution of 1:20 diluted in
normal rabbit serum (NRS). The secondary linking antibody was mouse-anti-rabbit
biotinylated used at 1:500 in NRS. After the final wash in TBS the detection process involved
incubating the slides in lOOmM Tris-MgCl buffer (lOOmM NaCl and 50mM MgCl; pH 9.5)
before the addition of the NBT developing solution (337.5 gg/ml NBT, 175 gg/ml 5-bromo-4
chloro-3-indolylphosphate and 0.001% levamisole in 10ml ofTris-MgCl buffer). The slides
were then counterstained and coverslipped.
3.2.6 Photomicroscopy
The slides were photographed as described in Section 2.5.1.
3.3 Results
3.3.1 Oestrogen Receptor (3 Immunolocalisation in the Testis and Epididymis of the
Marmoset
Figure 3.1 illustrates the localisation of ERp by immunocytochemistry within the marmoset
from day 1 to peripubertal life at around 62 weeks of age. Panels (a) and (b) respectively
illustrate ERp staining within marmoset bladder epithelium (positive control tissue) and the
negative control slide treated with antibody preabsorbed with cognate peptide. Bladder was
shown to be ERp positive by Saunders et al., 1998. Figure 3.1(c) illustrates ERp staining of
blood vessel endothelial cells and the surrounding adipocytes located within the epididymal fat
pad. Similar staining was observed in endothelia and adipocytes throughout the body. This
image was taken from tissue obtained from an 8 week old marmoset but similar staining was
evident from day 1 to adulthood. Panels d-f are from a day one postnatal marmoset and
depict a low power image of the testis and overlying epididymis, and higher power images of
the seminiferous cords and developing epididymis respectively. The trend from panel (d)
suggests that ERp is most evident within the developing epithelial tissues of the testis and
epididymis, although there was obvious stromal cell staining within the epididymis and at the
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Figure 3.1 Immunocytochemical Localisation of ER(3 Within the Marmoset
from Perinatal Life to Adulthood
Panel (a,b) represent the positive control tissue, the bladder with ERp localisation and
staining pattern observed after the antibody is preabsorbed with peptide. Panel (c) shows
endothelial cells from a blood capillary and surrounding adipocytes. Panels (d-f) illustrate
ERp immunolocalisation of day 1 postnatal marmoset (d) testis (e) and epididymis (f). An
infant marmoset (8 weeks) is depicted in panels (g-i), testis (g), efferent ducts (h) and caput
epididymis (i). Peripubertal animals (62 weeks) illustrated in panels (j-l) representing efferent
ducts (j), caput epdidymis (k) and vas deferens (I). The adult marmoset ERp is depicted in
panels (m-o), testis (m), efferent ducts (n) and caput epididymis (o). All images
are x400, except (d) x100. The scale bar in (a) denotes 100pm and that in (d) denotes
200pm.
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circumference of the testis within the apical layer of cells. There were many developing blood
vessels in this region. It is evident in panel (e), that the majority of positive staining within the
testis was located within the seminiferous cords. Both immature Sertoli cells and gonocytes
were immunopositive as determined by their distinct morphological features. The developing
epididymis (panel (f)) showed a diffuse cytoplasmic cell staining which may be nonspecific as
distinctive nuclear staining was only evident in a few cells. The surrounding stromal tissue had
more distinct nuclear staining.
ERp immunolocalisation from an infant marmoset (8 weeks) is depicted in Figure 3.1 (panels
g-i). At 8 weeks, the seminiferous cords of the testis clearly showed nuclear Sertoli cell and
spermatogonia cell staining. There was also peritubular myoid cell staining and staining of
interstitial cells (presumptive Leydig cells?). There was clear nuclear staining within the
efferent duct epithelium and surrounding stroma. This staining pattern was also evident in the
caput epididymis. ERp immunostaining was evident in principal, basal and apical cells of the
marmoset epididymis. Around puberty (62 weeks), it was clear that not all epithelial cells
within the efferent ducts expressed ERp (Figure 3.1 panel (j)). However, both ciliated and
non-ciliated cells were immunoreactive for ERp so that a lack of ERp staining was not due to
expression in one particular cell type. The staining within the epithelium of the caput
epididymis was identical to that at 8 weeks but the underlying stromal cells appeared to be
less immunoreactive for ERp than at earlier ages (k). Panel (1) illustrates ERp
immunoexpression within the marmoset vas deferens. The thick muscular layer showed a
high density of ERp positive cells whereas the epithelium had a very weak reaction to this
antibody. The testis of the adult marmoset (Figure 3.1 panel (m)) showed immunoexpression
of ERp within Sertoli cells, spermatogonia and some (but not all) spermatocytes, round
spermatids but not in elongating spermatids. Interstitial cell staining of presumptive Leydig
cells was also evident. Within the efferent ducts (panel n) the pattern of immunostaining was
as described in panel (j) and it was more evident that both ciliated and nonciliated cells
expressed ERp. The cauda epididymis of the adult marmoset depicted a tissue in which all
epithelial cell types were immunopositive for ERp as were the surrounding stromal cells.
3.3.2 Comparison of Sex Steroid Receptor Expression in the Adult Marmoset Testis
and Epididymis
Figure 3.2 is a comparison of the immunoexpression of ERp (panels a-c), ERa (panels d-f)
and AR panels (g-i) within the testis (panel a, d. g), efferent ducts (panel b, e, h) and caput
epididymis (panel c, f, i) of the adult marmoset monkey. The three sex steroid receptors
exhibited a different pattern of expression within the testis. ERp had the widest cellular
distribution with localisation evident within the seminiferous tubules (Sertoli cells,
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Figure 3.2 A comparison of Androgen and Oestrogen (a and 3) Receptor
Immunoexpression in the Male Reproductive Tract
Illustrates the comparative sites of expression of ERa (a-c), ER3 (d-f) and AR (g-i) within
the testis (a, d, g), efferent ducts (b, e, h) and caput epididymis (c, f, i) of the marmoset.
All images are x400 and the scale bar denotes 100pm.
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spermatogonia, and some spermatocytes and round spermatids) and interstitium. ERa did not
localise within the seminiferous tubules but only in Leydig cells of the interstitium (panel d).
AR expression within the testis was evident in the Sertoli cells within the seminiferous tubules
and within the interstitium. AR staining was also evident within the residual bodies of
spermatozoa and this is believed to be a non-specific precipitate.
The efferent ducts of the marmoset were immunopositive for all three steroid receptors, and
each showed a similar checker-board pattern of expression. Not all epithelial cells were
positive for these receptors but both cell types (ciliated and non-ciliated) displayed some
positive cells. Stromal cells surrounding the ducts were only positive for ERp
immunolocalisation (panel b). The caput epididymis showed a similar pattern of
immunostaining for ERp and AR but ERa did not localise to the epididymis of the marmoset.
AR had the strongest immunolocalisation as judged by staining intensity (panel i), though
ERp immunolocalised to a higher percentage of apical cells than did AR.
In summary, ERp expression was widespread throughout the testis and epididymis, in contrast
to ERa which was expressed only in Leydig cells of the testicular interstitium and in the
efferent duct epithelium. AR expression was present in the testis and efferent ducts but was
expressed with highest intensity in the caput epididymis.
3.4 Discussion
The immunolocalisation of ERp within the marmoset testis and epididymis throughout
neonatal to adult life suggests that oestrogen action via this steroid receptor could have
important developmental and maturational functions within these tissues. The staining pattern
once clearly established (at ~ 8 weeks) did not alter significantly. Except after puberty and the
initiation of spermatogenesis, it was clear later spermatocytes and early spermatids also
expressed ERp. The pattern of staining within the efferent ducts and epididymis did not alter
from infancy to adulthood, similar to previous findings for ERa within the efferent ducts
(Fisher et al., 1997).
Finding that the steroid receptors (AR, ERa and ERp) have some overlapping and some
discrete sites of expression suggest room for interplay between the actions of androgens and
oestrogens. Until recently, the endocrine control of the testis and epididymis was regarded as
being androgen driven. The sites of AR expression (primarily Leydig, peritubular myoid and
Sertoli cells) suggested that spermatogenesis was driven by androgens not acting directly on
germ cells but indirectly via Sertoli cells (Bremner et al., 1994), (Shaipe, 1994). The
immunolocalisation of ERa (Fisher et al., 1997) only to Leydig cells within the testis upheld
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this hypothesis. However, the description of ERp within multiple cell types of the marmoset
seminiferous tubules, together with similar published data in the rat (Saunders et al., 1998),
(van Pelt et al., 1999) suggest that the androgen dominated model of spermatogenesis may
require reassessment. Within the seminiferous epithelium of the rat, ERp has been shown to
be expressed in Sertoli cells (which unlike AR expression is not stage dependent (Bremner et
al., 1994)) (Saunders et al., 1998), spermatogonia, and later spermatocytes and early
spermatids (Saunders et al., 1998), (van Pelt et al., 1999). These data are identical to the
results obtained for the marmoset testis. The presence of a steroid receptor within the
developing germ cells is unique for ERp and is not observed for either AR or ERa. Other
recent studies have localised aromatase to the testis and particularly to spermatocytes,
spermatids and spermatozoa (Nitta et al., 1993), (Janulis et al., 1998; Janulis et al., 1996a;
Janulis et al., 1996b) suggesting a local source of testosterone conversion to oestrogen which
may allow local production and action of steroids on germ cells.
In the rat, ERp has been identified in fetal/neonatal gonocytes (Saunders et al., 1998) and the
data shown here for 1 day old marmoset would also support these findings. Immature rat
Sertoli cells are also known to synthesise aromatase (Weniger, 1993), again suggesting a role
for oestrogen in the early development of the testis and germ cells. A recent study of ERp
expression within the rat located ERp mRNA to gonocytes of fetal day 16 and postnatal day 4
testes (van Pelt et al., 1999). Prior to puberty and the onset of spermatogenesis at days 11-15
postnatal, the only germ cells that produced a strong ERp signal were spermatogonia. In the
adult testis, ERp mRNA was localised to pachetyne spermatocytes at stages VII-XIV and in
round spermatids from stages I-VIII. This study did not find any signal within the
interstitium and only weak signals in adult Sertoli cells and spermatogonia (van Pelt et al.,
1999). This study supports a role for oestrogen in germ cell development and maturation.
Within the epididymis, the efferent duct epithelium is the only region that localises all three
steroid receptors. The luminal fluid in the efferent ducts is high in testosterone that can be
converted to dihydrotestosterone or oestrogens. The principal cells of the epididymis contain
5a-reductase and spermatozoa travelling through these ducts and the epididymis have been
shown to express aromatase (Janulis et al., 1996b). This suggests that there is a strong
interplay between androgens and oestrogens within the male excurrent duct system. Both AR
and ERp are expressed throughout the epididymis but the remainder of the epididymis does
not express ERa which is consistent with previously published data (Fisher et al., 1997). AR
has a much more intense signal than ERp within the caput epididymis. The pattern of staining
for these two receptors within the epididymis is very similar and it would be of great interest
to determine whether or not these receptors can dimerize under physiological conditions. An
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earlier study examined the expression of ERa and ERp in the excurrent ducts of the adult rat
using immunocytochemistry (ERa only) and RT-PCR (Hess et ai, 1997) and demonstrated
that the level of ERa mRNA was found to be 3.5 times higher per milligram of total RNA
than rat uterus. This study also located ERp to all the different regions of the epididymis
including the efferent ducts and the vas deferens and prostate (Hess et al., 1997). The results
for the marmoset show that ERp is expressed in a far wider range of cell types than is either
ERa or AR. The only sites where all three receptors were expressed were the Leydig cells of
the testis and the efferent duct epithelium. It is known that the two ERs form heterodimers
with each other but it is not yet known whether or not the ER can interact to form
heterodimers with AR. This could influence steroid interactions in Leydig and Sertoli cells
within the testis and the efferent ducts and epididymis.
In summary, the discovery of ERp has broadened the number of oestrogen target cells within
the male reproductive tract. Particularly in the testis, the discovery of a steroid receptor
expressed in germ cells may have far reaching implications for our current understanding in
the control of spermatogenesis. Similarly, the wide expression of ERp (but not ERa) within
the epididymis indicates that this organ may not be solely an androgen dependent target and
may suggest an interaction between the effects of androgens and oestrogens. The efferent
ducts are known to be an important site of ERa expression but it should not be forgotten that
both ERp and AR are also expressed in this tissue and must have roles to play in its function.
Chapter 4 Aquaporin-1 Immunoexpression in
the Efferent Ducts of the Rat and Marmoset
4.1 Introduction
As shown in Chapter 3 and previous studies (Fisher et al., 1997) the efferent ducts are a
site of oestrogen receptor expression. Oestrogen receptor-a expression is particularly
high in the efferent ducts and is on a par with levels observed in the uterus. This
highlights the likely relevance of the efferent ducts in oestrogen action and why studies of
the role of oestrogen in male reproduction and the consequences of abnormal oestrogen
exposure are important. At the outset, these studies aimed to identify functional marker/s
of efferent ducts which were oestrogen regulated. Such a marker would allow a
comparison between compounds regarded as potent (e.g. high doses of DES or ethinyl
oestradiol) or weak (e.g. environmental) oestrogens. As the efferent ducts of the male
reproductive tract are embryologically related to the kidney, and in particular the proximal
convoluted tubule, a likely candidate was a recently identified water channel protein called
Aquaporin-1 (AQP-1). This chapter describes a preliminary study to determine whether
AQP-1 was expressed in the efferent ducts during the postnatal development of the
efferent ducts in the rat and marmoset. Determining whether AQP-1 was expressed at this
time point was important as many of the later studies focus on this time period.
The efferent ducts of the male reproductive system and the proximal tubules of the kidney
are two sites which are responsible for a high rate of fluid reabsorption. The movement
of water across most biological membranes is attributed to simple diffusion through the
lipid bilayer. However, there are a number of specialised cell membranes which show a
much higher water permeability than is accountable for by diffusion alone. The epithelia
lining the efferent ducts and the proximal tubules exhibit a high rate of solute flux-
dependent reabsorption of luminal fluid. Initially the high absorption rate was explained
by the transport of water across the membrane secondary to ion transport but recently a
family of proteins have been discovered, termed 'Aquaporins', which are involved in fluid
movement. Water channels have been localised to many cell types, including, but not
restricted to, kidney proximal tubule cells, erythrocytes, selected cells in vasopressin
sensitive tissues e.g. kidney collecting duct and amphibian urinary bladder (Brown, 1989),
(Sabolic et al., 1992).
In 1988, a water permeable channel was identified in erythrocytes and proximal kidney
tubules which was related to the lens protein MIP (Major Intrinsic Protein of the lens)
(Denker et al., 1988; Smith and Agre, 1991). This protein was originally called CHIP-28
(Channel-forming Integral Protein of 28 KDa) but was renamed Aquaporin-1 (AQP-1)
after it was shown to function as a water-selective channel by expression in Xenopus
oocytes and reconstruction of highly purified CHIP-28 protein into proteoliposomes
(Preston et al., 1992) (Zeidel et al., 1992). Erythrocyte AQP-1 was purified and used to
raise antisera to map other AQP-1 sites by immunolocalisation (Sabolic et al., 1992).
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Western blotting has identified AQP-1 as one distinct band of 28kDa and more diffuse
band/s between 35-60kDa which are assumed to represent glycosylated moieties (Danker
et al., 1988),(Sabolic et al., 1992). In the kidney, AQP-1 localises predominantly to the
proximal tubules and the thin descending limb of the loop of Henle in both rats and
humans (Sabolic et al., 1992). It is present on both apical and basolateral membranes of
the proximal tubule and also on apical vesicles (Sabolic et al., 1992); AQP-1 comprises
3.8% of isolated proximal tubule brush border protein (Nielsen et al., 1993).
AQP-1 is a hydrophobic integral membrane protein that functions as a water channel
(Skach et al., 1994), although the pore through AQP-1 has been shown to be permeable to
other substrates. Both ethylene glycol and glycerol, but not urea, are able to pass through
AQP-1 proteins (Abrami et al., 1995). The molecular pathway that solutes take through
the channel has not been fully elucidated but the molecular structure of the channel has
been partially determined (Jung et al., 1994). Some authors predict that the structure of
AQP-1 may be analogous to many ion channels. Hydropathy analysis for both MIP and
AQP-1 suggested the protein consisted of six bilayer-spanning a-helices connected by 5
loops (A-E) (Preston et al., 1992). Both the amino- and carboxyl-termini were
immunologically determined to be intracellular (Smith and Agre, 1991), (Nielsen et al.,
1993) and the model determined that loops A, C and E were extracellular and loops B and
D cytoplasmic. A series of site directed AQP-1 mutants were synthesised to determine
which loops were required for the functional protein (Jung et al., 1994). The mutants were
expressed in Xenopus oocytes and it was determined that cytoplasmic loop B and loop E
were structural components of a single, narrow aqueous pathway through each sub-unit of
AQP-1 (Jung et al., 1994). Each of these loops contains a conserved NPA motif
(asparagine-proline-alanine) which has been located in homologues from plant and animal
species (Jung et al., 1994). The tertiary structure may allow these loops to be in contact in
the folded protein, forming structures which may dip into and emerge from the
cytoplasmic face and extracellular face of the lipid bilayer. The meeting of these two loops
at a central neck would form an hourglass structure (see Figure 4.1 )(Jung et al., 1994).
AQP-1 is believed to function as a multi-subunit oligomer which freeze-fracture studies
have shown to be a tetramer (Verbavatz et al., 1993). Further analysis by two-dimensional
crystallization provided a high resolution view of AQP-1 and revealed it to be an
asymmetric tetramer with central depressions extending deep into both the cytoplasmic
and extracellular surfaces (Walz et al, 1994), thus supporting the hour glass model.




Figure 4.1 Diagram of Aquaporin-1 Protein Structure and Folding
Representing a model of how the AQP-1 protein folds to form a water transporting pore
termed, the hourglass model. The final image represents the tetrameric protein structure
which is believed to comprise the functional protein (Jung et cil.} 1994).
A recent study examined the sites of AQP-1 expression developmentally by both
immunocytochemistry and in situ hybridisation from fetal day 14 in the rat to maturity
(Bondy et al., 1993). This paper described three patterns of AQP-1 expression. Strong
expression was found in the haematopoetic tissues and kidneys of mature rats with strong
staining only observed after birth. AQP-1 mRNA was found to be abundant in the
choroid plexus epithelium throughout fetal life to maturity. Messenger RNA was also
transiently expressed in the periosteum, heart, vascular endothelium and cornea during
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fetal life (Bondy et al., 1993). The ontogeny of kidney and erythrocyte AQP-1 coincides
with the ability of the kidneys to concentrate urine, suggesting that AQP-1 promotes water
resorption in the proximal nephron and provides red cell osmoregulation required for
passage through the hypertonic medulla of the kidney. The presence of AQP-1 in the
choroid plexus suggests that AQP-1 mediated water transport contributes to the secretion
of cerebrospinal fluid (Bondy et al., 1993). This study demonstrates the wide variety of
tissues which AQP-1 is important, not only in adults but also developmentally. This
suggests there must exist complex mechanisms to regulate the expression of AQP-1. The
study by Bondy et al., (1993) did not investigate the reproductive system to determine
whether AQP-1 was expressed in fetal / neonatal / adult life.
As described in the literature review of this thesis, some regions of the male reproductive
tract are embryonically related to the kidney and the efferent ducts exhibit a similar
resorptive capacity to the kidney nephron. The efferent ducts are responsible for
reabsorbing a high percentage of the fluid which enters from the rete testis. Additional
fluid resorption occurs along the epididymis adding to sperm concentration. The non-
ciliated cells of the efferent ducts are morphologically similar to the cells of the renal
proximal tubule to which they are embryologically related (Brown et al., 1993). AQP-1
was immunolocalised in the efferent ducts of the adult male rat. AQP-1 was localised to
the apical and basolateral membranes of the non-ciliated cells but no AQP-1
immunostaining was observed in the ciliated cells.
The studies described in this chapter re-examined the sites of AQP-1 immunolocalisation,
not only in the adult rat but also at specific time points from late fetal / early neonatal,
pubertal to early adulthood in both the rat and marmoset, enabling determination of
whether AQP-1 is a potential functional marker of the excurrent ducts during earlier
developmental stages. The aim was to establish whether or not AQP-1 expression was
evident before or around the time of puberty when fluid flow from the testis increases, and




Tissues from untreated control rats were obtained on fetal days 17.5 - 20.5 and on
postnatal days 4, 8, 10, 15, 18, 25, 35, 48 and 90. Animals were killed as described in
Section 2.1 and tissues were fixed in Bouin's fluid as described in Section 2.3.3. These
tissues were processed for paraffin embedding as previously described (Section 2.3.3).
Marmoset tissues were collected with the testis and epididymis attached. The tissue was
classed as being from either neonates, infants, prepubertal or adults (aged 1 day, 8-24, 54-
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62, 92-112 weeks, respectively; n= 2-4 per group). These tissues were collected from
control animals from a different experiment and had been processed into paraffin blocks.
4.2.2 Antibody Production
The AQP-1 antibody was a gift from Professor Dennis Brown (Harvard Medical School,
Boston). The immune serum was prepared from human erythrocytes. AQP-1 was
isolated from potassium-iodide stripped erythrocyte ghosts (Van Hoek and Verkman,
1992). The antibody was then produced as described by Sabolic et al., (1992). Briefly,
0.25 mg of purified AQP-1 was injected subcutaneously with Freunds complete adjuvant
into New Zealand white rabbits. Boosters of 0. lmg protein were given every three weeks
with Freunds incomplete adjuvant. Sera from bleeds were checked for specific antibody
production by immunocytochemistry and Western analysis (Sabolic et al., 1992). In the
present studies AQP-1 antiserum and its pre-immune control were used at a dilution of
1:500.
4.2.3 Western Blot Analysis
Western blots were performed using 75gg of adult efferent duct and kidney proteins that
were separated using 12% acrylamide SDS-PAGE blotted onto PVDF membrane and
probed with AQP-1 antiserum and pre-immune serum at 1:5000. The methods are fully
described in Chapter 2 (sections 2.6-2.8) using ECL detection.
4.2.4 Immunoctyochemistry on paraffin tissue sections
Immunocytochemistry was performed as described in Section 2.4.1.
4.2.3 Photomicroscopy
The slides were photographed as described in Section 2.5.1.
4.3 Results
4.3.1 Western Blot Analysis of AQP-1
The result shown in Figure 4.2 demonstrates the specificity of AQP-1 antibody in
recognising the 28kDa protein in both adult rat kidney and efferent duct protein samples.
The higher band represents the glycosylated form of the AQP-1 protein.
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Figure 4.2 Aquaporin-1 Detection by Western Blot
Western Blot analysis of AQP-1 in adult kidney (lane 1.3) and efferent duct (2, 4) protein.
Lanes 1 and 2 represent blots incubated with pre-immune serum while lanes 3 and 4 were
incubated with AQP-1 antisera. The arrow indicates 28 KDa.
4.3.2 Developmental Pattern Of AQP-1 Immunoexpression in the Rat
The results shown in Figure 4.3 are digital photomicrographs. A positive control tissue
section of rat kidney is shown in panel (a) and depicts AQP-1 immunostaining (brown
precipitate) within the thin descending limb of the loop of Henle, the kidney collecting
ducts also expressed AQP-1. It is evident from the figure that AQP-1 was expressed in the
efferent ducts at all ages from fetal life onwards. During fetal life AQP-1
immunoexpression was evident from day 17.5 (earlier time points were not assessed) and
persisted throughout the rest of fetal life (days 17.5 and 19.5 are shown in panels c and d
respectively; days 18.5 and 20.5 are not shown). Note also that the lumens of the
developing efferent ducts were patent even at this early time point. In early postnatal life
(day 4, Figure 4.3 (e)), it was not yet possible to distinguish different cell types within the
epithelium and all cells had a columnar appearance.
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Figure 4.3 Aquaporin-1 Immunolocalisation in the Rat
Immunoexpression of AQP-1 in the efferent ducts of the rat from fetal life to adulthood. A positive
control tissue section of rat kidney (a) and a negative control (b) of postnatal day 4 efferent ducts
are shown. Representative patterns of immunostaining are shown for rats aged (c) fetal day 17.5,
(d) fetal day 19.5, postnatal days (e) 4, (f) 10, (g) 18, (h) 25 and (i, j) 90 days.panels b, c, d, e, h, j
are shown at a higher magnification of x1000 using oil immersion. All other panels are shown at
x400. The scale bars in (a) and (b) denote 100 and 20pm respectively. The arrows (j) indicate
ciliated cells.
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AQP-1 immunolocalisation appeared as a thick apical band staining the brush border of
the epithelial cells though there was also immunostaining of the basolateral membrane. A
similar section incubated with pre-immune serum as a negative control, revealed no
immunostaining (panel b). The situation was almost identical at days 10, 18 and 25 except
that it was possible to see that the epithelial cells were differentiating such that ciliated cells
could be identified by the apical position of their nuclei (Figure 4.3 (f, g, h)). At day 35
(late puberty) the ciliated cells were absent from AQP-1 immunostaining (not shown).
From day 18, the lumen of the efferent ducts increased in diameter until adulthood
consistent with the age at which production and flow of STF has been shown to
commence (Setchell et ciL, 1994). The pattern of AQP-1 immunostaining is identical in
adulthood (Figure 4.3 (i)). The morphology of the adult epithelium is clearly shown in
Figure 4.3 (j), the high columnar epithelium displayed an extensive brush border. The
apical nuclei of the ciliated cells were clearly visible as were the basal nuclei of the non-
ciliated cells. It was quite clear that ciliated cells did not immunoexpress AQP-1 whereas
non-ciliated cells showed high levels of expression (panel j; arrows). The testicular
parenchyma and the epididymis were never immunopositive for AQP-1 (not shown).
4.3.2 Developmental Pattern of AQP-1 Immunoexpression in the Marmoset
The results of AQP-1 immunolocalisation in the marmoset monkey were broadly similar
to the rat (Figure 4.4). A section of adult marmoset kidney was immunostained with AQP-
1 as a positive control (panel a). The staining was identical to rat kidney with AQP-1
localising to the collecting ducts and the thin descending loop of Henle; panel (a) shows
the collecting ducts. On day one postnatal the developing efferent ducts showed a similar
pattern of expression to the fetal rat (Figure 4.4 (b)). The fixation of this tissue is not as
good as the rat and many of the ducts have collapsed but there were a few which clearly
had a patent lumen. By eight weeks the efferent duct lumens were more obvious and the
brush border was clearly immunostained with AQP-1 as were the basolateral membranes
(Figure 4.4 (c)). The situation was identical at 17.6 weeks of age (panel d). The
epithelium of the marmoset efferent ducts showed a more intense reaction to the AQP-1
antisera than did the rat tissue. The brush border displayed intense immunoreaction and
the cytoplasm of many of the epithelial cells were also heavily immunostained. At 62
weeks (peripubertal; Figure 4.4 panel e) the efferent duct lumen had expanded and the
intracellular immunostaining appeared to have increased. It was not possible to locate an
apical cell membrane (i.e. from a ciliated cell) which was not immunoreactive for AQP-1.
The situation was identical in the adult marmoset (92 weeks, panel f).
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Figure 4.4 Aquaporin-1 immunoiocaiisation in the Marmoset
Immunolocaisation of the efferent ducts from marmoset monkey from the perinatal period
through to adulthood. A positive control section of marmoset kidney is shown in panel (a).
AQP-1 staining is shown for animals ages (b) one day, (c) 8 weeks, (d) 17.6 weeks, (e) 62
weeks and (f) 92 weeks. Panel (g) depects the testis and (h) rete testis at 8 weeks. All
photomicrographs are shown at x400 and the scale bar denotes 100pm.
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Figure 4.5 Aquaporin-1 Immunocytochemistry in the Marmoset Epididymis
immunocytochemical staining of the marmoset epididymis at 8 weeks (a; initial segment),
17.6 weeks (b; initial segment), c (caput region), 62 weeks (d; caput, f; cauda). All images
are shown at x400 and the scale bar denotes 100^m.
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As in the rat, there was no expression of AQP-1 within the seminiferous tubules or
interstitium (Figure 4.4 (g)). However, where cross-sections of the rete testis were evident
(neonatal and peripubertal animals) there was a narrow apical band localised to the rete
testis and this extended to the basolateral membrane in some cells (panel h).
Unlike the rat, however, the marmoset epididymis was immunopositive for AQP-1 when
assessed at 8, 17.6 and 58.7 weeks of age (Figure 4.5). Aside from the efferent ducts, the
most intense immunoreaction was within the initial segment of the epididymis (Figure 4.5
(a,b); ages 8 and 17.6 weeks respectively). In the caput epididymis of the younger
animals (17.6 weeks) there was a fine apical band of immunostaining along the epididymal
epithelial cells (panel (c)) but at puberty (58.7 weeks; panel (d)) a specific subset of
principal cells termed apical cells showed a strong immunoreaction along their apical and
basolateral surfaces. This was still evident but less common in the corpus epididymis (not
shown) with some staining evident in the cauda neonatally (Figure 4.5 (e)). Around
puberty, there was no epithelial staining of the cauda epididymis (panel f).
4.4 Discussion
The possibility that the water channel AQP-1 may be a potential functional marker of the
efferent ducts was investigated in these experiments. The efferent ducts are an important
site of ER action and their major function is fluid resorption. The strong expression of
AQP-1 in the efferent ducts from fetal life through to adulthood strongly suggests it is an
important factor in fluid dynamics within this region. The Western blot demonstrates the
specificity of this antibody in detecting the AQP-1 protein (Figure 4.2).
The presence of AQP-1 during fetal and early neonatal life was unexpected as fluid flow
through the rete testis and efferent ducts is generally considered as being coincident with
puberty and the production of seminiferous tubule fluid (Setchell et al., 1994). The
present results imply that fluid is flowing through these ducts earlier in development than
the published data would suggest. The observation that the ductules are always patent,
even in fetal life, supports this interpretation. It was evident however that the lumens of the
efferent ducts expanded in rats from day 18 postnatal onwards and continued to increase
in diameter until adult life presumably indicative of increased fluid flow from the testis at
puberty.
AQP-1 localisation in the rat was limited to the efferent ducts with no immunolocalisation
to either the testis or the epididymis. During the neonatal period before the ciliated
epithelial cells had differentiated in the efferent ducts, all the epithelial cells showed a
strong immunoprecipitate along the apical brush border and a weak reaction in the lateral
and basal membranes. Between day 18-25 postnatal, it was clear that ciliated cells did not
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express AQP-1. These finding are in agreement with those already published for the adult
rat which indicate that only non-ciliated cells express AQP-1 (Brown et al., 1993).
The immunolocalisation of AQP-1 within the efferent ducts of the marmoset showed
broadly the same pattern of expression as the rat, except the immunoprecipitate was more
intense and in some animals cytoplasmic staining was evident. It appeared that all
epithelial cells were immunostained, suggesting that either all epithelial cells within the
marmoset epididymis express AQP-1 or that the precipitation reaction to the antibody was
so intense that it was not possible to distinguish any unstained cells. The marmoset also
showed positive immunostaining in other regions of the excurrent duct system, though in
the rat, the testis showed no staining for AQP-1. The rete testis was positive and there was
an apical layer of staining along the rete epithelium and there were also some specific cells
that had a stronger apical staining and also basolateral immunolocalisation. This might
indicate that the cell types within the rete testis are not homogeneous and that different cell
types exist and perform specific functions such as fluid resorption.
The transitional zone at the terminal region of the seminiferous tubules also displayed
some positive cells.
The epididymis of the marmoset, but not the rat, also showed some immunolocalisation of
AQP-1 throughout development. In general the most intense immunoexpression was in
the efferent ducts and initial segment of the epididymis where a strong apical
immunoexpression was evident along the epithelium. Within the caput epididymis
apical/narrow cells were staining and the distribution of this cell type decreased towards
the cauda region of the epididymis with hardly any cells (probably clear cells) staining in
this region. This would suggest that AQP-1 is differently distributed in the marmoset.
The increase in staining density may be a true reflection of the sites of AQP-1 expression
in the marmoset or it may indicate a cross reaction with another protein by the polyclonal
antiserum used in these studies
The AQP-1 staining on the apical surface of the non-ciliated cells within the efferent ducts
supports the morphological findings that the resorptive apparatus is confined to this cell
type (Brown et al.., 1993), (Hermo and Morales, 1984), (Goyal and Hrudka, 1980). These
results update the model of fluid resorption within the efferent duct that was proposed by
Ilio and Hess (1994). This model suggested that water resorption occurs secondary to ion
transport, and during transit through the efferent ducts the fluid concentration of Na+ is
lowered whilst that of H+ is increased indicating the presence of ion channels within the
efferent duct epithelial membrane (Ilio and Hess, 1992). The immunolocalisation of AQP-
1 to the apical membrane implicates this protein as a primary candidate for the absorption
of water into nonciliated cells. However AQP-1 does not transport electrolytes (Preston
et al., 1992), therefore other channels must exist to facilitate the entry of Na+ and maintain
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the osmotic environment. How water exits the cell is not clear, but this may occur partly
secondary to ion transport as a Na+K+-ATPase has been localised to the basal and
basolateral membrane of the efferent ducts (Byers and Graham, 1990), (Uio and Hess,
1992). There is some immunoreactive AQP-1 along the basal and basolateral membrane
of the non-ciliated cell but the staining is less intense than at the apical surface suggesting
that AQP-1 is of less importance in water transport across this membrane.
The exact time of onset of AQP-1 expression was not determined in this study but as the
efferent ducts develop from the mesonephric tubules which do function as a kidney in fetal
life one might hypothesise that it is expressed throughout its development and
differentiation. Studies would have to be performed to test this possibility. It has been
proposed that during sexual differentiation, testosterone from the fetal Leydig cells may be
transported along the Wolffian duct by fluid flow rather than by simple diffusion (Tong
et al, 1996). The presence of AQP-1 in the fetal ducts at this time supports this train of
thought and raises the question as to what induces AQP-1 expression in fetal life. It has
been shown in the fetal lung that maternal corticosteroids induce expression of AQP-1
(King et al., 1996). This finding together with strong expression of ER-a and AR in the
efferent ducts, raises the possibility that sex steroids are involved in the expression of
AQP-1 in the efferent ducts. This possibility will be addressed in Chapter 6.
Chapter 5 The Effect of Neonatal Exposure to
Oestrogenic Chemicals on Testis Weight and the
Morphology of the Rete Testis
5.1 Introduction
The experiments described in Chapters 5 and 6 are based on investigating alterations to the
morphology of the rete testis and efferent ducts of the rat reproductive tract after neonatal
exposure to oestrogenic compounds. These chapters are based on results from the same
treatment groups and the background information regarding the rationale for these studies is
detailed below and applies to both these chapters.
The studies examined the effects of oestrogen administration during the neonatal period. As
discussed in the literature review, the neonatal period is important for the normal development
of the reproductive system. In particular, it is the period of major Sertoli cell multiplication,
which determines the adult spermatogenic output of the testis, and also a time of growth and
development of the male excurrent duct. During this time accessory organs are still
developing. Studies in the literature have shown that this time point is very sensitive to
disruption by exogenous steroids. The aim was to examine the effects of treating rats during
this time period in order to determine possible roles of oestrogen within the excurrent ducts
and also to determine whether any weak 'environmental' oestrogens could induce any
detectable effects similar to those induced by more potent oestrogens. These studies will aid
understanding of the role of oestrogen within the developing reproductive tract and determine
whether any information can be gained from animal models to elucidate the role of
environmental chemicals in the observed changes to male reproductive health discussed in the
literature review.
In essence, the basic strategy was to use high doses of DES (starting at lOgg/injection)
administered subcutaneously to neonatal animals (on alternate days from days 2-12 postnatal)
to determine the effects of high dose oestrogen exposure on the excurrent duct system. DES
was used in these studies as it is known to be a potent oestrogen which can induce adverse
effects on the male reproductive tract of both humans and laboratory animals (see Sections
1.2.6 and 1.7.3). In essence this compound acted as a positive control. Two lower doses (lpg
and 0. lpg/injection) were used to determine whether there was a dose-response for any of the
observed effects and whether it was possible to establish a no observable effect level (NOEL).
A cohort of animals were treated with ethinyl oestradiol to ensure the effects induced after
administration of the DES were comparable to those induced by the administration of another
synthetic oestrogen (ethinyl oestradiol) at the same dose (lOgg/injection).
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It was also necessary to ensure that any effects observed were due to the direct actions of
oestrogen acting on the target organs and were not secondary effects from oestrogen acting
via the hypothalamo-pituitary axis. To determine this, a GnRH antagonist was administered to
a cohort of animals to suppress LH/FSH secretion to allow us to determine if this affected the
excurrent ducts. This study would differentiate between the effects of gonadotrophin action
and those induced as a direct result of oestrogen exposure. The effect of tamoxifen
administration was also examined as it may act as an oestrogen receptor antagonist and would
also allow the effects of decreasing oestrogen levels within the developing neonatal rat to be
assessed. Finally, cohorts of animals were treated neonatally with one of the following weakly
oestrogenic compounds namely, octylphenol, bisphenol A, parabens or the phytoestrogen
genistein, to determine whether these induced any of the effects observed after DES exposure.
In order to examine the nature, severity and reversibility of the effects, groups of treated
animals were examined at various time points during prepubertal, postpubertal and adult life
(10, 18, 25, 35 and 75 days).
The lack of known oestrogen-regulated endpoints in male animals encouraged the use of a
histology based approach to identify changes in the excurrent ducts between control animals
and those which had been treated neonatally with either potent or weakly oestrogenic
compounds. This chapter assesses changes in rete testis morphology induced by oestrogen
treatment so it is necessary to review the literature describing normal rete testis morphology
and its development.
The rete testis is not a well-studied structure. Unlike the testis, which is responsible for
producing sperm, or the epididymis, which is important for sperm storage and maturation, the
rete testis does not appear to have such a vital biological function (as judged by the paucity of
published reports!). However, were it not for the rete testis the sperm and testicular fluid
would never reach the epididymis, so although many authors consider this structure as a
conduit for sperm transport, this would appear a rather vital function, enabling sperm to reach
the epididymis and allowing sperm maturation to occur. The function of the rete testis or the
need for this structure is not clear but this structure has an intratesticular region that then
passes through the tunica albuginea into an extra-testicular region and, developmentally, it is
the region of urogenital union. After the onset of spermatogenesis this structure appears to
function a bit like a roundabout. The sperm leaving the testis enter the rete testis from different
seminiferous tubule junctions where they are all mixed and then exit out of the testis and enter
the excurrent duct system.
Basic anatomical information regarding the rete testis has been described in the literature
review (Section 1.3.3). The rete testis of the rat has both intra- and extra- testicular regions,
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which has raised an interesting embryological question as to the origin of these structures.
The intratesticular rete forms from the gonadal blastema which consists of a great number of
epithelial and germ cells (Roosen-Runge, 1961). It arises on day 12 of fetal life by
proliferation of the coelomic epithelium which covers the ventro-medial aspect of the
mesonephric ridge. Development of the rete occurs together with the sex cords as they are
linked at their terminal regions. On day 19 p.c., the rete strands show the first signs of lumen
formation (Roosen-Runge, 1961). By day nine postnatal the intratesticular rete has
completely anastomosed within the rete structure and sex cords and has essentially merged
into a single cavity. During fetal development the rete testis epithelium shows a similar
composition and structure to the sex cords but by day 19 p.c., when lumen formation occurs,
it has become a simple low columnar epithelium containing occasional germ cells. During
postnatal development the epithelium gradually reduces in height and germ cells are no longer
observed. The reduction in rete testis epithelial cell height is most evident 3-4 weeks after
birth when spermatogenesis is initiated. This is also the time when the greatest increase in rete
testis lumen size occurs (Roosen-Runge, 1961).
The origin of the extratesticular portion of the rete testis is less certain. Prior to the
connection between the gonad and mesonephros there exists an aggregation of cells between
these two structures on day 13 of fetal life (Roosen-Runge, 1961). Bridges of cells can be
observed between these two structures which are morphologically different from cells of either
structure. By the end of day 14 p.c. there are rudiments of an extratesticular rete (rete
blastema). By 15.5 p.c. many fine basement membranes can be observed which vaguely
outline a network of strands within the rete blastema. These basement membranes become
progressively thicker. Canalization of the extratesicular rete does not occur until day 20 p.c.
and continues after birth (Roosen-Runge, 1961).
Very few abnormalities involving the rete testis have been described, except those induced
experimentally by efferent duct ligation. This is often performed in studies examining the
composition of seminiferous tubule fluid and few studies exist which have examined the
effects of ligation on the rete testis itself. Efferent duct ligation in the rat leads to the
accumulation of fluid behind the ligature that continues in a linear manner for up to 30 hours
(Setchell, 1970). The build up of fluid often induces dilatation of the rete testis which aids
researchers in cannulating the rete but few have studied the eventual morphological changes in
the rete testis induced by this dilatation. Rete testis distension has been observed six hours
after efferent duct ligation whereas dilatatory effects were not observed within the
seminiferous tubules until 12 hours (Smith, 1962). The central cavities of the rete testis have
been shown to undergo a marked dilatation 24 hours after efferent duct ligation with much
less distension observed in the tubuli recti which are supported by connective tissue struts.
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Some tubuli recti appear to be compressed by a valve-like rete septum and can resist back¬
pressure up to 12 or 24 hours after ligation. After this time the valves appeared to invert,
which is a sign of retrograde flow from the rete testis into the seminiferous tubules (Nykanen,
1980). Although ligation studies have been used as a means of differentiating between
systemic (hormonal) regulation of the epididymis and factors deriving from testicular STF
(Robaire and Hermo, 1988), the effects of fluid distension alone on reproductive tract
physiology have yet to be established.
5.2 Materials and Methods
5.2.1 Animals
The animals were housed and treatments administered as described in sections 2.1 and 2.2.
Prior to fixation, one testis was removed and weighed after the removal of the epididymis. To
examine the effect of treatment on rete morphology, tissue that had been embedded in paraffin
wax (as described in sections 2.3.3 and 2.3.4) was carefully sectioned. As the rete is a diffuse,
flattened structure, care was taken to ensure tissue sections from different animals were from
comparable regions of the rete. Therefore, only sections that were seen to pass through the
tunica albuginea and join the extratesticular portion and efferent ducts were compared. This
meant carefully examining every 5-10th paraffin section using light microscopy to locate the
rete testis and efferent ducts. When the rete was located, haematoxylin and eosin staining
determined the quality of the cross section.
5.2.2 Haematoxylin and Eosin (H&E) Staining Protocol
Slide mounted tissue sections were deparaffinised in Histoclear for 5 min before being
rehydrated through a decreasing series of alcohols (absolute, 95% and 70%) each for
approximately 20 seconds. The slides were then rinsed in water and placed into Harris's
haematoxylin for 5 min and then rinsed. To remove any cytoplasmic staining the slides were
immersed in 1 % acid alcohol for a few seconds and then washed in water. The slides were
then placed in Scott's tap water until the nuclei turned blue and the slides were again washed
in water. The slides were incubated briefly in eosin (5-20 seconds) and washed in water. The
slides were then dehydrated through a series of increasing alcohols and cleared in xylene
before being coverslipped. The tissue sections were examined microscopically and digital
images were captured and analysed as described in section 2.5.1.
5.3 Results
5.3.1 Testicular Weights
Testicular size is known to be decreased after postnatal exposure to oestrogenic compounds
(Fisher et al., 1998) and provides a gross indication of the number of cells within each testis.
Therefore testis weights were compared between control and treated cohorts at 18, 25, 35 (not
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shown) and 75 days of age (Figure 5.1 A-C). All testis weight values quoted in the text
represent the mean±SD mg.
The results shown in Figure 5.1 A are those for animals at 18 days of age. Normal control
animals had testis weights of 64.3±12.2mg. In comparison with this, GnRHa treated animals
showed a highly significant reduction in testis weight (22.4±3.4mg), demonstrating that
inhibition of the hypothalamo-pituitary axis inhibits normal testis growth. Higher doses of
DES (lOgg/injection) showed a similar reduction in testis weight (24.6+2.5)mg in comparison
with control. Although the response to DES was dose dependent, at the lowest concentration
used (O.lgg/injection), testicular weights were similar to control animals (61. 1±11.9mg).
Ethinyl oestradiol (lOgg/injection) and the oestrogen receptor antagonist/ agonist tamoxifen
both produced similar results to the highest dose of DES and the GnRHa (30.7+2.6mg;
23.2±2.6mg respectively). These results indicate that potent oestrogens (DES, ethinyl
oestradiol) and tamoxifen are capable of inhibiting normal testis growth.
Figure 5.1 A also demonstrates that weak oestrogens (octylphenol, methylparabens, bisphenol
A and genistein) did not cause any reduction in testis weight at this time point. However, both
octylphenol treated rats and animals whose mothers were fed on a soy-free control diet
showed increased testis weights (87.0±10.2mg, 82.7+18.8mg respectively). The increase in
testis weight in soy-free animals suggests that either the amount of soy protein in normal
animal feed is enough to cause a significant reduction in normal control testis weight, or that
soy-free feed induces an increase in normal testis size. Similarly, neonatal octylphenol
treatment may increase normal testis weight perhaps due to a possible anabolic action of this
compound. Neonatal treatment with the phytoestrogen genistein induced a significant
reduction in testis weight (74.4±7.8mg), when compared to control animals whose mothers
were fed on a soy-free diet. However, the testis weights of genistein treated animals was not
different from normal control animals. This may suggest that genistein treatment reduced
testis size (compared to soy-free controls) but this decrease was simply returning testis
weights to values comparable to normal control animals whose diet contained phytoestrogens,
including genistein.
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Figure 5.1A Comparison of Testis Weight (mg) at Day 18 Postnatal After
Neonatal Administration of Oestrogenic Compounds
Testis weights were compared in 18 day old rats after neonatal treatment with vehicle (Control;
n=l 1), GnRHa (n=12), DES 10pg (n=14), DES l.Opg (n=10), DES 0.1 gg (n=10), ethinyl
oestradiol (n=4), tamoxifen (n=4), octylphenol (n=8), parabens (n=6), bisphenol A (n=6),
soy-free control (n=13) and genistein (n=14); the doses administered were as detailed in
Chapter 2 (Section 2.2). The data represents the mean ± S.D. (**p<0.01 compared with the
soy-free control group; ***p<0.001 compared to the normal control group).
Figure 5.IB demonstrates testis weights for rats killed at day 25; these show a similar pattern
to those described on day 18 (Figure 5.1 A). The highly significant reduction in testis weight
induced by neonatal treatment with GnRHa (46.6±24.6mg) was still apparent when compared
with controls (165.5±27.5mg). However in comparison with day 18 data, neonatal treatment
with DES (l.Opg) had not decreased in the dose-dependent manner observed at the earlier
time point. The reason for this is unclear. However DES at all doses administered, decreased
testis weight, although the data for DES (1 .Opg) was not significantly reduced when compared
to controls. Ethinyl oestradiol again significantly reduced testis weight (56.6±12.3mg), to a
similar degree as GnRHa treatment. Octylphenol, at this time point did not affect testis weight
in comparison with control, contrary to the data shown for day 18. The genistein
(150.7±62. lmg) and bisphenol A (179.0±37.2mg) treated animals showed no change in testis
weight when compared to control animals.
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Testis weight at day 35 (data not shown) and in adults (Figure 5.1C) demonstrated similar
changes to the earlier ages. GnRHa treatment again reduced testis weight (249.7±28mg)
compared to control (759.8±90.0mg), while DES dose-dependently decreased testis weight
similar to the results shown for day 18 (Figure 5.1 A). Bisphenol A treatment caused no
significant change in testis weight in adulthood but at 35 days of age there was a slight but
significant decrease in testis weight in this group (not shown). Animals treated neonatally with
genistein had marginally but significantly larger testes in adulthood (2384±100.8mg).
Figure 5.1 (A-C) illustrates that testis weights were significantly reduced at all ages after
neonatal exposure to GnRHa, ethinyl oestradiol and all three doses of DES (in adulthood).
As the data from the soy-free control group did not differ significantly from control animals
in any parameter assessed at day 18 (except testis weight), for simplicity, at all other ages






















Figure 5.IB Comparison of Testis Weight at Day 25 Postnatal After
Neonatal Administration of Oestrogenic Compounds
Testis weights were compared in 25 day old rats after neonatal treatment with vehicle (Control;
n=12), GnRHa (n=14), DES lOgg (n=8), DES 1 .Ogg (n=5), DES 0.1 pg (n=4), ethinyl
oestradiol (n=7), octylphenol (n=6), bisphenol A (n=5) or genistein (n=7); the doses
administered were as detailed in Chapter 2 (Section 2.2). The data represents the mean ±S.D.
(***p<0.001 compared to the normal control group)













Figure 5.1C Comparison of Testis Weight at Day 75 Postnatal After Neonatal
Administration of Oestrogenic Compounds
Testis weights were compared in 75 day old rats after neonatal treatment with vehicle (Control;
n=6), GnRHa (n=5), DES lOpg (n=6), DES l.Ogg (n=4), DES 0.1 pg (n=4), bisphenol A
(n=3) or genistein (n=5); the doses administered were as detailed in Chapter 2 (Section 2.2).
The data represents the mean ± S.D. (**p<0.01, ***p<0.001 compared to the control group).
5.3.2 The Rete Testis
Description of the rete testes of control and neonatally oestrogen treated rats will be presented
in chronological order i.e. day 10 (neonatal), followed by day 18 (peripubertal), day 25
(pubertal), day 35 (late puberty) and day 75 (early adulthood).
Figure 5.2 panels (a, b) depict the rete testis of a control rat on postnatal day 10. Panels (a, c, e,
f) show low power images, while panels (b, d, f, i) are high power images which allow the rete
epithelium cells to be clearly viewed. Panel (a) demonstrates the position of the rete testis at
the apical pole of the testis just beneath the spermatic cord. The rete testis is clearly patent at
day 10. Figure 5.2 (b) illustrates the features of the rete testis epithelium at this age. In
control animals the rete testis epithelium was highly columnar/cuboidal in appearance and
generally displayed large ovoid nuclei located towards the base of the cell.
Panels (c, d) demonstrate the effect of neonatal DES administration (lOpg/injection). The
animals were treated on alternate days between day 2-8 postnatal and killed on day 10, so
these animals were assessed during the treatment period. Panel (c) illustrates that the rete has
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accumulated fluid and undergone considerable distension and appears to have partially
invaded the testicular parenchyma. The irregular shaped canaliculi of the rete testis in control
animals has been replaced with regular almost sphere-like region, which appear stretched and
turgid. Panel (d) highlights that the distension has been accompanied by a change in the rete
testis epithelium. The high columnar cells, which should characterise the epithelium at this
age, appear low cuboidal/squamous in appearance.
Panels (e, f) and (g, h) show the rete testis from rats treated with bisphenol A (a weak
'environmental' oestrogen) and genistein (a phytoestrogen) respectively. Neither of these
compounds produced any noticeable effect on rete testis morphology and, at both low and
high power, the rete testis appeared comparable in size and morphology to that in the control
animal shown in panels (a, b).
Figure 5.3 illustrates the rete testis at day 18 postnatal, which is around the time that
seminiferous tubule fluid production is increased, Sertoli cell junctions are formed in the testis
and lumens are formed in the seminiferous tubules. Panel (a) depicts the rete testis in a
control animal at day 18. It is clear that the epithelial cell height is reduced compared to day
10 and lumens are evident within the testicular cords. Panel (b) shows the rete testis after
neonatal administration of a GnRHa. It is clear that the rete testis appears less distended than
the control (panel a) and still maintains the epithelial cell pattern characteristic of the day 10
rete. Lumens have not yet developed within the seminiferous cords. Overall these animals
appear less developed than the corresponding controls.
Figure 5.3 (c, d) demonstrates the effect of neonatal ethinyl oestradiol and DES administration
respectively (both lOgg/injection). Both treatments induced rete testis distension but it was
evident that DES invoked a more severe and invasive distension than did ethinyl oestradiol.
DES administration caused the rete testis to invade into the testicular parenchyma such that the
rete testis no longer occupied only the superficial region underneath the testicular capsule. It
was also quite evident that the testicular cords were not as well developed as in control animals
with few cords, if any, showing signs of lumen formation. Panels (e, f) illustrate the effect of
administration of lower doses of DES (1 and 0. lgg/injection, respectively). Administration of
lgg/injection induced a level of rete testis distension, which was similar in severity to that
observed after the administration of ethinyl oestradiol (lOgg/injection). The administration of
DES appeared to cause the rete testis to invade further into the testicular parenchyma than
after treatment with ethinyl oestradiol. Testicular development appeared impaired in both
ethinyl oestradiol- and DES (10pg) - treated groups when compared to controls (panel a), as
few seminiferous tubules showed lumen formation. At the lower dose of DES
(0. lgg/injection) there was no apparent distension of the rete testis and its morphology and
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that of the testis appeared similar to control animals with seminiferous tubules displaying
lumen formation. Figure 5.3 (g, h, i, j) illustrates the effect of neonatal exposure to weak
oestrogens (octylphenol, bisphenol A, parabens and genistein, respectively). None of these
treatments induced any obvious rete testis distension and both rete testis and testicular
morphology was similar to the control group.
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Figure 5.2 The Morphology of the Rete Testis in Control and Treated Animals at Day 10
Morphology of the rete testis (shown by asterisks) at 10 days of age in control rats (a, b) and in
animals treated with DES (10pg/injection; c, d), bisphenol A (e, f) or genistein (g, h). panels a,
c, e and g are low power images and the scale bar in (a) denotes 200pm. The images shown
in panels b, d, f and h are high power and the scale bar measures 50pm.
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Figure 5.3 The Morphology of the Rete Testis in Control and Treated Animals at Day 18
Morphology of the rete testis (shown by asterisks) in rats aged 18 days. Panels show the rete
testis from rats treated with (a) vehicle control, (b) GnRHa, (c) ethinyl oestradiol (10pg), (d, e, f)
DES at 10, 1.0 and 0.1 pg/ injection respectively, (g) octylphenol, (h) bisphenol A, (i) parabens
or (j) genistein. The scale bar (a) denotes 200pm.
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At day 25 (Figure 5.4) the control rete testis appeared more distended than at day 18,
presumably reflecting the increase in STF production at puberty. Panel (b) illustrates the rete
testis after neonatal exposure to GnRHa that appeared similar to control animals although the
rete testis epithelium appeared higher and more cuboidal than in control animals. Panel (c)
illustrates the rete testis after neonatal treatment with ethinyl oestradiol. There was no obvious
sign of rete testis distension. The only animals which showed severe distension of the rete
testis at day 25 postnatal were those which were treated with lOgg DES, a change still evident
almost two weeks after the cessation of DES administration. Treatment with lower doses of
DES (1 and 0.1 gg/ injection; panels e, f, respectively) did not result in any signs of rete testis
distension and appeared similar to control animals. Similarly, there was no evidence of rete
testis distension after postnatal treatment with octylphenol (panel g), bisphenol A (panel h) or
genistein (panel, i).
Figure 5.5 illustrates the rete testis at day 35. At this age, there was no obvious difference in
morphology of the rete testis in control or GnRHa treated animals (panel a, b respectively). In
contrast panels (c) and (d) depict rete testes from DES treated animals (lOgg and
lgg/injection respectively). In comparison with the control (panel a) both were noticeably
distended. Panel (c) (DES (lOgg/injection) demonstrated an abnormal sloughing of germ
cells into the lumen of the rete testis (compared with control (panel (a)), suggesting that
spermatogenesis was adversely affected. Animals treated neonatally with ethinyl oestradiol
were not assessed at this time point; those treated neonatally with DES at 0.1 gg/injection
(panel e) or bisphenol A (panel f) appeared similar to control animals.
The rete testis of rats treated neonatally with oestrogenic compounds was also assessed in
early adulthood (day 75, Figure 5.6). The rete testis of control and GnRHa treated animals
appeared similar with no signs of abnormal rete testis distension (panels a, b). However,
animals treated neonatally with either ethinyl oestradiol or DES (lOgg/injection) still showed
signs of rete testis distension, although not as severe as that observed at day 18. Panels (d, g)
illustrate the effect on testis morphology after DES (lOgg/injection) but comparable results
were obtained after treatment with ethinyl oestradiol. There were a large number of
seminiferous tubules, particularly in the region of the testis directly underneath the rete testis,
which were largely devoid of germ cells or were Sertoli-cell- only tubules. The rete testis
from animals treated neonatally with lower doses of DES (1.0 or 0.1 gg) or bisphenol A did
not show any signs of distension and appeared similar to control animals.
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Figure 5.4 The Morphology of the Rete Testis in Control and Treated Animals at Day 25
Morphology of the rete testis in rats aged 25 days (shown by asterisks), panels show the rete
testis from rats treated with (a) control vehicle, (b) GnRHa, (c) ethinyl oestradiol (10,ug), (d, e, f)
DES at 10, 1.0 and 0.1 pig/injection respectively, (g) octylphenol, (h) bisphenol A, or (i) genistein
The scale bar (a) denotes 200pm.
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Figure 5.5 The Morphology of the Rete Testis in Control and Treated Animals at Day 35
Morphology of the rete testis in rats aged 35 days (shown by asterisks). Panels show the rete
testis from rats treated with (a) control vehicle, (b) GnRHa, (c, d, e) DES at 10, 1.0 and 0.1tug/
injection respectively or bisphenol A (f). The scale bar (a) denotes 200um.
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Figure 5.6 The Morphology of the Rete Testis in Control and Treated Animals at Day 75
Morphology of the rete testis in rats aged 75 days (shown by asterisks). Panels show the rete
testis from rats treated with (a) control vehicle, (b) GnRHa, (c) ethinyl oestradiol (10,ug), (d, e)
DES at 10, and 0.1pg/injection respectively or bisphenol A (f). The scale bar (a) denotes
200pm. panel (g) shows a cross section from an adult rat after neonatal DES (10pg/injection)
treatment. Scale bar shows 500pm and the arrow (g) illustate the region of disrupted
spermatogenesis.
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5.4 Discussion
Testis weight is a parameter that is often assessed in studies to determine toxic insult to the
reproductive tract. In this study, the effect of various oestrogenic compounds (both weak and
potent) on testis weight was determined and are shown in Figures 5.1 A-C. These figures
show the overall increase in testis weight during postnatal development (day 18) until
adulthood (day 75). On day 18 the mean testis weight in controls was 64.3±12.1mg and this
had increased to 1989.9±175.0mg by day 75. Suppression of the secretion of
gonadotrophins from the pituitary gland (using a GnRFI antagonist) induced a permanent
reduction in testis weight. This was apparent at all time points examined. By day 75 (Figure
5.1C), the testis weight in GnRHa treated animals was approximately 50% of control, due to a
reduction in Sertoli cell numbers (Atanassova et al., 1999), but spermatogenesis was grossly
normal.
In rats treated neonatally with DES (all doses) there was a permanent reduction in testis
weight in adulthood. This reduction was mirrored by administration of ethinyl oestradiol at
least up to day 35 (data not shown). As with GnRHa, all of these treatments induce a
permanent, dose-dependent reduction in Sertoli cell numbers (Atanassova et al., 1999). At
day 18, neonatal administration of tamoxifen had also decreased testis weight to levels
comparable with GnRHa. The high degree of reduction induced by these chemicals (GnRHa,
DES, ethinyl oestradiol and tamoxifen) suggests that they may all be capable, to some degree
or other, of inhibiting the hypothalamo-pituitary axis. Studies have shown that suppression of
this axis induces a reduction in testis weight (Bianco-Rodriguez and Martinez-Garcia, 1996).
While octylphenol initially appeared to increase testis weight (Figure 5.1 A), by day 25 this
was no longer apparent. The reason for the initial increase is not known. At day 18, neither
parabens nor bisphenol A (at any age) had any significant effect on testis weight. At day 18
(Figure 5.1 A), animals treated with genistein showed a decrease in testicular weight compared
to controls maintained on a soy-free diet, but was not significantly altered from normal soy-
fed controls. However, by day 75 (Figure 5.1C) testis weights of the genistein treated cohort
were significantly increased when compared to normal control animals. The reasons for this
are unknown. Weakly oestrogenic compounds did not appear to inhibit normal testis growth
using the treatment protocols assessed in these studies. However, more potent compounds
(i.e. more oestrogenic at the same dose) appeared to have a detrimental effect on testicular
development as assessed by their effects on testis weight.
The literature review discussed the idea that in adults the bulk of testis weight is due to the
germ cells and that this number is determined ultimately by the number of Sertoli cells.
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Sertoli cell mitosis in the rat occurs prior to puberty and is partly an FSH driven process.
Therefore any reduction in pituitary function (via GnRHa or oestrogen administration) leading
to a reduction in FSH levels during this critical time period may permanently disrupt testicular
development. In prepubertal animals (day 18), around the time the initiation of
spermatogenesis, exposure to potent oestrogens (DES, ethinyl oestradiol) and GnRHa
induced highly significant reductions in testis weight. As the treatments were administered
during early neonatal life (i.e. while Sertoli cell replication was occurring) it is possible that
the number of Sertoli cell mitoses has been reduced (and consequently the number of germ
cells), in those animals showing a reduction in testis weight. Alternatively, these treatments
may affect the replication of germ cells, or at later ages the ability of Sertoli cells to nurture the
developing spermatozoa. Recent studies have shown that both Sertoli cell number and germ
cell/per Sertoli cell are significantly reduced after neonatal treatment with ethinyl oestradiol
(lOgg) demonstrating a reduced efficiency of Sertoli cell support for spermatogenesis
(Atanassova et al., 1999). These authors also detected increased numbers of apoptotic germ
cells after both DES and ethinyl oestradiol treatment which occurred across the spermatogenic
cycle (Atanassova et al., 1999).
The studies reported in this chapter have not attempted to investigate the effects of neonatal
oestrogen exposure on the testis. It is well known that neonatal exposure to potent oestrogens
during gestation and early neonatal life induces permanent disruption to spermatogenesis
which are believed to involve both direct and hypothalmo-pituitary mediated effects
(Atanassova et al., 1999). Although the exact mechanisms remain unclear, direct effects are
believed to include oestrogen effects on the regulation of Sertoli cell cytoskeletal
reorganisation along the spermatogenic cycle (Bianco-Rodriguez and Martinez-Garcia, 1996).
The cytoskeleton seemed a probable candidate as the germ cell sloughing observed after
oestrogen treatment was not stage related. The loss of germ cells produces a tubule which
appears to only have germ cells in the basal compartment, as the adluminal germ cells do not
have enough time to mature before being sloughed into the seminiferous tubule lumen
(Bianco-Rodriguez and Martinez-Garcia, 1996). Other studies, which have assessed
spermatogenesis in animals treated using the same protocols described in this chapter, have
found that DES induced dose-dependent reductions in germ cell and Sertoli cell volume per
testis, and that Sertoli cell number is dose-dependently reduced at postnatal day 18 in rats
(Atanassova et al., 1999). The authors of the latter study suggest that changes in Sertoli cell
function or altered fluid dynamics within the male excurrent duct system may be causal
factors in the changes observed in spermatogenesis.
As part of the studies examined in this chapter, changes in rete testis morphology in response
to oestrogenic compounds were examined (Figure 5.2-5.6). Profound changes occurred after
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neonatal high dose oestrogen treatment (DES 10 and 1.0 pg and ethinyl oestradiol lOpg). At
day 18, neonatal exposure to DES (10, 1, 0,1 pg/injection) induced dose-dependent distension
of the rete testis with DES (lOpg/injection) displaying the most severe effects. The rete testis
of animals treated with DES (0.lug/injection) showing no observable signs of fluid
accumulation, whilst those treated with DES (lpg/injections) showed an intermediate level of
distension.
The most severe distension of the rete testis in DES (10gg)-treated rats was evident at days 18
and 25 postnatal, whereafter the effects were less severe. The highest dose of DES however
induced permanent distension as the rete testis was still swollen in comparison to control
animals at day 75. How quickly after DES administration rete testis distension occurs was
not assessed by this study but distension was evident in rats at day 10 postnatal (Figure 5.2)
which was during the treatment period, and at this age the distension was less pronounced
than at days 18 and 25.
In animals that were treated with ethinyl oestradiol (lOpg), a comparable dose to the highest
dose of DES administered, rete testis distension was also evident when assessed at day 18.
The level of distension was not as severe in comparison with a similar dose of DES. However
the induction of rete testis distension after both DES and ethinyl oestradiol treatments (both at
lOpg) demonstrates that this effect is due to an oestrogenic effect and not to other toxic effects
of DES. The distension was not caused by an oestrogenic effect on the hypothalamo-
pituitary-gonadal axis as there was no sign of distension in the animals treated neonatally with
GnRHa. Neonatal treatment with high doses of weakly oestrogenic compounds (octylphenol.
bisphenol-A, parabens and genistein) did not induce any abnormal distension of the rete testis.
Abnormal distension and overgrowth of the rete testis has been reported in a few other studies
which have analysed the effects of either gestational or neonatal treatment with DES or ethinyl
oestradiol on male rodents. In a recent study a single injection of oestradiol benzoate
(0.5mg/5g body weight or 1 mg/ 5g bodyweight) was administered to rats on the day of birth
(Aceitero et al., 1998). In adulthood these rats showed disrupted spermatogenesis in a
manner which bears a striking resemblance to Figure 5.6 (g) with the most pronounced
degenerative changes in spermatogenesis found in the cranial region of the testis. Dilatation
of the rete testis in these animals including both intra- and extra- testicular rete was observed
from day 10. The degree of rete testis distension induced was of similar magnitude to the
shown in Figure 5.6 (g) despite the massive dose of oestradiol benzoate administered by
Aceitero et al.,(1998). This study also reported enlarged lumens in some seminiferous
tubules near the dilated rete testis, even at day 10 postnatal, which the authors suggest
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indicates a retrograde flow of fluid (Aceitero et al., 1998). Distended seminiferous tubule
lumens were not apparent in the work presented in this chapter (Figure 5.2-5.6) and therefore,
this phenomena may only be induced after exposure to the high level of oestradiol benzoate
used by Aceitero et al. This group also reported the presence of multinulcleate germ cells in
the seminiferous epithelium and evidence of germ cell sloughing from day 22 postnatal.
Evidence of germ cell sloughing was evident within the rete testis of our animals but this effect
did not seem to be evident until the rats were 35 days of age (Figure 5.5 panel(c)) suggesting
that the impairment of spermatogenesis occurred slightly later in our animals. However, this
difference in timing could simply be a question of the dose of oestrogen administered.
The results described in this chapter demonstrate that DES produced gross distension and
apparent overgrowth of the rete testis epithelium. The rete testis appeared to invade the
testicular parenchyma instead of remaining in its superficial position under the tunica. This
effect seems unlikely to be explained just by the distension. Abnormalities of the rete testis
have been described in mice which were exposed during gestation to lOOgg/Kg DES
administered to the mother on days 9-16 of gestation and then examined in adulthood
(Newbold et al., 1985). A total of 233 DES-exposed male mice were examined and 56% of
these displayed various degrees of rete testis hyperplasia which consisted of knob-like
protrusions of cuboidal epithelia or proliferative overgrowths forming papillary structures
consisting of small cuboidal cells. These structures were never found in control animals. Of
the DES treated males, 5% displayed a severe adenocarcinoma-like lesion that often infiltrated
into the seminiferous tubules or efferent ducts. Rete testis adenocarcinoma is a very rare
neoplasm in both humans and animals and based on the results of Newbold's experiments,
prenatal exposure to DES induced a 20-fold increase in the prevalence of rete
adenocarcinoma-like lesions (Newbold et al., 1985; Newbold et al., 1986).
The reason why neonatal oestrogen administration induces distension and the apparent
accumulation of fluid is not clear, and this is particularly true in animals assessed at day 10
postnatal before the Sertoli cell tight junctions and seminiferous tubule lumens have formed.
The accumulation of fluid in the rete testis at day 10 postnatal suggests that fluid is flowing
through the male reproductive tract prior to the formation of seminiferous tubule lumens and
Sertoli cell junctions or alternatively, that fluid may enter the rete testis from another source
such as lymphatic fluid. It is known that the rete testis can reabsorb fluid so it may be
possible that the epithelium could undergo a 'polarity reversal' and become secretory.
Oestrogen can induce mammary epithelial cells in culture to undergo a reversible loss of
polarity (Failka et al., 1996). Oestrogen, acting via a c-JunER fusion protein, induced a
transcriptional regulation of a variety of AP-1 target genes. The loss of epithelial cell polarity
involved the redistribution of both apical and basolateral proteins to the entire plasma
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membrane (Failka et al., 1996). If such a reversal of cell polarity could be induced in the rete
testis in vivo, it might result in an epithelium which secretes fluid instead of resorbing it.
Based on these results the induction of rete testis distension only occurs after the
administration of potent oestrogens and the severity of the distension varies dose-dependently.
However, as distension was never induced after exposure to weakly oestrogenic compounds it
is concluded that rete testis distension is not a useful marker to assess exposure to
'environmental oestrogens'. The available evidence suggests that exposure to inappropriate
levels of oestrogen can induce perturbations in normal fluid dynamics within the excurrent
duct system of the male reproductive tract and these changes could have consequences for
male fertility. As the major site of fluid resorption within the male reproductive tract are the
efferent ducts, the effect of neonatal oestrogen exposure on this tissue will be addressed in
Chapter 6.
Chapter 6 Morphological Changes in the
Efferent Ducts After Neonatal Oestrogen
Treatment
6.1 Introduction
Chapter 5 assessed the effects of neonatal oestrogen exposure on the morphology of the rete
testis. This chapter initially assessed the morphological changes induced in the efferent ducts
of the epididymis by neonatal exposure to oestrogenic compounds and then assessed changes
in the expression of functional markers such as Aquaporin-1 and the androgen and oestrogen
steroid receptors at pertinent time-points.
An extensive introduction to the morphology of the efferent duct epithelium and its role in
fluid resorption has been described in Chapter 1 (Section 1.3.2) and will not be repeated here.
Similarly, the rationale and basic structure of the treatments administered in these studies was
described in the Introduction to Chapter 5 (Section 5.1) and the reader is referred to these
sections. The efferent ducts of the epididymis share one striking similarity to the rete testis, in
that together they comprise the least studied structures in male reproductive physiology! This
is because they are regions that are largely destroyed when the testis is dissected from the
epididymis by researchers studying one or other of these two organs. This introduction will
address what is known regarding the hormonal control of the efferent ducts and the effects
that have been induced by toxic insult to this tissue.
In general, the hormonal control of the excurrent ducts is ascribed to androgens (which is
largely true for the epididymis), but the epithelia of the rete testis, efferent ducts and initial
segment of the epididymis also appear to be under the control of other testicular factors
present in luminal fluid (Klinefelter and Hess, 1998). The exact mechanisms involved in the
regulation of the efferent ducts are not understood. The effects of efferent duct ligation and
androgen withdrawal have been addressed with respect to changes in the efferent duct
epithelium. Fawcett and Hoffner found that efferent duct ligation in the rat at the level of the
rete had little effect on the distal segment of the efferent ducts, but it did induce epithelial
regression in the initial segment of the epididymis. This could not be prevented by the
administration of exogenous androgens (Fawcett and Hoffer, 1979). Recent studies have
found that rete testis ligation reduces the number of dense granules within the efferent duct
epithelium (Klinefelter and Hess, 1998).
The activity of the Na7K+-ATPase localised to the basal region of the efferent duct epithelium
has been suggested to be stimulated by circulating androgens (Ilio and Hess, 1994) and
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factors within the luminal fluid are important in modulating the enzymatic activity of the
epithelium. Castration or ligation of the ducts near the testis decreases enzyme activity in both
the efferent ducts and initial segment of the epididymis; this could not be completely restored
by exogenous androgen (testosterone or dihydrotestosterone) administration. The
administration of 17p-oestradiol to intact rats lowered enzyme activity in both the proximal
segments of the efferent ducts and caput epididymis but did not affect the distal conus region
of the efferent ducts or the initial region of the epididymis (Ilio and Hess, 1994). This
suggests that oestrogens may selectively modulate the activity of certain enzymes in different
regions of the excurrent ducts.
Chapter 3 of this thesis and the published literature described in Chapter 1 (section 1.7.1 and
1.7.4) demonstrate the known expression of the AR and ERs (a and p) within the efferent
duct epithelium. The expression of these sex steroid receptors suggests that the efferent ducts
are a target for sex steroid hormone action. However, the functional significance of their
expression remains to de determined. Hormone receptors for opioids and proenkephalin have
also been reported in the efferent duct epithelium but their functions are not known
(Klinefelter and Hess, 1998).
A major problem in trying to identify the direct effects of oestrogen on the excurrent ducts is
that oestrogen is known to have inhibitory effects on both the testis and pituitary gland. The
only way to decipher cause and effect in these studies was to compare the effects induced after
DES administration with those induced when the reproductive axis was shut down by the
administration of a GnRHa. There have been many studies which have examined the effect of
hypophysectomy (removal of the pituitary gland) or oestrogen administration as a means of
disrupting spermatogenesis (Bianco-Rodriguez and Martinez-Garcia, 1996). Both techniques
induce a marked decrease in testicular weight, in seminiferous tubule diameter and the number
of germ cells within the seminiferous epithelium, together with a thickening of the basement
membrane (all features observed with the current DES and ethinyl oestradiol
(lOgg/injection)). Hypophysectomy also causes a major decline in the levels of plasma FSH,
LH and testosterone, and similar but more gradual decreases have been described after
oestrogen treatment (Bianco-Rodriguez and Martinez-Garcia, 1996). As these effects are also
shared by animals treated with GnRHa, they are indirect actions of oestrogens and so will not
be pursued by the present studies as it is the aim of this thesis to determine the direct effects
of oestrogen induced on the excurrent duct system.
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Studying the toxic effects of chemicals, specifically on the excurrent ducts of the male is a
relatively new field as it shares the problem of trying to separate direct and indirect effects, as
just discussed. This is because many of the chemicals administered to animals affect testicular
function and the functional impairment of Sertoli or Leydig cells can have pervasive influences
on the functioning of the excurrent duct epithelia. Aside from a major role in fluid resorption,
the efferent ducts are also involved in sperm and ion transport, protein resorption, steroid
metabolism and spermiophagy (Ilio and Hess, 1994). These processes can be affected by the
administration of toxic compounds that then have specific effects on the efferent ducts.
a-Chlorohydrin (3-chloro-l,2-propanediol) is a chemical which causes damage within the
male reproductive tract, particularly the efferent ducts. At high doses it induces
histopathological lesions in the efferent ducts and initial segment of the epididymis and at
lower doses it has direct effects on sperm, (Mohri et al., 1975). High doses of a-
chlorohydrin induce the formation of intratubular spermatoceles in the efferent ducts which
are more severe towards the rete testis (Cooper and Jackson, 1972). The epithelium of the
spermatoceles is fragmented and sperm can be seen within the underlying connective tissue
resulting in granuloma formation and ultimately hyalinization and ductal fibrosis. The first
effects of exposure are ductal occlusion, sperm stagnation and subsequent luminal dilatation.
The dilation of the efferent duct lumen is thought to induce an inflammatory response and
sperm granuloma formation. The lack of fluid movement causes the rete testis to become
swollen with seminiferous tubule fluid which can flow back due to increased pressure which
can lead to atrophy of the testis (Ilio and Hess, 1994). Ethane dimethanesulphonate (EDS)
which is used to ablate Leydig cells, also induces hyperplasia of the efferent ducts and small
intratubular sperm retention cysts have been observed (Cooper and Jackson, 1972). Five to
seven days after EDS treatment these cysts join into large spermatoceles which can rupture
and form granulomas (Cooper and Jackson, 1973). Unlike a-chlorohydrin, EDS lesions can
be resolved and fertility recovers in some males (Cooper and Jackson, 1973).
Exposure to environmental fungicides (benzimidazole carbonates) such as benomyl and its
metabolite carbendazim induce occlusion of the efferent ducts (Klinefelter and Hess, 1998).
These chemicals are used for controlling mould, fungus and other organisms that infest lawns,
gardens and orchard plants. Within hours of administration, benomyl induces increases in
testicular weight and in the long-term this leads to testicular atrophy and infertility. As with
the other toxins described above, benzimidazole carbonates induce occlusion of the efferent
ducts, and fluid back-pressure then causes seminiferous tubule swelling, loss of germ cells
and eventual testicular atrophy (Klinefelter and Hess, 1998).
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Some chemicals that have toxic effects on the reproductive system have their primary effect
elsewhere in the body. For example, effects on the reproductive tract can be induced by
chemicals which affect the testicular vasculature. A 5-hydroxytryptamine-l receptor
antagonist (GR40370D, Glaxo Wellcome) was under investigation as treatment for migraine
relief until it was found to have both testicular and epididymal toxicity. GR40370D was
found to act on the testicular vasculature to induce constriction and in some cases closure of
the veins of the mediastinal venous plexus and arterial-venous anastamoses respectively
(Piner, 1997). Acute administration of GR40370D to adult rats caused an increase in
testicular weight, increased diameter of seminiferous tubules and distension of the rete testis
observed 12- 48h after administration. Within the epididymis, increased luminal size of the
initial segment and caput regions, oedema of the interstitial space and an increase in organ
weight were noted 24-48h post-treatment. These changes were reversible after 168h (7 days).
The initial action of this drug was to induce vascular constriction and the mechanisms which
led to oedema and reduced fluid resorption through the testis and excurrent duct system are
unknown (Piner, 1997).
Exactly how all of these chemicals act to induce efferent duct lesions is not understood and
there are few studies that have examined the morphology of the efferent duct epithelium after
toxic injury. Toxicological studies examine doses and responses and there are very few
studies, which examine mechanisms. This chapter aims to assess changes in the efferent
ductules and their epithelium after exposure to both potent and weakly oestrogenic
compounds and suggests possible mechanisms behind these effects.
6.2 Materials and Methods
6.2.1 Animals
The animals were housed and neonatal treatments administered as described in sections 2.1
and 2.2. To obtain sections of efferent ducts, tissue (which had been embedded in paraffin
wax as described in sections 2.3.3 and 2.3.4) was carefully sectioned, examining every 5-10th
paraffin section using light microscopy to locate the efferent ducts. When the efferent ducts
were located the quality of the cross section was determined by haematoxylin and eosin
staining (as described in Chapter 5, section 5.2.3).
6.2.1.1 Acute Administration of 5HT-1 Receptor Antagonist (GR40370D)
Adult rats were administered 75mg GR40370D/ml sterile water by oral gavage. The test
solution was freshly prepared and administered within 4 hours at a volume of lOml/Kg and
the animals were killed 4 or 21 hours after dosing.
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6.2.2 Image Analysis - Measurement of Epithelial Cell Height
H&E staining was performed on efferent duct cross-sections of all animals in all treatment
groups at all time points examined in order to analyse the morphology of the efferent ducts
after treatment. The staining protocol was performed as described in Chapter 5 (section
5.2.3). The slides were used to assess changes in efferent duct epithelial cell height.
Epithelial cell height was measured using an Olympus BH2 microscope fitted with a 40x plan
achromat objective and a 3.3x phototube (Olympus Optical). The image was captured using a
Sony XC77CE video camera (Sony, Tokyo, Japan) linked to a personal computer with frame
grabber and image pro image analysis software (Media Cybernetics, Silver Spring, MD). The
length tool was used to measure the height of the epithelial cells at right angles to the
basement membrane. The cell was measured from the centre of the basal cell membrane and a
line drawn from the basal to the apical membrane. After measuring the length, the angle of the
line was measured to ensure that it was 90 degrees. For each animal, at least 50 cells were
measured with sampling from at least 3 ductule cross sections. The mean epithelial cell height
was calculated for each animal. The data was assessed using analysis of variance and where
significant differences were found, subgroup comparisons were analysed using the same test,
but using the overall variance as the measure of error.
6.2.3 Immunocytochemistry on Paraffin Sections
6.2.3.1 Aquaporin-1 Immunocytochemistry
Aquaporin-1 immunocytochemistry was performed as described in Chapter 2, section 2.4.1
using the antibody described in Chapter 4 (section 4.2.2). The level of immunostaining was
assessed in the efferent ducts from animals at all ages (10, 18, 25, 35 and 75 days) and from
all treatment groups. To ensure that the changes described in immunostaining were real and
were not an artefact of different times when the staining procedures were performed,
immunocytochemistry was always performed with a section of control and treated tissue on
the same slide. Any changes in the level of immunostaining were due to changes in protein
levels as the slides had been treated identically. Immunocytochemistry was performed at least
3 times, on tissue from each animal to ensure the reproducibility of the results.
6.2.3.3 Sex Steroid Receptor Immunocytochemistry
The immunocytochemistry protocols used were identical to those described in Chapter 4
(sections 3.2.3, 3.2.4, 3.2.5).
6.2.4 Photomicroscopy
The slides were photographed as described in Section 2.5.1.
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6.2.5 Western Blot Analysis
Western blots were performed using 75gg of protein from adult efferent duct and kidney and
efferent ducts from control and DES (1Opg/injection) treated rats aged 25 days postnatal. The
proteins were separated using a 12% acrylamide SDS-PAGE, blotted onto a PVDF membrane
and probed with AQP-1 antiserum and pre-immune serum at 1:5000. The methods are fully
described in Chapter 2 (sections 2.6-2.8) using ECL detection.
6.3 Results
As formerly discussed in Chapter 5 the most striking change in neonatal animals administered
potent oestrogens were fluid retention and the subsequent swelling of the rete testis.
Therefore, initially the morphology of the efferent ducts was assessed to determine whether
distension was present in this tissue.
6.3.1 Epithelial Cell Morphology
Figure 6.1 illustrates a cross section of control (panel a) and ethinyl oestradiol treated animals
(panel b) at day 18 postnatal for comparison. Panel (a) demonstrates the high columnar
appearance of the efferent duct epithelial cells. The nonciliated cells have basely situated
nuclei and an extensive brush border on the apical membrane, whereas the ciliated cells have
centrally located nuclei and a ciliated apical surface membrane. The epithelium is surrounded
by a layer of periductular myoid cells (1-2 cells thick) and by loose connective tissue and
stromal cells. In contrast, in the ethinyl oestradiol treated animal (panel b) efferent duct
morphology was greatly altered. The most noticeable change was the reduction in epithelial
cell height. Both ciliated and nonciliated cells had lost or not developed the majority of their
apical cytoplasm. The apical brush border was greatly reduced but clumps of cilia could still
be identified. It was not possible to distinguish the two cell types based on nuclear
morphology as both now lay just above the basement membrane. Cell nuclear morphology
was greatly changed, as they were reduced in size and were short, elongated and flattened
against the basal side of the cell; the nucleus now occupied the majority of the intracellular
space. The periductular tissue also appeared altered, with an increase in the cell density
surrounding the ductule and an increase in the amount of connective tissue. These gross
changes in morphology were present throughout the length of the efferent ducts and extended
into the epididymis (but the latter was not addressed in these studies).
6.3.2 Epithelial Cell Height
To determine whether changes in cell height were induced after exposure to potent oestrogens
and to determine the degree of change in cell height, epithelial cell height was measured. The
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graphs shown below demonstrate changes in epithelial cell height induced after neonatal
exposure to either potent or weakly oestrogenic compounds. The data for each age group are
illustrated in separate graphs.
The data shown in Figure 6.2A is the epithelial cell height measured in 10 day old neonates
which were still undergoing treatment. At this age, cell height in control animals
(12.9±1.8pm) was indistinguishable from animals being administered large doses of the
weakly oestrogenic compounds bisphenol A and genistein. However, there was already a
significant reduction in epithelial cell height in animals treated with DES (lOpg/injection;
8.7+1.0pm).
At day 18 (Figure 6.2B) there were numerous treatment groups as this was the time point
which had shown the most severe effects after neonatal treatment with potent oestrogens
(DES or ethinyl oestradiol). At day 18, all treatments, except butyl parabens induced a
significant reduction in efferent duct epithelial cell height but the severity of the reductions
varied considerably. Administration of either DES or ethinyl oestradiol both at lOpg/injection
induced similar, major reductions in epithelial cell height (DES lOpg 7.8±0.9pm; ethinyl
oestradiol 6.7+1.3pm) with values reduced to less than 50% of control cell height (Control
16±1.3pm). Treatment with GnRHa and the two lower doses of DES (1 and 0. lpg/injection)
also caused smaller, but significant reductions in cell height which were of similar magnitude
(GnRHa 11.6+1.5pm; DES lpg 12.1+2.8pm; and DES O.lpg 12.7±l.lpm), whilst animals
treated neonatally with tamoxifen showed a smaller decrease (13.1+0.8pm). Animals treated
with genistein also showed a small reduction in epithelial cell height when compared to that
measured in control animals whose mothers were fed a soy-free diet; there was no statistical
difference in epithelial cell height between soy free and 'normal' control animals. In all other
graphs, data for control and 'soy-free' control animals have been pooled. Small but
significant changes were noted in epithelial cell height after neonatal treatment with weakly
oestrogenic compounds (octylphenol (14.5± 1. lpm), and bisphenol A (13.9±2.4pm)).
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Figure 6.1 Comparison of Efferent Duct Morphology at day 18 in Control and
Ethinyl Oestradiol Treated Animals
Photomicrograph of the efferent duct epithelium at day 18 in a control rat (a) and an
animal treated neonatally with 10pg ethinyl oestradiol (b). Scale bar shows 20pm.






Figure 6.2A Measurement of Epithelial Cell Height (pm) at Postnatal Day 10
Animals were treated with a vehicle control (n=5), DES (lOpg/injection; n=4), Bisphenol A (n=4) or genistein
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Figure 6.2B Measurement of Epithelial Cell Height (pm) at Postnatal Day 18
Animals were treated with a vehicle control (n=13), DES (l()pg, lpg or 0.1 pg/injection; n=10. n=5, n=10
respectively), ethinyl oestradiol (n=4), tamoxifen (n=4), octylphenol (n=6), bisphenol A (n=5), parabens (n=5),
soy free control (n=8) or genistein (n=7). Doses were administered as described in Section 2.2. (* p<0.05. **
p<0.01, *** pcO.001 when compared to controls).
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Figure 6.2C shows the epithelial cell height data obtained from 25 day old animals. It is
important to note that by day 25 there was no significant change in efferent duct epithelial cell
height between control animals and those treated neonatally with GnRHa. Treatment with
GnRHa at day 18 (fig. 6.2B) had induced a similar reduction to animals treated with lower
doses of DES (1 and 0. lgg/injection), but the latter treatment groups still showed a significant
reduction in epithelial cell height at 25 days of age, [DES lgg, 12.5±4.1gm; DES 0.1 gg,
10.5+1.9pm] when compared to controls (16.4±1.5pm). Higher doses of DES and ethinyl
oestradiol (1Ogg/injection) induced highly significant reductions in epithelial cell height (DES
7.5+1. lpm; ethinyl oestradiol 7.2± 1.2pm), with values approximately 50% of control levels.
Neonatal treatment with either octylphenol (14.4+1.3pm) or bisphenol A (14.3±0.9gm)
induced small but significant reductions in epithelial cell height. At 25 days of age, genistein
treated animals no longer showed any significant reduction in epithelial cell height.
The epithelial cell height of neonatally oestrogen treated rats was also assessed at day 35
(Figure 6.2D). Similar to findings at day 25, animals treated with GnRHa displayed no
difference in cell height when compared to control animals (Control =17.l±2.8gm, GnRHa
16.7±1.0gm). Treatment with the high dose (lOgg) of DES still caused a highly significant
reduction in cell height (11.9+2.3gm), but it was clear that this decrease was of smaller
magnitude than that seen at day 25. Treatment with lgg/injection DES still caused a
significant reduction in cell height, whereas in animals treated with the lowest dose of DES
(0.1 jig/injection) cell height (13.7+2.7gm), was not significantly different from control
animals (17.5+1.3gm). Similarly, animals treated neonatally with the weak oestrogen,
bisphenol A showed no significant change in cell height at day 18 postnatal, whereas at day
25 of age this treatment had caused a small but significant decrease in epithelial cell height.











Figure 6.2C Measurement of Epithelial Cell Height (pm) at Postnatal Day 25
Animals were treated with a vehicle control (n=20), DES (lOpg, lpg or O.lpg/injection, n= 9, n=4, n=3
respectively), ethinyl oestradiol (n=5), octylphenol (n=6), bisphenol A (n=4), or genistein (n=7). Doses were
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Figure 6.2D Measurement of Epithelial Cell Height (|tm) at Postnatal Day 35
Animals were treated with a vehicle control (n=9), GnRHa (n=3), DES (lOpg, 1 pig or O.lpg/injection; n=6,
n=5, n=4 respectively), or bisphenol A (n=3). Doses were administered as described in Section 2.2. (***
p<0.001 in comparison with controls)
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Cohorts of treated animals were allowed to mature into adults and the efferent duct epithelial
cell height was assessed at day 75 (Figure 6.2E). At this age there was no significant change
in epithelial cell height with any of the treatments assessed. There was a downward trend in
epithelial cell height with increasing dose of DES but this did not reach significance.
□ Control
m DES (1 Oug)
m DES (1 ug)




Figure 6.2E Measurement of Epithelial Cell Height (pm) at Postnatal Day 75
Animals were treated with either vehicle control (n=7), DES (lOpg, lpg or 0. lpg/injection;
n=6, n=5, n=3 respectively), bisphenol A (n=3), or genistein (n=5). Doses were administered
as described in Section 2.2.
6.3.3 Efferent Duct - Functional Changes
The previous section described the changes in efferent duct morphology induced by neonatal
exposure to oestrogenic compounds. Given the gross morphological changes induced, this
section addresses functional changes induced in the efferent ducts after neonatal exposure to
potent or weak oestrogens.
6.3.3.1 Aquaporin-1 Immunoexpression After Neonatal Oestrogen Exposure
Aquaporin-1 immunocytochemistry was performed on tissue from all tissue from animals
from all treatment groups at all of the time points sampled. Due to the volume of data this
amassed, only selected ages and treatment groups will be presented but all the data has been
tabulated and is shown in Table 6.1. Images from all treatment groups are shown for day 18
(Figure 6.3, 6.4, 6.5) but the data for day 25 has been omitted as the results were essentially
identical to those at day 18. Selected data is shown for day 35 (Figure 6.6) and all data
groups sampled at day 75 are shown (Figure 6.6).
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At day 10 postnatal a cohort of control, DES (lOgg/injection), genistein and bisphenol A
treated animals were assessed for AQP-1 immunostaining (see Table 6.1). This was the only
time point sampled when the animals were within the treatment period. In control animals,
AQP-1 formed a strong apical band along the brush border of the efferent duct epithelial cells
as shown in Chapter 4 (Figure 4.2). DES treatment (lOgg/injection) greatly reduced the level
of AQP-1 immunoexpression, the efferent duct lumens appeared distended, and epithelial cell
height was noticeably reduced (Figure 6.1). Treatment with weakly oestrogenic compounds
(genistein or bisphenol A) caused no detectable reduction in the intensity of AQP-1
immunostaining or changes in efferent duct morphology (see Table 6.1).
At postnatal day 18 (the results are summarised in Table 6.1), representative
photomicrographs of efferent ducts at low (x400) and high power (xlOOO oil immersion) are
shown in Figures 6.3 and 6.4. A fluorescently stained photomicrograph is also shown in
Figure 6.5 to display the level of residual AQP-1 immunostaining at 18 days of age after
treatment with ethinyl oestradiol (lOgg/injection). In control rats at day 18, AQP-1
immunostaining was clearly evident along the brash border of the efferent duct epithelial cells
as shown in panel (a) Figure 6.3. The higher resolution photomicrograph in panel (b) clearly
shows that AQP-1 immunostaining was evident along the lateral membranes but there is little
AQP-1 immunostaining observed along the basal membrane of the epithelial cells. Similarly,
in animals treated with GnRHa, there was strong, apical immunolocalisation of AQP-1 to the
efferent duct epithelium and a weaker lateral staining which was at a level comparable to
control animals (Figure 6.3 panels c and d). In contrast, treatment with the potent oestrogen
DES (lOpg/injection) induced a gross reduction in the level of AQP-1 immunostaining
(Figure 6.3 panel e).In many ductules, AQP-1 positive cells were only apparent at high power
magnification (panel f). There was a dramatic loss of both the apical and lateral membrane
immunostaining observed in control animals (panel f). In animals treated with the lower doses
of DES (1.0 and 0.1 gg/injection; panels g, h and panels i and j respectively) a sharp reduction
in the level of AQP-1 immunostaining was observed when compared with control animals.
The reduction observed with the lower doses of DES was not as severe as that observed after
treatment with the highest dose (lOpg/injection) of DES. At higher magnification, lateral cell
membrane staining was still evident but was much more pronounced after treatment with 0.1
pg/injection of DES (panel j) than with lgg/injection of DES (panel h). Neonatal treatment
with ethinyl oestradiol (lOgg; Figure 6.4 panels a and b induced a comparable reduction in
AQP-1 immunostaining to that observed after treatment with lOgg DES (Figure 6.3 panel e).
To illustrate more effectively the reduction in AQP-1 immunostaining after neonatal exposure
to potent oestrogens (DES or ethinyl oestradiol at lOgg/injection) a fluorescent image
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captured using a confocal microscope by Dr James Evans is shown in Figure 6.5. AQP-1
immunofluoresence appeared green and the nuclei were stained red by the addition of
propidium iodide to the mounting medium. Panel (a) illustrates an efferent ductule from a
control animal in which AQP-1 immunostaining on both the apical and lateral membranes are
clearly observed. In contrast, panel (b) demonstrates the stark loss of AQP-1
immunolocalisation from both the apical and lateral membranes in a DES treated animal. The
loss of the columnar epithelial cell appearance is also highlighted by this photomicrograph.
Day 0 Day 18 Day 25 Day 35 Day 75
Treatment AQP-1 n AQP-1 n AQP-1 n AQP-1 n AQP-1 n
Control +++ 5 +++ 11 +++ 20 +++ 6 +++ 6
Control -SF / / +++ 13 / / / / / /
GnRHa / / +++ 12 +++ 8 +++ 3 +++ 5
DES lOgg + 4 ± 14 + 9 ++ 6 +++ 6
DES lpg / / + 10 + ± 4 ++ + 5 +++ 4
DES 0.1 pg / / + 10 +± 4 +++ 4 +++ 4
EE lOgg / / + 4 + 7 / / / /
Genistein
4mg/kg
+++ 5 +++ 14 +++ 7 / / +++ 5
Bisphenol A
0.5 mg
+++ 4 +++ 6 +++ 5 +++ 7 +++ 3
Octylphenol
2mg
/ / ++ 8 ++ 6 / / / /
Parabens
2mg/kg
/ / + + 6 / / / / / /
Tamoxifen
2mg/kg
/ / +± 5 / / / / / /
Table 6.1 Changes in Aquaporin-1 Immunostaining in Efferent Ducts in
Response to Neonatal Oestrogen Treatment
Subjective comparison of changes in AQP-1 immunostaining in the efferent ducts of control
and treated animals at 10, 18, 25, 35 and 75 days of age. Key: +++, control level of AQP-1
immunostaining; ++, reduced level of immunostaining; +, major reduction in the level of
immunostaining; ±, occasional cells with immunostaining.
Figure 6.4 panels c and d, demonstrate the effect of neonatal treatment with the oestrogen
receptor antagonist/agonist tamoxifen on the efferent duct epithelium and on the level of AQP-
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1 immunostaining. Tamoxifen also induced a sharp reduction in the level of AQP-1
immunostaining (panel c) to a similar extent to that observed after injection of lpg DES
(Figure 6.3, panel g). The higher magnification shown in panel (d) demonstrates the
reduction in epithelial cell height induced by this treatment and also the loss of lateral
membrane immunostaining for AQP-1. AQP-1 immunostaining was also performed on 18
day old animals after treatment with the weakly oestrogenic compounds octylphenol (panels e
and f), bisphenol A (panel g and h), butyl parabens (panel i and j) or genistein (panel k and 1).
None of these treatments induced gross reductions in AQP-1 similar to those induced by
DES or ethinyl oestradiol but some of the treatments consistently appeared to show slight
reductions in the level of immunostaining as judged subjectively.
Thus, when compared to the control slides, both octylphenol (Figure 6.3, panel e) and
butylparabens (panel i) appeared to cause a slight reduction in AQP-1 immunostaining and, at
higher power, there was very little lateral membrane staining for AQP-1 (panels f and j).
Animals treated neonatally with bisphenol A (panels g and h) or genistein (panels k and 1) did
not show any significant change from control animals. However, at higher power
magnification, ducts from animals treated with either bisphenol A or parabens had lateral
membrane AQP-1 immunostaining in the efferent duct epithelium (panels h and 1
respectively).
The AQP-1 immunostaining data for 25 day old animals is tabulated in Table 6.1. Control
animals showed a similar level of immunostaining to those assessed at day 18 postnatal.
Similarly, there was very little difference in any of the DES or ethinyl oestradiol treatment
groups which all appeared very similar to the data shown for day 18. DES still induced a
dose-dependent reduction in AQP-1 immunoexpression. Neonatal treatment with genistein,
bisphenol A or octylphenol were again identical to the data presented for day 18.
By days 35 and 75 of age, many of the animals showed a less severe response after neonatal
oestrogen treatment (see Figure 6.6). Photomicrographs of ducts from 35 day control rats
and from animals treated neonatally with GnRHa or 10pg DES are shown in Figure 6.6
(panels a-c respectively). Data from other treatment groups sampled at 35 days of age are
reported in Table 6.1. The control and GnRHa treated animals had similar levels of AQP-1
immunostaining (panels a and b respectively). By 35 days of age, animals which were treated
neonatally with 10,ug DES showed an increase in the level of AQP-1 immunostaining
compared to the levels in similarly treated animals at 18 and 25 days of age. This coincided
with an increase in epithelial cell height compared with the previous ages though this was still
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significantly reduced compared to control levels. Some epithelial cells appeared to show
increased basolateral immunostaining for AQP-1. The lower panels (d-i) represent
respectively, data from adult animals assessed at 75 days of age comprising control rats, or
animals treated with genistein, bisphenol A, DES 10gg/injection, DES lgg/injection or DES
0.1 gg/injection. It was quite clear that the level of AQP-1 immunostaining was very similar
between all treatments and that even animals treated with lOpg DES showed detectable AQP-1
immunoexpression on the apical membrane of efferent duct epithelial cells which was not




Figure 6.3 Comparison of Aquaporin-1 Immunoexpression in the Efferent Ducts at
Postnatal Day 18 After Neonatal Oestrogen Treatment
Immunoexpression of AQP-1 in the efferent ducts at postnatal day 18 in control rats (a, b)
and animals treated neonatally with GnRHa (c, d), DES (10, 1.0 and 0.1 jig/injection; panels
(e, f), (g, h) and (i, j) respectively). Panels (a, c, e, g, f) are shown at x400 and the scale bar
in panel (a) denotes 100pm. Panels (b, d, f, h, j) are shown at x1000 and the scale bar in (b)
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Figure 6.4 Comparison of Aquaporin-1 Immunoexpression in the Efferent Ducts
at Postnatal Day 18 After Neonatal Oestrogen Treatment
Immunoexpression of AQP-1 in the efferent ducts at postnatal day 18 in animals treated
with ethinyl oestradiol (a, b); tamoxifen (c, d); octylphenol (e, f); bisphenol A (g, h); butyl
parabens (i, j) or genistein (k, I). Panels (b, d, f, h, j, I) are shown at x1000 and the scale
bar in (b) denotes 20pm.
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Figure 6.5 Fluorescent Immunostaining of Aquaporin-1 at day 18
Immunoexpression of AQP-1 visualised in the efferent ducts at day 18 in a control rat (a)
and a rat treated neonatally with ethinyl oestradiol (10pg/injection) (b). AQP-1 is stained
green and the cell nuclei are stained red by propidium iodide.
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Figure 6.6 Comparison of Aquaporin-1 Immunoexpression in the Efferent Ducts
at Postnatal Days 35 and 75 After Neonatal Oestrogen Treatment
Immunoexpression of AQP-1 in the efferent ducts at 35 (a-c) and 75 (d-i) days of age.
Results are shown for control animals (a, d) and animals treated neonatally with GnRHa
(b), DES (1Ojug/injection, panels c, g), genistein (e), bisphenol A (f), DES (1.0pg/injection,
panel h) or DES (0.1pg/injection, panel i). The scale bar (a) denotes 100pm.
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6.3.4 Aquaporin-1 Protein Expression After Neonatal Oestrogen Treatment
The level of AQP-1 protein levels was examined by Western blot. This would establish
whether protein was still being synthesised but was not being inserted into the membrane and
whether there was a real reduction in AQP-1 protein levels. Figure 6.7 demonstrates that
neonatal treatment with DES (lOgg) induced a dramatic decline in the level of AQP-1 (lane 8)
compared to the level observed in the age matched control (lane 7). This suggests that there is
a real decrease in the level of AQP-1 protein after the administration of a high dose of DES.
However, it is possible that the AQP-1 protein is synthesised but is folded incorrectly and is
no longer recognised by this antibody. This possibility has not been addressed.
MW 1 2 3 4 5 6 7 8
j i w iP
68 j
j " i
Figure 6.7 Western Blot Analysis of Aquaporin-1 Protein Levels After Neonatal
Oestrogen Treatment
This figure demonstrates a specific 28 KDa band localised to both the kidney and efferent
ducts. Lanes 1 and 5 contain adult efferent duct protein; lanes 2 and 6 were loaded with adult
kidney protein; lanes 3 and 7 contained control efferent duct protein from an 18 day old
control rat and lanes 4 and 8 were loaded with protein from a neonatally treated (DES
lOgg/injection) rat at day 18 postnatal. Lanes 1-4 were incubated with pre-immune serum
whilst lanes 5-8 were incubated with the AQP-1 antiserum.
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6.3.5 Aquaporin-1 Immunoexpression in Adult Rat Efferent Ducts After Treatment
with GR40370D
Short term treatments were performed on adult rats to determine if the loss of AQP-1
immunoexpression and/or change in epithelial cell height induced by DES treatment might be
a consequence of the DES-induced distension of the efferent duct lumen as opposed to a
specific effect of oestrogen treatment. The compound GR40370D has been shown to induce
distension of the rete testis and efferent ducts and so animals were killed at either 4 or 2 1
hours post-treatment with this compound (see Section 6.2.1.1). The efferent duct epithelium
was examined for both changes in cell height and AQP-1 immunostaining. To ensure that
similar regions of the efferent ducts were compared, Figure 6.8 shows photomicrographs that
were taken at the rete testis/efferent duct junction.
Figure 6.8 panel (a) illustrates a high power oil immersion photomicrograph of a control
section of efferent duct with a connecting section of rete testis epithelium. The characteristic
columnar epithelium was evident as was the apical immunolocalisation of AQP-1 to the
efferent duct epithelial surface. Panels (b and c) illustrate similar areas 4 and 21 hours after
the administration of GR40370D respectively. As there was essentially no difference
between these two time points they are described together. It was clear that the administration
of GR40370D induced a reduction in epithelial cell height but this was not associated with a
loss of apical AQP-1 immunolocalisation although there did appear to be a reduction in the
level of lateral membrane localisation. Nor did the distension of the ductule lumen result in
complete loss of the apical cytoplasm as is found in DES-treated rats at days 18-25. This
treatment suggests that distension per se and reduced epithelial cell height do not necessarily
induce a loss of AQP-1 immunostaining. However, the rats were not assessed at any later time

















Figure 6.8 Comparison of Aquaporin-1 Immunoexpression in the Efferent ducts of
AduitRats After trewatment with GR40370D
Immunoexpresion of AQP-1 in the epithelial cells of the effetent ducts of control rat 9a0
and from animals treated with GR040370 either 4 (b) or 21 (c) hours earlier. The scale
bar shows 20|im.
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6.3.6 Aquaporin-1 Immunoexpression in Efferent Ducts of Adult Oestrogen
Receptor-a Knockout (ERKO) and Wild Type Mice
Tissue sections of testis and efferent ducts from wild type and ERKO mice were kindly gifted
by Professor Rex Hess (Dept. Vet. Biosciences, University of Illinois, USA). A similar
phenomenon of efferent duct distension has been described in male ERKO mice which are
infertile (Hess et ai, 1997). It was important to determine whether these mice, which have no
functional ERa, also had changes in the level of AQP-1. Figure 6.9 illustrates the
immunolocalisation of AQP-1 to a control mouse kidney (panel a) which was performed to
ensure that a pattern of immunostaining could be reproduced with the antibody which was
comparable to that obtained for rat and marmoset tissue. Panel (a) demonstrates AQP-1
immunolocalisation to the thin descending loop of Henle. Panel (b) demonstrates a similar
section of mouse kidney incubated with the pre-immune serum. Panels (c and d) are images
of the proximal region of the efferent ducts (i.e. nearest the rete testis) whereas panels (e and
f) show the conus region of the efferent duct (i.e. nearest the epididymis). Panels (c and e)
show a section from a wild type mouse whereas panels (d and f) are from an ERKO mouse.
Comparison of panels (c) and (d) illustrate 3 features of the ERKO phenotype, 1. the efferent
ducts were distended 2. there was a loss of AQP-1 immunostaining from the apical
membrane, and 3. there was a dramatic reduction in efferent duct epithelial cell height. These
three features are identical to the phenotype observed after neonatal DES and ethinyl
oestradiol treatment (10pg/injection), as described above. However, when the distal region of
the efferent duct was examined in the ERKO mouse (panel f) none of these features were
present and the ductules appeared similar to the wild type animal (panel e), except that
epithelial cell height still appeared reduced. AQP-1 was only reduced in the proximal region
of the efferent ducts which were also the only region which displayed fluid retention. The rete
testis of these animals was not present on these slides so it was not possible to determine
whether this structure had shown any signs of fluid accumulation but published data has
shown gross distension of this region (Lubahn et al, 1996). The fluid distension in the
ERKO mouse appeared more localised that after neonatal treatment with potent oestrogens.
142
Figure 6.9 Comparison of Aquaporin-1 Immunoexpression in the Efferent Ducts
of Adult ERKO and Wild Type Mice
Immunoexpression of AQP-1 in adult mouse kidney (a) and in the efferent ducts of wild
type (c, e) and ERKO mice (d, f). a section of mouse kidney incubated with pre-immune
serum is shown as a negative control (b). Panels 9c, d) show proximal regions of the
efferent ducts, while panels (e, f) show distal regions. The scale bar in panel (a) shows
100pm.
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6.3.7 Sex Steroid Receptor Expression After Neonatal Oestrogen Exposure
The loss of AQP-1 immunolocalisation in the proximal region of the efferent ducts of the
ERKO mouse, which has no functional ERa, prompted the question of whether there was any
relationship between sex steroid receptor expression and the changes in AQP-1 expression.
The expression of the AR and oestrogen receptors a and (3 were assessed in the efferent ducts
from 18 day old rats treated neonatally with vehicle (control), GnRHa or DES
(lOgg/injection). This time point was chosen to assess sex steroid receptor expression as it
showed the maximum reduction in both AQP-1 protein levels and epithelial cell height. Figure
6.10 demonstrates the comparison between the expression of these 3 sex steroid receptors in
the treatment groups mentioned above. Panels (a-c) illustrate ERa immunostaining, while
panels (d-f) demonstrate ERp immunolocalisation and panels (g-i) demonstrate AR
immunocytochemistry. Panels (a, d, g) are tissue sections from a control rat, whilst panels (b,
e and h) are efferent ducts from a GnRHa treated animal and panels (c, f and i) are ductules
from animals treated neonatally with DES (lOgg/injection).
Figure 6.10 demonstrates that none of the treatments induced any change in the
immunoexpression of either ERa or ER(3. Both of theses receptors displayed a characteristic
checkerboard expression pattern with some cell types showing positive nuclear staining and
others being negative. This was identical to the staining pattern observed in the marmoset
efferent ducts described in Chapter 2. However, expression of the AR was altered by neonatal
treatment (panels g-i). Panel (g) demonstrates the control pattern of AR expression with
strong staining in the nuclei of periductular myoid cells and moderate staining of epithelial
nuclei which was similar to that observed for both ERa and ERp. There was also weak AR
staining of the stromal cell nuclei. In animals treated neonatally with a GnRHa (panel h) there
is a similar pattern of immunostaining to the control panel (g). The same cell types are stained
positive for AR but the intensity of the immunostaining appeared reduced. However, after
neonatal DES (1Ogg/injection) treatment there was a dramatic decrease AR staining (panel i).
Weak AR immunostaining was still apparent in the stromal cell layer, but nuclei within both
the periductular and epithelial cell layer appeared devoid of AR immunostaining.
The level of AR immunostaining was also altered in other regions of the male reproductive
tract (Figure 6.11). This figure demonstrates a more detailed account of the changes in AR at
day 18 postnatal.
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Figure 6.10 Comaprison of Sex Steroid Receptor Immunoexpression in the Efferent
Ducts Control and Neonatally treated Rats at Day 18
Photomicrographs of efferent ducts from control rat (a, d, g) and from animals treated
neonatally with either GnRHa (b, e, h) or DES (10pg/injection; c, f, i). The tissue sections
were immunostined for ERa (a-c) using NBT chromagen; ER|3 (d-f) and AR (g-i) were both
detected using DAB chromagen. The scale bar shows 20pm.
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Panels (a-c), (d-f) and (g-i) are images of testis, efferent duct and caput epididymis from a
control, GnRHa and DES (lOpg/injection) treated animals respectively. Panel (a)
demonstrates the pattern of AR immunostaining within the control testis, which showed strong
peritubular myoid cell staining and pronounced Sertoli cell staining which appeared stage
specific. AR immunostaining was also localised to Leydig cells of the interstitium. Neonatal
GnRHa treatment induced a more variable pattern of AR staining which ranged between
control levels to the more extreme phenotype demonstrated in panel (d) after DES treatment.
This variability was probably due to either the efficacy of the initial suppression by the
antagonist or was due to the faster recovery from suppression in some animals. Both GnRHa
and DES caused a reduction in the intensity of the AR immunostaining in all positive cell
types but the reduction in intensity was consistently more severe after DES treatment.
AR immunostaining in the efferent ducts was identical to that described for Figure 6.10
(panels g-i) with only DES treatment inducing a complete loss of epithelial cell AR
immunostaining. The caput epididymis is the site of the most intense AR immunostaining
and this demonstrated in the epithelium of the control epididymis (Figure 6.11 panel c). The
epididymal epithelium showed intense AR immunolocalisation in all cell nuclei. A less
intense reaction was also evident in the nuclei of the surrounding stromal tissue. After
neonatal GnRHa treatment (panel f) the intensity of the AR immunostaining was noticeably
reduced in comparison to that observed in control animals. As shown in both panels (c and f),
all unstained epithelial nuclei appeared to be those actively undergoing mitosis. There was also
a sharp reduction in the intensity of AR immunostaining in stromal cells. Neonatal treatment
with DES (lOgg/injection) induced a dramatic reduction in the intensity of AR
immunostaining in the caput epididymis (in both the epithelial and stromal cell nuclei). Several
other morphological changes were also evident (panel i). Firstly, there was gross distension
of the epididymal lumen compared to the control tissue (panel c), demonstrating that abnormal
amounts of fluid were present within the epididymis. The height of the epithelial cells from
the DES treated animal were sharply reduced in height. These changes suggest that unlike the
ERKO mouse the abnormalities in fluid dynamics in neonatally DES treated animals are not
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Figure 6.11 Comparison of AR Immunoexpression in the Testis, Efferent Ducts
and caput Epdidymis of Control and Neonatally Treated Rats at Day 18 Postnatal
Immunoexpresion of the AR in control rats (a-c), and animals treated neonatally with
GnRHa (d-f) or 10pg DES (g-i). The tissues examined were testis (a, d, g); efferent
ducts (b, e, h) and caput epididymis (c, f, i). Scale bar in (a) denotes 100pm.
Chapter 6 Efferent Ducts - Morphology and Function 147
6.3.8 AR Expression in Adult ERKO and Wild Type Mice
The alteration in AR immunoexpression after neonatal exposure to DES (lOpg/injection)
prompted evaluation of AR immunolocalisation in the reproductive tract of the ERKO mouse
to determine whether the lack of functional ERa had any impact on AR immunoexpression
within the reproductive tract. In rats, the administration of DES drastically decreased AR
immunostaining, possibly mediated by oestrogen receptors, as the data presented in Figure
6.10 demonstrated that DES treatment had no effect on ER immunoexpression.
The data shown in Figure 6.12 demonstrates AR immunostaining within the ERKO mouse.
There was no difference in the level of AR immunostaining between the ERKO and wild type
mouse although the impression gained was that the immunostaining was more intense in the
efferent ducts and caput epididymis of the ERKO mouse when compared to wild type. The
loss of AR immunostaining is unlikely to be responsible for the loss of AQP-1
immunostaining observed in either the ERKO mouse or DES treated rat as the level of AR
immunostaining is not altered in the proximal region of the efferent ducts in the ERKO
mouse. This demonstrates that AQP-1 is not regulated via the AR and that the loss of
immunostaining for both AQP-1 and AR after neonatal DES treatment is probably induced by
different mechanisms.
6.3.9 Summary of Results
Due to the volume of data contained in this section it seems appropriate to recap the major
findings:
1. Neonatal administration of DES/Ethinyl Oestradiol to rats induced:
- luminal distension of the efferent ducts
- reduction in epithelial cell height
- reduction the level of AQP-1 protein levels
- no change in oestrogen receptor (a or (5) immunoexpression
- reduction in the immunoexpression of AR
2. ERKO mouse findings:
- reduction in AQP-1 in the proximal efferent ducts which exhibited distension
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Figure 6.12 AR Immunostaining in Adult Wild Type and ERKO Mice
Immunoexpression of AR in wild type (a, c, e) and ERKO mice (b, d, f).
Immunostaining was compared between testis (a, b), proximal efferent
ducts (c, d) and caput epididymis (e, f). Scale bar in (a) shows 100pm.
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6.4 Discussion
The results presented above demonstrate that neonatal administration of potent oestrogens can
induce major effects on the morphology of the excurrent duct system of the male reproductive
tract. The severity of these morphological effects was related to the dose of oestrogen
administered and appeared to lessen with the time elapsed since cessation of treatment.
Functional changes within the excurrent ducts were also identified although only the
immunoexpression of AQP-1 was assessed throughout neonatal life and into adulthood so the
reversibility of the other changes is not known. The administration of weakly oestrogenic
compounds had little effect on either the morphology or functioning (where assessed) of the
efferent duct epithelium except for a transient reduction in epithelial cell height observed with
some treatments.
6.4.1 Morphological Changes After Neonatal Administration of Potent Oestrogens
There were two major morphological changes to the efferent ducts induced by DES and
ethinyl oestradiol (lOgg/injection) administration. Firstly, there was an increase in lumen size
of the efferent ducts caused by fluid accumulation. In cross sections from control animals the
efferent ducts were irregularly shaped but after neonatal oestrogen exposure the cross sections
were often spherical and appeared turgid. Secondly, the columnar efferent duct epithelial cells
were reduced greatly in height after neonatal oestrogen administration and appeared low
cuboidal in shape when assessed at postnatal days 10, 18, 25 and 35. The efferent duct
epithelial cells appeared to have lost much of their apical cytoplasm which houses the
endocytotic apparatus (Hermo and Morales, 1984). This effect appears to be dose dependent
as step-wise reductions in cell height were achieved with increasing dose of DES administered
(0.1, 1, lOgg/injection). However, in adulthood, efferent duct epithelial cell height in DES-
treated rats was not significantly altered from the control group. This suggests that the
morphological alterations observed in the efferent ducts after neonatal oestrogen
administration were not permanent.
6.4.1.2 Changes in Efferent Duct Epithelial Cell Height
The reason for the reduction in epithelial cell height after neonatal oestrogen administration is
not known but the reduction of epithelial cell height has been studied by researchers who
examine epithelial cell function (from various systems) in culture systems. A reduction in cell
height in vivo is a common problem whenever epithelial cells are removed from their in vitro
setting and placed in culture. Pertinent data from the literature will be discussed to explore
possible mechanisms that may regulate cell height in epithelial cells.
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Epithelial cell height is reduced in human efferent duct and epididymal epithelial cells when
they are grown in monolayer culture (Raczek et al., 1994). The height of the cultured efferent
duct epithelial cells is always lower than the height of the cells from which the cultures were
seeded (5.5pm v's ~20pm). However when the cells were grown on filters overlying some
non-epithelial portion of the original tissue fragment the cell height was increased to (14pm)
(Raczek et al., 1994). This suggests that some of the factors required to maintain the shape of
the epithelial cell are released from the cells or matrix surrounding the efferent duct tubules.
The degree of epithelial cell height reduction that occurs in this experimental system is not
dissimilar to that observed in the in vivo studies described in this chapter after neonatal
oestrogen treatment (see Section 6.3.2). This might suggest that neonatal oestrogen treatment
induces a loss of the factors required to maintain the columnar epithelial cell height which is a
characteristic of the differentiated cell.
Raczek et al., also tried to determine if epithelial cell height could be increased by the addition
of 14C- testosterone to the cultures (Raczek et al., 1994). They found that in both efferent
duct and epididymal epithelial cells, the labelled androgen was principally converted by 17-(3
oxidation to androstenedione. The epididymal cultures were more effective at converting both
of these androgens to 5a-reduced metabolites. However, the addition of I4C- testosterone had
no effect on epithelial cell height (Raczek et al., 1994). This study also assessed androgen
withdrawal as a mechanism of height reduction in cultured epithelial cells. Cultures were
established for 3 days in the presence of androgen but after it was withdrawn there was no
observable reduction in cell height. The authors suggested that the short height of the epithelia
at the start of the experiment probably prevented any further height reduction following
androgen withdrawal (Raczek et al., 1994). However, the changes in epithelial cell height
during cell culture may be due to the unphysiological conditions imposed on the epithelial
cells during the culture experiments. In these experiments, both the apical and basal surfaces
were exposed to the same culture medium, unlike the in vivo situation where apical membranes
respond to luminal contents.
Epididymal cell height has also been examined in organ culture experiments. Epithelial cells
of human epididymal tubules in organ culture, display androgen dependence of cell height
(Tezon and Blaquier, 1981) and tissue organisation (Vazquez et al., 1989). When human
epididymal tubules were cultured for 8 days, the addition of androgens (testosterone, 5a-
dihydrotestosterone or 5a-androstane-3a, 17p-diol) to the culture medium significantly
increased the epithelial height. The presence of 0.1 pM testosterone in the culture medium
during the last 4 days of culture increased epithelial cell height from 9.2pm in control cultures
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to 20.2pm after testosterone culture (Tezon and Blaquier, 1981). This suggests that
testosterone can regulate epithelial cell height. However, no studies have been performed to
directly assess whether oestrogen (which is a metabolite of testosterone) has any impact on
epithelial cell height. Its is clear however, from the observations on the ERKO mouse
contained in this thesis and the published data that the efferent duct epithelium is reduced in
height after the disruption of ERa, yet the ERKO mouse is known to have raised plasma
testosterone levels (Eddy et al., 1996), suggesting that oestrogen or ERa-regulated genes may
have an influence on epithelial cell height in the efferent ducts.
One other piece of evidence which suggests that epithelial cell height is controlled by either
sex steroids or gonadotrophins comes from studies of seasonally breeding animals. In such
animals, the reproductive tract shuts down, spermatogenesis ceases and the excurrent ducts
regress every year. There is a report on changes in the structure of the efferent ducts of the
ground squirrel (Citellus lateralis) (Pudney and Fawcett, 1984) which has shown that prior to
testicular regression, the cells of the efferent ducts appeared highly differentiated, with
distinctive cytological features specialised for resorption and the movement of luminal
contents. However, at the onset of testicular regression, the lumen of the efferent ducts
became occluded with masses of apical cytoplasm protruding from the epithelial cells and with
degenerating cells sloughed into the lumen. At complete regression, the ducts were comprised
of cells which were greatly reduced in height and contained fewer organelles. The membrane
bound granules characteristic of principal (nonciliated) cells were virtually absent. The exact
mechanisms controlling these effects are not understood (Pudney and Fawcett, 1984).
However, in our treatments the neonatal administration of a GnRHa did not induce gross
changes in cell height or other morphological characteristics of the efferent duct epithelial
cells. This suggests that the changes observed in cell height after the administration of
oestrogen are either due to the direct action of oestrogen on the epithelial cell or are a
secondary consequence of other oestrogen induced changes e.g. reduced androgen action due
to a loss of AR expression.
6.4.1.2 Neonatal Oestrogen Treatment and Distension of the Rete Testis and Efferent
Ducts
The mechanisms behind the changes in the morphology of the efferent ducts are not clear but
there was also evidence of fluid accumulation and distension within the efferent ducts, rete
testis and (to a lesser extent) the testis. These changes probably need to be viewed together
with the other effects induced by neonatal oestrogen treatment. The results presented in
Chapters 5 demonstrated that within the testis there was evidence of germ cell sloughing
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around puberty, which became progressively worse and by adulthood. In the adult testis, there
were many seminiferous tubules which had few germ cells or which were Sertoli cell-only,
especially in the cranial region of the testis underlying the distended rete testis.
The rete testis became grossly distended during neonatal oestrogen exposure and this
worsened after the cessation of treatment (until around day 25). At 35 days of age there
appeared to be a lessening of this effect but the rete remained distended in adulthood, although
at this age the change was not as severe, in relative terms, as that observed at days 18 and 25
postnatal. The most probable cause for the fluid distension is a lack of fluid resorption.
However there are no studies which examine whether the efferent duct epithelium performs
endocytosis in early neonatal and prepubertal life, and if so what the source of the luminal
fluid is. The studies on AQP-1 immunolocalisation (presented in Chapter 4) showed that the
efferent ducts/mesonephric tubules always had a patent lumen, and therefore fluid is presumed
to be flowing along these ducts in fetal and postnatal life. The most probable source of this
fluid is the Sertoli cell but as the Sertoli cell tight junctions have not yet formed there are no
lumens within the seminiferous cords giving the appearance that no fluid flow is occurring.
This suggests that the composition of the fluid within the postnatal excurrent duct system may
be different to the adult, as interstitial fluid can still diffuse into the seminiferous cords altering
the composition of the fluid.
The changes in fluid dynamics induced after neonatal oestrogen administration appeared to
correlate with changes in epithelial cell height in the efferent ducts. Even during neonatal
treatment (postnatal day 10), efferent duct and rete testis epithelial cell heights were noticeably
reduced compared to controls. The most severe effects were noted at days 18 and 25 with
subsequent recovery to control levels by adult life. The major question is, whether this
alteration in epithelial cell height induced a deficiency in fluid resorption or whether fluid
accumulation and distension induce alterations in epithelial cell function? Since there are no
studies which have directly addressed this question, evidence will be gathered from various in
vitro organ and cell culture experiments together with studies which have assessed the role of
oestrogen within the female reproductive tract to draw comparisons. As most of the published
studies have been performed using adult tissue, they may not have direct relevance to our
studies, but it is hoped that similar mechanisms occur in the efferent duct epithelial cells
during both postnatal and adult life.
In v/va studies have examined the role of sex steroids in controlling fluid reabsorption in the
adult efferent ducts (Hansen et al., 1997). Two separate techniques were performed to verify
Chapter 6 Efferent Ducts - Morphology and Function 153
this data. Initially cannulation studies were performed. Cannulae were inserted in the
proximal region of the epididymis and the rete testis to assess the rate at which fluid enters
and leaves the efferent ducts. The flow rate in control rats was compared in rats injected for a
week with either testosterone propionate (lmg/day), oestradiol benzoate (400|lg/day),
flutamide (lOmg/day) or tamoxifen (lmg/day). Oestrogen administration greatly increased
the volume of fluid entering the epididymis from the efferent ducts i.e. fluid resorption was
decreased, while tamoxifen and flutamide decreased the amount of fluid entering the
epididymis (Hansen et al., 1997). Testosterone caused a small but non-significant increase in
fluid resorption. The treatments did not induce any major changes in osmotic pressure in
efferent duct fluid suggesting that sex steroid or sex steroid antagonist treatment had little
effect on the mechanisms of water transport which arise from solute-solvent coupling (Hansen
etal., 1997). The rate of fluid transport was also assessed by microperfusion of individual
efferent ducts which produced results consistent with the previous method described above
(Hansen et al., 1997). The results suggest that sex steroids are involved in the chronic
regulation of fluid resorption by the efferent duct. Exactly how this regulation is achieved is
not known but some earlier studies suggest that changes in steroid balance can induce
ultrastructural regression within the efferent ducts (see (Hansen et al., 1997)) which could
alter membrane folding and other features which influence epithelial transport. The lack of
ERa action, as observed in the ERKO mouse has been shown to induce changes in the
ultrastructure of the efferent ducts (discussed later) (Nakai et al., 1998).
Whether oestrogen normally acts to induce changes in the ultrastructure of the efferent duct
epithelial cells is not clear but the neonatal administration of oestrogen (DES or ethinyl
oestradiol) induced changes in efferent duct epithelial cells which suggested almost a complete
loss of the apical cytoplasm. There is evidence in the literature that oestrogen can induce
rapid, direct effects on the apical membrane of endometrial cells of ovariectomised rats
injected intravenously with 17(3-oestradiol or DES (Rambo and Szego, 1983; Szego et al.,
1988). These effects are rapid and are believed to occur via non-genomic actions of oestrogen
at the cell surface. New data from various cell systems suggest that steroids can induce rapid
effects through a non-classical, non-genomic action at many sites including the reproductive
system (Revelli et al., 1998). Non-genomic effects are suspected when responses to steroid
addition are too rapid (seconds to minutes) to be explained via the classical route. Steroid
induced effects have been observed in spermatozoa where neither protein or mRNA synthesis
occurs and in cell clones devoid of classical steroid receptors. Steroid induced responses have
also been elicited when the steroid is coupled to a high molecular weight substance which is
unable to cross the plasma membrane. The non-genomic effects of steroid action are not
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blocked by classical steroid hormone antagonists (Revelli et al., 1998). Non-genomic effects
have been observed after the administration of physiological doses of oestrogen, progesterone
and androgen in granulosa and endometrial cells, and in oocytes, spermatozoa and Sertoli cells
(reviewed in Revelli et al., 1998).
Non-genomic effects of oestrogen in endometrial cells are thought to be a physiological part
of reproductive cycling in mammals, in which the endometrial morphology undergoes cyclical
changes in ultrastructure. Endometrial cell morphology has been examined after intravenous
injection of 17p-oestradiol or DES (0.5pg/0.25ml perlOOg body weight) (Rambo and Szego,
1983). In control rats, the endometrial luminal surface was normally characterised by short,
sparse microvilli, but 30-60 seconds after oestrogen administration the number of
microvesicles on the cell surface was significantly increased and similar results were produced
after DES administration (Rambo and Szego, 1983). The number and length of microvilli
continued to increase up to 7 minutes after oestradiol injection and then underwent a dramatic
regression, and within 15-30 minutes there was a distinct diminution of both microvillar length
and numbers (Rambo and Szego, 1983). This surface activity was observed again 1 hour after
the initial oestrogen stimulus suggesting that the architectural modifications were biphasic
(Rambo and Szego, 1983).
Szego et al., used the same model as described above to assess the effect of oestrogen
injection on cytoskeletal microtubules (Szego et al., 1988). This study demonstrated that the
endometrial cell microtubular apparatus also undergoes a striking biphasic response in
number and length that correlates temporally with reciprocal changes in microvesicle activity
(Szego et al., 1988). In control endometrial cells, cytoplasmic microtubules were
conspicuous in length and number but, after oestrogen administration, there was a rapid and
significant decrease in microtubule length and number so that virtually no microtubules were
present 80 seconds after oestradiol injection (Szego et al., 1988). Cytoskeletal microtubule
structures began to reappear after 2 minutes and increased progressively to control levels by
30 minutes and as with microvilli formation this phenomenon re-occurred after ~1 hour
(Szego et al., 1988). The authors suggest that this extensive reorganisation of the cellular
architecture is an early response to oestrogen recognition by the target cell but that the effect
of the transitory loss of microtubule integrity on the cell is not understood. The reason for the
reoccurrence of these effects after 1 hour was not explained by these studies nor whether they
occurred via non-genomic interactions.
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The idea that steroid hormones may influence the cytoskeletal ultrastructure of the cell is not
new. In 1956, a letter to Nature proposed the idea of a 'cytoskeletal hypothesis' of steroid
action (Peters, 1956). The basic tenet of the hypothesis was that steroids did not act to
regulate one specific step in a reaction or process but had a much wider impact on the cell.
They could act through the rearrangement and reformation of the cytoskeletal elements and so
co-ordinate the movement of intracellular substances within and across the cell and its
membranes (Peters, 1956). The validity of this hypothesis has neither been proven nor
refuted but the evidence presented above suggests that one action of steroid hormones may
involve the control of cytoskeletal changes at the apical cell surface.
Whether such non-genomic changes are induced by oestrogenic compounds at the apical
surface of the efferent ducts is not known. However, the work presented in this thesis has
shown that neonatal oestrogen administration induced dramatic changes in cell shape, a loss or
major reduction of the apical brush border and lack of fluid resorption (which can best be
explained by disruption to the endocytotic pathway). All of these changes are consistent with
changes to cytoskeletal elements. Similar apical membrane changes to those induced after
neonatal DES administration have been reported in the efferent ducts of ERKO mice (Nakai et
al., 1998). However, no alterations in cell shape or apical membrane morphology were
detected after the neonatal administration of GnRHa. This suggests that the changes observed
in these parameters after neonatal oestrogen administration are due to a direct action of
oestrogen on the epithelial cells and are not dependent on gonadotrophin action.
The major component of the cytoskeleton is the microtubule and they are known to be
critically involved in the maintenance of epithelial cell polarity and membrane trafficking
(Elkjaer et al., 1995). They are hollow tubes comprised of heterodimers of alternating tubulin
molecules (a and (3) which are bundled in parallel to form a cylinder. Microtubule
polymerisation occurs by the addition of tubulin subunits from a tubulin pool and this
process can be disrupted by the addition of the anti-mitotic drag colchicine. A study has been
performed on the effects of colchicine induced microtubule disruption on the kidney proximal
tubule which is an homologous structure to the efferent ducts (Elkjaer et al., 1995). Five hours
after colchicine treatment there were virtually no endocytotic invaginations or large endocytotic
vacuoles present, consistent with the idea that disruption of microtubule polymerisation blocks
endocytosis. There was also a marked reduction in the number of dense apical tubules (the
exocytic vehicle for membrane recycling) but an extensive accumulation of small vesicles,
suggesting a disruption in membrane recycling (Elkjaer et al., 1995). Immunofluoresence and
immunoelectron microscopy revealed colchicine induced changes in the apical membrane
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localisation of AQP-1. After treatment, AQP-1 was redistributed to small cytoplasmic vesicles
and the apical membrane staining of the kidney proximal tubule epithelium was grossly
reduced (Elkjaer et al., 1995). The level of AQP-1 reduction induced by Elkjaer et al., was
not dissimilar to that induced in the efferent ducts after DES or ethinyl oestradiol
administration (see Figure 6.5). This suggests that microtubules are involved in maintaining
AQP-1 in the apical membrane. If the administration of DES or ethinyl oestradiol affects
microtubule formation within the efferent ducts, then the fluid build up would be due to a lack
of fluid resorption induced by a breakdown in the endocytotic pathway resulting from a lack
of microtubule polymerisation. This suggests that the changes in AQP-1 expression could be
a result of disruption to the endocytotic pathway.
Studies performed on the efferent ducts of the ERKO mouse have shown that they have
impaired endocytosis (Nakai et al., 1998). The epithelial cells were found to be low
columnar/cuboidal with shorter microvilli which appeared disorganised and fewer in number
than in wild type mice (Nakai et al., 1998). The cytoplasmic components of the endocytotic
apparatus were greatly reduced compared to wild type mice e.g. the number of vacuoles was
significantly reduced in ERKO mice. Both groups of mice were capable of endocytosis but
the amount of material taken up in ERKO mice was reduced (Nakai et al., 1998). The
changes induced in the ERKO mouse are consistent with reduced or inhibited endocytosis.
6.4.2 Functional Changes in the Efferent Ducts After Neonatal Administration of
Potent Oestrogens
6.4.2.1 Aquaporin 1
The major functional marker addressed in these studies was the expression of Aquaporin-1.
This protein was investigated as it is known to act as a water channel and is normally present
on the apical brush border of the nonciliated cells of the efferent ducts from fetal to adult life.
This made it a good marker which could be assessed at various time points throughout
neonatal life. The neonatal administration of DES induced a dose-dependent reduction in
AQP-1 immunostaining with the highest dose (10pg/injection) inducing almost complete
abolition of immunostaining while the other two doses induced less severe reductions. The
loss of AQP-1 immunostaining was also apparent after neonatal treatment with ethinyl
oestradiol (lOgg/injection) at a similar level to the corresponding dose of DES. The reduction
in AQP-1 protein observed by immunocytochemistry was confirmed by Western blotting.
The change in AQP-1 protein levels may be inteipreted in at least two ways. Firstly, that
oestrogen regulates the expression of AQP-1 or secondly, that the accompanying changes in
cell morphology and loss of the apical cytoplasm are responsible for the changes in AQP-1
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expression (as addressed in the previous section). No change in AQP-1 immunostaining was
observed in animals treated neonatally with a GnRHa suggesting that AQP-1 levels are not
dependent on gonadotroph ins for expression.
Whether oestrogen regulates AQP-1 has not been fully addressed by this study. It is clear
that oestrogen induces a reduction in AQP-1 immunostaining and that the level of reduction is
associated with the dose of oestrogen administered. The reduction in AQP-1 immunostaining
was not permanent and by adulthood the efferent ducts from all treatment groups displayed
control levels of protein but the effect of an oestrogen challenge on the efferent ducts of an
adult, neonatally oestrogenised rat was not assessed. If this again reduced the level of AQP-1
this would suggest that oestrogen does have a direct effect on AQP-1 immunoexpression.
However, when the levels of AQP-1 protein were assessed at day 18 by Western Blot there
was a substantial reduction in protein levels detected after neonatal DES treatment
(lOgg/injection). There was never a complete loss of AQP-1 immunostaining, suggesting that
at most oestrogen could repress but not inhibit AQP-1 expression.
There is evidence from studies on other organ systems that AQP-1 expression can be
regulated. AQP-1 was shown to be one of the delayed early response genes expressed by
cultured fibroblasts after growth factor stimulation (Lanahan et al., 1992). There have also
been reports that AQP-1 can be regulated by steroids. In the fetal lung, AQP-1 expression
was initially noted on embryonic day 19 (King et al., 1996). The level of AQP-1 increased 5-
fold between El9 and postnatal day 1 and this higher level of AQP-1 expression persisted
into adult life. Maternal corticosteroids increased AQP-1 protein and mRNA expression in
fetal lung. This rapid increase in AQP-1 expression coincides with major physiological
alterations in lung development in preparation for parturition (King et al., 1996). There is also
evidence which supports the short term regulation of AQP-1 by a membrane trafficking
system in secretin-stimulated cholangiocytes (Marinelli et al., 1997).
To determine whether the AQP-1 gene is capable of being influenced by oestrogen, the
promoter region of the gene needs to be examined to determine whether there are any
oestrogen response elements (ERE), that would allow oestrogen receptor complexes to bind.
Oestrogen can induce target gene transcription in at least two ways. Oestrogen receptors can
be transactivated by interaction with an ERE which is composed of two hexonucleotide
repeats. The ligand bound dimeric oestrogen receptor binds to this region and activates
transcription of the target gene (Paech et al., 1997). ERs can also mediate gene transcription
from an API enhancer element that requires ligand and the API transcription factors Fos and
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Jun for transcriptional activation (Paech et al., 1997). The AQP-1 promoter has been
examined to find functional response elements and enhancers (Umenishi and Verkman,
1998). The AQP-1 promoter was found to contain various TATA and CCAAT boxes and
various other elements including an API site (Umenishi and Verkman, 1998). This suggests
that if oestrogen does regulate AQP-1 expression via an oestrogen receptor mediated pathway
then this would have to occur via interaction with the API site.
Further evidence which supports the idea that AQP-1 is regulated via ERs were results from
animals treated the neonatally tamoxifen which were assessed at day 18 postnatal. Tamoxifen
is an ER antagonist/agonist. In the male reproductive system tamoxifen administration
induced a reduction in cell height and AQP-1 immunostaining and caused distension of the
efferent ducts (a phenotype similar to the administration of lgg DES) suggesting that
tamoxifen works as an agonist in the male excurrent duct system. According to studies
examining the activation of oestrogen responsive genes, tamoxifen activates the transcription
of genes that are under the control of an API element (Paech et al., 1997).
6.4.2.2 Aquaporin-1 Immunoexpression in GR40370D Treated Adult Rats and
ERKO Mice
The results presented in Chapter 6 provide evidence against cell morphology and distension
inducing changes in AQP-1 levels. This study illustrated the continued expression of AQP-1
after the administration of the 5HT-1 receptor antagonist GR40370D, a chemical known to
induce rete testis distension (Piner, 1997). GR40370D induced a reduction in efferent duct
epithelial cell height and caused efferent duct distension but did not induce a reduction in
AQP-1 immunoexpression. However, this compound may have induced these changes using
different mechanisms to DES and the 5HT-1 receptor antagonist experiment was performed
on adult rats so this may not be the most appropriate model system with which to compare the
effects observed on neonatal animals.
AQP-1 levels are altered by oestrogen administration, so to determine whether ERa modulates
AQP-1 levels, its expression was examined in the ERKO mouse. The ERKO mouse had
distended efferent ducts but this was less severe that that induced after DES (10gg/injection).
Only the proximal region of efferent ductules nearest the rete testis were distended and the
distal conus region of the efferent ducts appeared to have a similar phenotype to wild type
mice. AQP-1 immunostaining was reduced only in the proximal region of the ducts which
were also distended, but the level of AQP-1 staining in the conus region was similar to wild
type mice. This suggests that ERa is only important in controlling fluid dynamics in the
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proximal region of the efferent ducts or that the effects on epithelial cells induced by a lack of
ERa has induced a reduction in the level of AQP-1 observed at the apical membrane. The
phenotype induced after the loss of ERa in ERKO mice and after neonatal DES
administration share some similarities therefore the studies examining the male reproductive
tract of ERKO mice will be described.
Male ERKO mice are infertile (Korach, 1994) suggesting an essential role for ERa in
regulating male fertility. Similar to neonatal DES administration, adult ERKO mice have a
reduced testis weight (which is 50% of wild type testis weight) and elevated serum
testosterone levels (Eddy et al., 1996). By 20-24 weeks of age the ERKO mouse testes
contained many atrophic and degenerating seminiferous tubules. Some seminiferous tubules
had dilated lumens, a Sertoli cell-only epithelium or a disorganised seminiferous epithelium
with few germ cells (Eddy et al., 1996). The rete testis and efferent ducts were dilated (Eddy
et al., 1996; Lubahn et al., 1996) and efferent duct endocytosis was compromised (Nakai et
al., 1998). Aside from the increased serum testosterone levels observed in ERKO mice, there
appear to be some similarities between the phenotypes induced in the ERKO mouse and after
neonatal oestrogen administration. However, there are also notable differences. For example,
the distension induced in the rete testis and efferent ducts in DES-treated rats is first evident
neonatally rather than postpubertally as in ERKO males and, unlike the latter, does not
become progressively worse. In fact, many of the effects induced by neonatal oestrogen
administration are reversed by adulthood. Again, DES treatment induced an overgrowth of the
rete testis before puberty, whereas no such change has been reported for ERKO males. It is
probable that the similarities and differences in the phenotypes induced in DES treated
animals and in ERKO mice are probably due to the unphysiological levels of oestrogen in the
neonatal period. This may induce changes in fluid dynamics which perhaps would normally
only occur after puberty as in the ERKO mouse. Whether the phenotypes displayed by these
two models are induced by the same mechanisms is not known.
6.4.2.2 Immunoexpression of Steroid Hormone Receptors in the Efferent Ducts after
Neonatal Oestrogen Exposure
The comparison of steroid receptor expression in the neonatally oestrogenised rat was
performed at day 18 as this was the age when most severe effects were observed and so any
difference in steroid receptor expression would be more likely to be noticed at this age. There
was no appreciable change in the immunoexpression of either ERa or ERp in the efferent
ducts after neonatal oestrogen treatment. However, when immunostaining for the AR was
performed a major reduction in the level of immunostaining was observed. On further
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examination it was noted that AR immunostaining was decreased throughout the testis, rete
testis, efferent ducts and most noticeably in the caput epididymis which normally has the most
intense immunoreaction of AR at this age. This result suggests that oestrogen can regulate AR
expression. There was no reduction in AR immunostaining within the testis, efferent ducts or
epididymis of the ERKO mouse suggesting that oestrogenic compounds such as DES or
ethinyl oestradiol can act directly to suppress AR expression and that an interaction with ERa
is not required.
A recent report by Yeh et al., has shown that 17(3-oestradiol (E,) can activate AR target genes
through a direct action of E: on the androgen receptor. Steroid induced gene transcription
occurs when the activated receptor (i.e. ligand bound) interacts with a hormone responsive
element and this complex communicates with the cellular transcriptional apparatus to induce
or repress the expression of target genes. Coactivators and repressors are involved in the
transactivation and may function as a bridge between the receptor and the basal transcriptional
factor complex. A coactivator of the AR (ARA70) has been isolated and shown to activate AR
target genes in the presence of lOnM E, but not in the presence of DES (Yeh et al., 1998).
The authors suggest that E, may represent a natural ligand for AR which may have an
important role in androgen action (Yeh et al., 1998). Other coactivators and repressors also
exist which may allow other oestrogenic compounds to induce the transcription or repression
of other AR target genes. One other report exists in the literature that suggests that oestrogen
can directly effect AR transcription (Cardone et al., 1998). In primary cultures of lizard testis,
oestradiol has been shown to autoregulate ER mRNA and downregulate AR mRNA (Cardone
et al., 1998). The downregulation of AR mRNA was reversed by the addition of the
antioestrogen ICI 164 384 and cycloheximide (to inhibit protein synthesis) (Cardone et al.,
1998). These two studies suggest that there is an intimate link between the actions of
oestrogens and androgens which may prove important in explaining the changes in AR
immunostaining observed in the studies presented in this thesis after neonatal oestrogen
exposure.
6.4.2.3 The Effect ofWeakly Oestrogenic Chemicals on the Rat Efferent Ducts
The results described in Chapters 5 and 6 suggest that weakly oestrogenic compounds
(octylphenol, bisphenol A, parabens or genistein) as assessed in this study had no major or
permanent effects on the male reproductive tract. In the absence of specific biochemical and
molecular markers of oestrogen function in the excurrent ducts, the morphological parameters
that were found to change after neonatal exposure to potent oestrogens (DES and ethinyl
oestradiol) were examined. In contrast to neonatal administration of potent oestrogens, testis
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weight was not reduced by the administration of weakly oestrogenic compounds. These
chemicals either caused no significant change or induced significant increases in testis
weights. The only objective assessment which showed any significant reduction after the
neonatal administration of weakly oestrogenic compounds was the measurement of efferent
duct epithelial cell height. Transient reductions were observed after treatment with
octylphenol and bisphenol A (days 18 and 25 postnatal) and genistein (day 18 postnatal).
When epithelial cell height was assessed after day 25 postnatal, none of the weakly
oestrogenic compounds had any effect. None of the weakly oestrogenic compounds induced
rete testis or efferent duct distension. AQP-1 levels did appear reduced after neonatal
treatment with octylphenol when assessed at day 18 and 25 postnatal, although this was a
subjective observation and any reduction was marginal when compared to the reductions
induced in AQP-1 immunostaining by DES and ethinyl oestradiol.
Since the oestrogenic properties of these chemicals were discovered, researchers have
performed further studies to define the biological effects of these chemicals. Octylphenol has
been shown to bind to oestrogen receptors and exert oestrogen effects on mammalian cells
(Blake and Ashiru, 1997). In the studies described in Chapter 6, it was found to induce
transient reductions in AQP-1 immunostaining and efferent duct epithelial cell height.
However, octylphenol induced no major effects on fluid resorption suggesting it induced a
weak oestrogenic response in the male rat reproductive tract when administered neonatally (at
2mg/day on days 2-12 inclusive). The effect of octylphenol administration to adult male rats
has been investigated (Boockfor and Blake, 1997) and was found to disrupt reproductive
hormone secretion after the injection of 80mg at 3 times weekly for 1 or 2 months. This
treatment was found to induce a decrease in the weights of the testis, epididymides and
accessory sex glands (Boockfor and Blake, 1997). In a similar study, the same dose of
octylphenol decreased serum levels of LH, FSH and testosterone but induced an increase in
prolactin concentrations (Blake and Bookfor, 1997). The effects recorded by these studies,
were induced after the administration of huge doses which may demonstrate the oestrogenicity
of this compound, but they are not physiologically relevant concentrations. Such studies add
little to the debate as to whether environmental levels of octylphenol or other 'environmental
oestrogens' are detrimental to reproductive health.
The identification of some parabens preservatives as weakly oestrogenic is a relatively recent
finding but no adverse effects on the male reproductive tract were observed in our studies.
Butyl parabens is weakly oestrogenic and binds the oestrogen receptor with a binding affinity
1-2 magnitudes lower than nonylphenol and is -100,000 times less potent than 17p-oestradiol
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(Routledge et al., 1998). In our studies, parabens was administered at a dose 18 times lower
than octylphenol, so perhaps the lack of observable effects was not surprising.
The other source of environmental oestrogens that has been proposed as possible causal
agents in the changes observed in male reproductive health, are those ingested via the diet
through the ingestion of plant and microbial oestrogens. The isoflavone phytoestrogen
genistein, may be responsible for some oestrogenic effects of soy in vivo (Strauss et al.,
1998). The administration of the genistein (2.5mg s.c./kg bodyweight) to adult male mice for
9 days induced reductions in both testicular and serum testosterone (Strauss et al., 1998).
When genistein was administered to neonatal male mice only high doses (lmg/pup/day)
induced prostatic changes (squamous epithelial metaplasia) similar to those induced after DES
administration (Strauss et al.. 1998).
The evidence regarding biological effects of environmental oestrogens within the published
literature is not very strong at present. There are only a handful of studies, which are
generally not directly comparable, due to the administration of different doses, routes and ages
of administration. The experiments performed in this thesis give little support to the
hypothesis that any adverse changes in male reproductive health are due primarily to increased
exposure to oestrogenic compounds (either 'environmental' or dietary oestrogens). The
marginal and transient effects induced in our studies suggest that chronic exposure to very
high levels of weakly oestrogenic compounds would be required to induce any adverse effect
on the male reproductive system. However, until we are sure exactly what exposure levels in
the environment are, and how these chemicals can or do interact with one another, we should
not be complacent and should continue to find some quantifiable oestrogen regulated
endpoints that can be used to assess the relative risk of these chemicals to human health.
6.4.3 Summary
The results in Chapters 5 and 6 of this thesis show that neonatal exposure to high levels of
oestrogen caused deleterious changes in testis weight and other endpoints. Although these
effects persisted after the cessation of treatment, most of the parameters measured except for
testis weight and rete testis morphology, had normalised by 75 days of age. Where changes
persisted, this was only in animals treated neonatally with high doses of potent oestrogens
(DES and ethinyl oestradiol lOgg/injection). The major problem with the parameters assessed
in this study is that they were largely subjective and not quantifiable. For example, it is
difficult to compare rete testis morphology between animals as cross sections from identical
regions of the tissue must be assessed, which is labourious and only gross changes can be
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detected with certainty. Similarly, it is also difficult to detect subtle changes in the level of
AQP-1 immunostaining, particularly that which might have arisen after neonatal treatment with
weakly oestrogenic compounds. The most useful parameters measured were efferent duct
epithelial cell height and testis weight. Changes in testis weight are very useful to gauge the
overall effects of a treatment. However, administration of other compounds such as GnRHa,
produced similar reductions in testis weight to DES (10gg/injection) demonstrating that this
parameter cannot be used as a specific endpoint to assess inappropriate oestrogen exposure.
The postnatal period is critical for normal testis growth and alterations in Sertoli cell number
induced during this time are permanent, whereas other regions of the male reproductive tract
appear to be more plastic and show signs of recovery from oestrogenic effects. For example,
at 75 days of age, rats treated neonatally with DES (all doses) have shown significant
reductions in testis weight, whereas efferent duct epithelial cell height was not significantly
different from control values. However, efferent duct epithelial cell height was a useful and
objective endpoint for assessing both gross and subtle effects of oestrogens earlier in life and
could also be used to monitor the duration of these effects. Although the parameters assessed
in these studies, when taken together, give a strong indication of effects induced by
oestrogenic chemicals on the reproductive tract, the specificity of these effects remain to be
established: can other compounds that are not oestrogenic induce similar changes?
Chapter 7 Epididymal Ion Channel
Expression after Neonatal Oestrogen Treatment
7.1 Introduction
In earlier chapters, the importance of proper fluid dynamics was described, showing
evidence for the distension and abnormal morphology of the testis, rete testis and efferent
ducts after treatment with either DES or ethinyl oestradiol. These changes occurred
coincidentally with the disappearance of the water channel protein AQP-1 from the brush
border of the efferent ducts. This water channel is not expressed in the remainder of the rat
epididymis but has recently been localised to the vas deferens (Andonian and Hermo,
1999). Many ion channels are known to be expressed in the epididymis and fluids are also
known to be transported secondary to ion transport. This chapter examines the effect of
neonatal exposure to DES, ethinyl oestradiol and GnRHa on the function of selected ion
channels in the epididymis. The adult epididymis is an important organ in inducing the
maturation of spermatozoa and the maintenance and storage of the mature sperm in a
quiescent state. The induction of this immotile state is attained via the steady lowering of the
epididymal luminal pH during passage through the epididymis (Hinton and Palladino,
1995). The alteration in pEl is referred to as luminal acidification. This fluid becomes
neutralised before ejaculation due to the basic secretions from the prostate (Carr and Ascott,
1989). The exact mechanisms responsible for luminal acidification are not fully understood
but studies which have used micropuncture and other techniques to examine the ionic
composition of epididymal fluid have shown that ion channels must be present on the
epididymal epithelial cell membranes to account for the changes in ion flux within the
epididymal fluid. Recent studies using immunocytochemistry have identified some of these
proteins. Two apical proteins, the Na/H exchanger and H+"ATPase have both been
implicated in the process of luminal acidification. Aside from luminal acidification, ion
channels are also involved in fluid resorption and the maintenance of osmotic balance within
the epithelial cell and the luminal environment.
The epididymis is generally regarded as an androgen target organ but there are a few studies
which suggest that some of the ion channel functions may in fact be under the control of
oestrogens. This chapter initially aimed to localise the chloride channel involved in the
pathology of cystic fibrosis (Cystic Fibrosis Transmembrane Conductance Regulator,
CFTR). Cystic fibrosis (CF) is the most common lethal autosomal recessive disorder of
Caucasians (Rochwerger etal., 1994). CF patients are affected by chronic obstructive lung
disease, pancreatic insufficiency and intestinal malabsorption and obstruction as well as
reduced or absent fertility in both sexes (Rochwerger et al., 1994).
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CFTR is a cAMP-regulated plasma membrane chloride channel which is a member of the
ABC (ATP-binding cassette) transporter superfamily. The CFTR protein contains two sets
of membrane spanning segments, two nucleotide -binding domains (NBD) and a large
intracellular regulatory domain (R domain) which contains the protein kinase A and C sites
of the molecule (Tummler and Puchelle, 1997). Opening the CFTR channel requires
phosphorylation of the R domain by cAMP- protein kinase A, and ATP binding and
hydrolysis by the NBD (Winter and Welsh, 1997). Parts of the transmembrane domains
form the channel pore, and the R domain functions as a channel inhibitor until it is
phosphorylated and undergoes a conformational change allowing chloride ions to travel
through the pore (Tummler and Puchelle, 1997). CFTR expression and functions are
regulated by multiple transcriptional and translational mechanisms. Several alternatively
spliced isoforms of CFTR have been identified of which at least some are functional and
organ specific (Tummler and Puchelle, 1997).
In human female, third trimester fetuses, CFTR expression is present in the cervix and
fallopian tubes (Tizzano et al., 1994). This expression pattern gradually decreases during
the first year of life. During puberty, CFTR expression reappears strongly in the cervix but
at a weaker level in the endometrial epithelium and glands and in the fallopian tubes. In
female reproductive tissues, CFTR is thought to play a role in fluid exchange and electrolyte
composition, both of which are influenced by the hormonal changes during the oestrus cycle
(Tizzano et al., 1994). Female patients with CF have a thick cervical mucus and do not
manifest a midcycle surge in cervical mucus electrolyte concentrations as observed in
healthy women (Kopito et al., 1973). In healthy cycling rats, CFTR is maximally expressed
in the luminal epithelium during pro-oestrus which coincides with a peak in uterine fluid
volume (Trezise et al., 1993). Experiments have shown that CFTR is regulated by steroid
hormones in rat uterine and oviductal epithelia in vivo (Rochwerger and Buchwald, 1993)
while no steroid hormone regulation appears to be present in other tissues such as the lung
and intestine (Tizzano et al., 1992). The administration of oestrogen to immature and
ovariectomised mature female rats was shown to induce CFTR expression (Rochwerger and
Buchwald, 1993). Studies have also shown that oestrogen regulates the expression of CFTR
in vitro using a novel uterine epithelial cell line (Rochwerger et al., 1994). In this cell line
CFTR expression was dependent on the presence of oestrogen (at physiological
concentrations, 10"9 and 10"10 M) in the culture medium and no expression of CFTR was
observed in cell cultures grown in serum devoid of steroid hormones (Rochwerger et al.,
1994).
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Most male patients with cystic fibrosis also have impaired fertility due to atrophy or
obstruction of the epididymis, vas deferens and seminal vesicles and the resultant
azoospermia (Tizzano et al., 1994). The relationship between the CFTR dysfunction and the
resulting pathological changes in the reproductive tract are not understood, to the extent that
researchers do not know whether these changes are a result of a morphogenetic defect
during development, or are a secondary effect induced by obstruction due to abnormal
secretions. CFTR mRNA has been localised to the testis of adult rats specifically within
round spermatids and also within the principal cells lining the initial segment of the
epididymis (Trezise et al., 1993). In human new-born, infants and children CFTR has also
been localised by in situ hybridisation to the epithelial cells within the head of the
epididymis with an irregular distribution of signal in the epithelial cells of the corpus and
cauda (Tizzano et al., 1994). CFTR was also localised within the vas deferens. Tissue from
adults displayed a similar pattern of expression. Even although all of the excurrent duct
structures are derived from the mesonephric duct, the head of the epididymis (which in
normal patients has the highest expression of CFTR) is the only region in which CFTR is
consistently present in CF patients (Tizzano et al., 1994). The lack of functional CFTR in
the head of the CF epididymis may induce problems downstream due to flow obstruction.
In the male, the sites of expression of CFTR have been identified but no studies have yet
addressed its regulation. The existing evidence that CFTR is oestrogen regulated in the
female reproductive tract, and that its peak expression coincides with the peak in uterine fluid
volume, suggests that CFTR needs to be investigated to determine whether it is an oestrogen
regulated gene in the male reproductive tract. This was the principal reason for investigating
CFTR expression after neonatal oestrogen treatment in male rats.
There are also a number of similarities between the ion transport functions within the
epididymis and those involved in urinary acidification within the kidney collecting duct.
Similar ion transporter channels and mitochondrial rich cell types (which are associated with
ion channel activity) are present in both organs. There are many features present in the
transporting epithelial cells of vertebrates which have been used to group this cell type
together as a family. These cells were originally referred to as mitochondria rich cells as
they have a greater number of mitochondria than the surrounding epithelial cells (Brown and
Breton, 1996). The major feature of these cells is that they express a vacuolar-type proton-
pumping ATPase (H+V-ATPase) within both intracellular vesicles and specific domains of
the plasma membrane (Brown and Breton, 1996). The mitochondria rich cells of the kidney
collecting duct are the intercalated cells. These cells contain a high level of carbonic
anhydrase and H+ATPase but virtually undetectable levels of Na+/K+-ATPase (Brown and
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Breton, 1996). Mitochondria rich cells also possess apical microvilli and/or microplicae
(broader plate-like extensions of the apical membrane), an active endocytotic pathway, as
characterised by fluid phase endocytotic markers (i.e. horseradish peroxidase) and rod
shaped intramembranous particles which are revealed during freeze fracture analysis (Brown
and Breton, 1996).
The rat epididymis and vas deferens have both been shown to contain a subset of proton-
pump rich cells which contain high levels of EPATPase on both their apical surface and in
intracellular vesicles. These cells share all the characteristics of mitochondria rich cells.
EPATPase has been localised to the apical or narrow cells in the caput epididymis and the
clear cells in the corpus and cauda regions of the epididymis (Brown and Breton, 1996). The
EPATPase can be specifically inhibited with bafilomycin and up to 80% of the
transepithelial proton-flux can be inhibited within the vas deferens (Brown et al., 1997). The
apical and clear cells are thought to perform an analogous function to the intercalated cells of
the collecting duct in that their primary function is in luminal proton secretion.
The studies presented in this chapter examined the state of the epididymal acidification
machinery in peripubertal life, prior to the appearance of sperm within the epididymal lumen.
A recent study has described the ontogeny of the EPATPase ion channel within the
postnatal rat epididymis as determined using immunocytochemistry (Breton et al., 1999). In
the first week after birth, EPATPase immunostaining was very rare in all sections of the
epididymis. The first staining in clear cells was evident during the second week after birth
and by 3 weeks postnatal, epithelial cells immunostained for EPATPase were common in all
epididymal regions. By week six it was evident that the number of EPATPase positive cells
per millimetre of epididymis was significantly higher in the cauda epididymis than in the
caput region and this pattern persisted into adulthood (Breton et al., 1999). The increasing
EPATPase activity in the distal regions of the epididymis supports its role in epididymal
luminal acidification. The peak expression of EPATPase within the epididymis is reached
before puberty and prior to the appearance of spermatozoa. This information has led
researchers to argue that EPATPase-rich cells within the epididymis are not under the
control of androgens (Breton et al., 1999). Earlier studies have also indicated that
maturation of the clear cells may not be driven by androgens (Hermo et al., 1992), (Martinez
et al., 1995), but that the maturation and maintenance may be stimulated by oestrogens
(Martinez et al., 1995). Therefore the status of the EPATPase ion channels in the neonatally
oestrogenised animals were an important target to check.
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The studies in this chapter aimed to categorise changes in ion channel expression
throughout the epididymis after neonatal oestrogen administration. The experimental work
largely focuses on the expression of CFTR and ion channels involved in luminal
acidification (H+"ATPase and the Na/H exchanger) but the expression of other ion channels
will be mentioned where pertinent.
7.2 Materials and Methods
7.2.1 Treatments Regimes
This chapter focused on neonatal rats at day 25 after the administration of either GnRHa,
DES (10pg/injection), ethinyl oestradiol or vehicle injected controls. For full details of the
treatment protocols see Chapter 2 (Section 2.2).
7.2.2 CFTR In Situ Hybridisation
The in situ hybridisation protocol used in these studies was fully described in Chapter 2
(Sections 2.10 - 2.13). Two sets of primers were synthesised using the CFTR cDNA
sequences in the published literature (Riordan et al., 1989), (Fiedler et ai, 1992) and those
entered into the GenBank database. The sequences chosen were
1. 5' CCT CAG CTG GAC CAC ACC ATT
3' CGC TGA TTC CCA ACA ATA TGC
After PCR this synthesised an insert 787 base pairs long corresponding to nucleotides 184
and 977 at the 5' end of CFTR.
2. 5' CGA GGT GGG ATT CTT AAG AGA
3' CAC AGA TCG CAT CAA TAT C
After PCR this synthesized an insert 576 base pairs long corresponding to nucleotides 3026
to 3602 at the 3' end of CFTR. Both primer sets produced bands of the correct size after
PCR from tissue-specific cDNA pools of lung, pancreas or efferent ducts. However, the
second set of primers produced a brighter set of bands and in subsequent PCRs only the
second set of primers produced bands of the correct size. The CFTR insert which was
initially amplified from the efferent duct cDNA was cloned into PCRII plasmid.
Unfortunately, no specific signal was ever obtained using this insert as a labelled riboprobe
with in situ hybridisation. Coincidentally, Dr P. Saunders performed studies on oestrogen
regulated genes in the testis and identified a CFTR partial clone using differential display.
Therefore this was used in future attempts at in situ hybridisation.
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7.2.2.1 Identification of Ion Channels by PCR
To try to identify other ion channels involved in osmotic control within the excurrent duct
system, primers were chosen to several ion channels (ATP-sensitive K+channel, epithelial
chloride channel, cGMP-gated cation channel and K-Cl Co-transporter) known to be
expressed in other epithelial cell types, to determine if these were present in the excurrent
ducts. Only the primers chosen for the ATPase sensitive KPchannel worked in PCR so only
data obtained from this ion channel will be described. The methods involved in cDNA
synthesis and PCR are fully explained in Chapter 2 (Sections 2.9 - 2.12). The primers used
in this study were chosen by retrieving ion channel cDNA sequences from the GenBank
database which were known to be expressed in epithelial cells. The primers chosen were
5' CTG TAC GAT ATC TCA GCC ACT
3' GTC TTA AGA GAC TCC TTC GCG
After PCR this represented a probe 322 base pairs long which started at nucleotide 1008 and
ended at nucleotide 1330.
7.2.3 Fluorescent Immunocytochemistry
The tissue preparation and immunfluorescence protocols were described in Chapter 2
(Sections 2.3.1, 2.3.2, 2.4.2). The ion channels investigated were H+ATPase (chicken
polyclonal antibody raised against the 31KDa sub-unit of the H+-ATPase) and the Na/H
exchanger (rabbit polyclonal antibody raised to the Na7H+ exchanger). This work was
performed at the Renal Unit, Harvard Medical School, MA and the antibodies were provided
by Prof. Dennis Brown and Dr Sylvie Breton.
These studies had to be completed within the 6 weeks of my visit to the Renal Unit and the
data represent preliminary studies which were performed on only 3 animals from each
treatment regimen, so all of the data presented must be regarded as preliminary. Due to the
constraints of time all the digital images captured in these studies were compiled into
montages in Edinburgh, and lack scale bars (Figures 7.3-7.5) as I did not have access to the
appropriate lenses in order to add these to the figures.
7.2.3.1 Image analysis / Quantification
The number of H+-ATPase positive cells in control and treated epididymides was quantified.
Black and white photomicrographs were taken of the whole epididymis using a x20
objective. The final magnification of each image was xlOO. For each photograph the
circumference of all tubules at the level of the basement membrane was determined using a
Wacom graphics tablet and digitising pen connected to NIH image software, version 1.62
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running on a Power Computing Power Tower Pro 225 computer. The software was
calibrated to convert all measured lengths to millimetres. The total number of positive cells
was counted for each photograph. These results were used to calculate the total number of
stained cells found per millimetre of tubule circumference (cells/mm). A previous study by
Breton et al., 1999 demonstrated that between weeks 1-4 postnatal there was no difference in
the number of immunopositive cells between the caput and corpus epididymis (Breton et al.,
1999). As the data in this study is from animals at 25 days of age the data are not separated
into caput and cauda epididymis.
7.2.3.2 Statistics
The number of positively stained H+-ATPase cells within the epididymis was compared
between control and treated cohorts using analysis of variance; where significant differences
between groups were shown, subgroup comparisons were made using the same test, but the
overall variance served as the measure of error.
7.3 Results
7.3.1 CFTR In situ hybridisation
These studies attempted to identify CFTR using radioactive in situ hybridisation in testes
and excurrent duct samples neonatally oestrogen treated rats and controls. Uterus and adult
testis samples were used as positive control tissues. No specific signal was ever detected in
the neonatally oestrogenised or control tissue examined at day 18 or 25 using either of the
riboprobes synthesised. Elowever the probe generated from the differential display
experiment (as described in Section 7.2.2) did produce a specific signal in both control
tissues as illustrated in Figure 7.1.
Figure 7.1 shows four panels, with (a, b) illustrating the specific signal obtained with the
antisense probe in adult testis and uterus respectively. Panels (c, d) demonstrate the non¬
specific signal obtained after incubation with the sense probe in testis and utems
respectively. Panel (a) shows a strong signal in the adult testis and clearly demonstrates that
CFTR expression within the adult testis is stage specific and panel (b) shows a specific
signal along the apical surface of the uterine epithelium although this signal is not as strong
as that found within the testis. This is probably because the uterus sample was not staged
and so was unlikely to be in pro-oestrus or oestrus which are the points in the oestrus cycle
which display maximal CFTR expression.
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Figure 7.1 In situ Hybridisation of CFTR in Adult Rat Testis and Uterus
Illustrating the localisation of 35S-UTP labelled CFTR riboprobe in (a, c) testis and (b, d)
uterus. The antisense strands are shown in (a, b) and the sense strands in panels (c, d).
The scale bar shows 150pm.
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7.3.2 Tissue Distribution of ATP-sensitive K+ Channel Detected by PCR
The tissue distribution of a ATP-sensitive K+channel (which is known to be in epithelial
cells of the heart (Hiraoka, 1997)) was checked with tissue specific cDNA libraries made
from a broad panel of adult rat total RNA samples. Figure 7.2 illustrates an agarose gel
displaying the tissue distribution of an ATP-sensitive K+ channel with positive lanes
showing bands corresponding with 322 base pairs.
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Figure 7.2 Distribution of ATP-Sensitive K+ Channel in Adult Rat Tissue
Demonstrates the tissue distribution of a 322bp (arrow) section of an ATP-sensitive K+
channel detected by PCR on an agarose gel containing 0.001% ethidium bromide. The
samples in lanes 1-14 are as follows; control (lane 1), pancreas (lane 2), intestine (lane 3),
brain (lane 4), caput epididymis (lane 5), lung (lane 6), heart (lane 7), efferent ducts (lane 8),
testis (lane 9), ovary (lane 10), cauda epididymis (lane 11), prostate (lane 12), kidney (lane
13) and striated muscle (lane 14).
Figure 7.2 demonstrates that the ATP-sensitive K+channel has a wide but specific tissue
distribution. Strong bands were apparent in samples from intestine (lane 3), heart (lane 7),
efferent ducts (lane 8), ovary (10) and faint bands were detectable in lung (lane 6) and testis
(9) samples; very faint bands may also be present in the prostate (12) and kidney samples
(13). No signal was detected in samples from the pancreas, brain, caput and cauda
epididymis or muscle.
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7.3.3 Immunofluoresence of H+ATPase at Day 25 Postnatal
From previous studies on the postnatal localisation of H+ATPase it is known to be
expressed in the rat at its highest intensity at around 3 weeks postnatal (Breton et al., 1999).
In the present studies the expression of ETATPase was examined after neonatal treatment
with either DES (lOgg/injection), ethinyl oestradiol or GnRHa. As the data obtained after
DES and ethinyl oestradiol treatments were essentially identical only photomicrographs of
DES treatments will be shown. Figure 7.3 demonstrates both the alteration in the
epididymal epithelium and the differences induced in H+ATPase expression after neonatal
treatment. Panel (a) demonstrates the intense immunostaining of EPATPase in the control
epididymis. The staining was most intense along the apical surface of the epithelium but the
whole of the apical cytoplasm was clearly strongly stained as were the lateral membranes.
Panel (b) demonstrates the pattern of HPATPase immunofluorescence obtained after GnRHa
treatment. It was clear that the number of positive cells was vastly reduced. The strong
immunostaining along the apical cell surface was still evident on some cells but the
cytoplasmic staining had largely disappeared. Similarly, panel (c) demonstrates the
epididymal epithelium after neonatal DES treatment. Many cells showed a very thin apical
band of H+ATPase staining but, unlike the results for GnRHa treatment, there was very
diffuse cytoplasmic staining which was not localised to the apical cytoplasm as it was in the
control tissue, but appeared spread throughout all regions of the cell. It was also clear from
these images that epithelial cells from the treated animals were grossly reduced in height.
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Figure 7.3 H+-ATPase Immunofluoresence in Control and Treated Epididymides
Immunoexpression of H+-ATPase in the epididymis of (a) control rat, or rats treated with (b)
GnRHa, or (c) 10pg DES at day 25. Note the strong immunostaining of the apicalmembrane
cytoplasm in (a) which is shown at a higher magnification to illustrate this feature.
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7.3.3.1 Immunofluorescence of H+ATPase and Na/H Exchanger at Day 25 Postnatal
Due to the profound morphological changes induced within the epididymal epithelium, it
was necessary to identify a marker that had not changed in the epithelium to show that any
changes were specific, and not a secondary effect induced by the malfunctioning of the
whole organ due to neonatal oestrogen administration. It was found that the Na/H
exchanger was not altered in expression in the epididymis of the Na/H exchanger and
H+ATPase visualised by fluorescence, with Figure 7.4 depicting a control animal while
Figure 7.5 is from an animal treated neonatally with DES. In both figures panel (a)
represents the merged image with both flurochromes present. The red staining represents
the H+ATPase and the green staining is the Na/H exchanger. Panel (b) illustrates the
H+ATPase staining only (red) and panel (c) shows only the Na/H exchanger (green).
Figure 7.4 clearly shows that both ion channel proteins are present in the control epididymis
at day 25 postnatal. Figure 7.4 (panel (a)) illustrates that the majority of the cells appear to
be double stained but others appear to have strong staining for only one of the ion channels.
Figure 7.5 panel (a) is also double stained though it is evident that only the Na/H exchanger
is present at any significant level in the neonatally treated DES epididymis. Panel (b)
depicts the level of H+ATPase ion channel staining and on careful examination a faint apical
band of staining can be observed in some cells. Panel (c) shows a strong apical band of
expression of Na/H exchanger though it is not as strong as in the control animal.
The various regions of the epididymis had different levels of ion channel staining, therefore
in order to get a clear picture of the level of H+ATPase ion channel staining present in the
whole organ, the number of positive cells in the whole epididymis was counted. Due to the
difference in the size of the epididymides induced after treatment, the circumference of each
cross section of epididymis was measured and the number of H+ATPase positive cells per
millimetre of epididymal membrane was calculated. Figure 7.6 illustrates the number of
H+ATPase positive cells in animals treated with either GnRHa, DES (lOgg/injection) or








Figure 7.4 H+-ATPase Immunofluoresence in Control Rat Epididymis
Immunoexpression of H+-ATPase and Na/H exchanger in the epididymis of control animals at
day 25. Panel (a) illustrates a double stained image with H+-ATPase staining appearing in red
and the Na/H exchanger localisation appearing green. Panels (b) and (c) illustrate the H+-




Figure 7.5 H+-ATPase immunofluoresence in DES Treated Rat Epididymis
Immunoexpression of H+-ATPase and Na/H exchanger in the epididymis of a 25 day old animal
treated neonatally with DES (10pg/injection). panel (a) illustrates a double stained image with
H+-ATPase staining appearing in red and the Na/H exchanger localisation appearing green.
Panels (b) and (c) illustrate the H+-ATPase and Na/H exchanger single staining respectively. All
images were aquired at the same magnification.
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The graph in Figure 7.6 is based on only 3 animals per treatment group. The control group
had an average of 27.5 (±7.9) H+ATPase-positive cells/mm of epididymal membrane. The
large standard deviation observed in the GnREla group (14.7±13.4 cells/mm) was due to one
animal which had a level of ETATPase cell staining comparable with the control group, while
the other two animals showed severe reductions in EPATPase cell staining. Both of the
oestrogen treatments (10pg DES or ethinyl oestradiol) induced highly significant reductions
in the number of HEATPase positive cells (2.44+1.59 and 5.86±8.15 respectively). The
mean of the three ethinyl oestradiol treated animals also produced a large standard deviation.
Again, was due to one ethinyl oestradiol treated animal which showed a far higher number of
positive EEATPase cells/mm than did the other two animals, although the number of positive
cells was still 50% of the control value. The results presented in Figure 7.6 require further
investigation to determine whether the loss in H+ATPase staining is due to a specific effect








Figure 7.6 Comparison of the Number of ETATPase Cells in the Epididymis of
Control and Treated Rats
The number of EPATPase cells/mm of epididymis were compared in 25 day old rats after
neonatal treatment with vehicle (Control), GnREla, DES (1 Oug/injection) or ethinyl
oestradiol. (n= 3 for all groups; "p< 0.01, *"*p< 0.001 compared to control values)
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7.4 Discussion
The studies presented in this chapter indicate that the mammalian excurrent duct system is a
highly complex epithelium which expresses a multitude of ion channel proteins which are
involved in the osmotic control and luminal acidification of the epididymis and its luminal
contents.
Studies were performed to identify CFTR within the testis and excurrent ducts of control
and neonatally oestrogenised testis and excurrent duct samples at 18 days of age. CFTR
expression was identified by in situ hybridisation in control samples of adult testis and
uterus, but no CFTR signal was detected in the postnatal control or neonatally oestrogenised
samples. This may suggest that CFTR expression was not present in these tissues at day 18
postnatal. Or, it may be possible that a different splice variant of CFTR is expressed at this
age which was not recognised by the probe used. Within the literature, the ontogeny of
CFTR expression in the male reproductive tract has not been well mapped. In the rat testis,
CFTR expression was first observed at day 10 postnatal and the hybridisation pattern was
considered to be most representative of Sertoli cells (Trezise et al., 1993). By day 28
postnatal CFTR expression was clearly evident in round spermatids (Trezise et al., 1993).
At postnatal day 10, CFTR expression is present throughout the proximal half of the
epididymis, but a more restricted pattern of expression is observed by day 26 with CFTR
expression resembling the adult pattern, with strong expression limited to the principal cells
of the initial segment of the epididymis (Trezise et al., 1993).
The lack of identification of CFTR in the postnatal samples is not due to the lack of
expression of this mRNA. Time constraints did not allow an exhaustive study of this ion
channel and it is important to determine whether or not CFTR is modulated by oestrogens in
the male reproductive tract. Oestrogen regulated endpoints have to be identified to allow the
oestrogenicity of 'environmental oestrogens' to be measured in an objective assay.
PCR studies attempted to identify other ion channels present with in the excurrent ducts.
These studies successfully identified an ATPase sensitive K+ channel in cDNA pools
synthesised from efferent duct total RNA samples. This channel was found to be
expressed in other tissues (heart, lung, intestine, ovary) but not in either the caput or cauda
epididymis. ATPase sensitive K+ channels are important in cardiac physiology and they are
characterised by a strong inhibition by intracellular ATP (Hiraoka, 1997). ATP has a dual
function in this channel, acting as a ligand which inhibits channel activity, however, it is also
necessary for maintaining the channels in an operative state. During cardiac ischaemia the
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opening of ATPase K+ channels may contribute to the development of serious arhythmias
but they also protect against cellular damage and improve recovery of cardiac function
during reperfusion (Hiraoka, 1997). In the kidney, ATPase sensitive K+ channels are
present on the apical surface of the principal cells of the rat cortical collecting duct and their
function is coupled to the basolateral Na+/K+ ATPase (Wang et al., 1993). Na+/K+ ATPase
has been localised to the efferent duct epithelium (Byers and Graham, 1990) raising the
possibility that a similar relationship may also exist in this organ. Further experiments are
required to confirm the expression of ATPase sensitive K+ channels in the efferent ducts of
the male reproductive tract.
The final studies described in this chapter involved the expression of two ion channel
proteins involved in epididymal luminal acidification. A low bicarbonate concentration and
an acidic pH in the luminal fluid of the epididymis are important for sperm maturation. Two
proton excretion proteins, an Na+/H+ exchanger and an H+ATPase have been proposed to be
involved in this process (Jensen et al., 1999). H+ATPase is known to be expressed on the
apical membrane of apical (narrow) and clear cells of the but the Na+/H+ exchanger has yet
to be described in situ (Jensen et al., 1999). This study illustrated the effect of neonatal
oestrogen treatment on the expression of these two ion channels in the epididymis of 25 day
old postnatal rats.
Figure 7.3 clearly demonstrated the change in H+ATPase immunostaining detected after
neonatal treatment with GnRHa or DES (10 ug/injection). The GnRHa treated animals
show a clear reduction in epididymal H+ATPase immunostaining, but intense apical staining
could clearly be observed. In contrast, DES treatment induce a vast reduction in the number
of cells showing clear apical staining. Positive cells showed a very thin band of apical
staining unlike the thick intense staining observed in the apical cells of the control
epididymis. Another stark change in H+ATPase immunostaining after neonatal DES
(10pg/injection) treatment was the diffuse cytoplasm staining which was not apparent in
control animals.
The vacuolar H+ATPase is structurally related to the F(1)F(0) ATP synthases of
mitochondria, chloroplasts and bacteria (Xu et al., 1999). The mammalian V-type
H+ATPases are composed of two subunits, a peripheral VI and an integral V0 domains.
The VI domain is a 570 KDa peripheral complex composed of 8 subunits (A-H) which is
responsible for ATP hydrolysis and the V0 domain is a 260 KDa integral complex
composed of 5 subunits which are responsible for proton translocation (Forgae, 1998).
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Aside from functions in luminal acidification in the epididymis and urinary acidification the
kidney, HTATPases are also involved in receptor-mediated endocytosis, intracellular
membrane trafficking, protein degradation as well as coupled transport (Forgae, 1998).
In the kidney and liver, microtubules are involved in the rapid and directed movement of ion
channels and transporters to and from the apical plasma membranes (Hamm-Alvarez and
Sheetz, 1998). Given the similarities between kidney and excurrent duct physiology, it is
probable that microtubules are involved in the insertion and removal of EPATPases into and
from the apical membrane. The change from primarily apical (in control rats) to diffuse
cytoplasmic staining observed in the DES treated cohort could be accounted for by a
displacement of the H+ATPase containing vesicles from the apical cytoplasm to other
regions of the cell. This could either be induced by disordered microtubule formation or an
alteration of signal peptides which prevent the molecules from being directed to their correct
cellular location.
These studies suggest that the distribution of ion channel proteins within the male excurrent
duct system is likely to be complex with each specific region of the duct expressing different
proteins. These proteins alter the luminal environment of the developing spermatozoa but
what regulates the expression of these protein remains to be determined. The relative roles
of the steroid hormones, peptide hormones or the spermatozoa themselves in determining
the pattern of protein expression remain an issue which has to be resolved before the roles
of a specific factor i.e. oestrogens or oestrogenic compounds can be determined with
certainty.
Chapter 8 General Discussion
The objectives of the work conducted for this thesis were several-fold:
• To determine sites of oestrogen receptor expression within the excurrent ducts of
the male reproductive tract.
• To identify the direct effects of neonatal oestrogen exposure on the excurrent
ducts
• To investigate functional markers of the excurrent duct system which could be
modulated by oestrogen, monitored throughout neonatal and adult life and that
could be used to assess the relative oestrogenicity of so called 'environmental
oestrogens'.
Firstly, the excurrent ducts were examined as recent studies suggested that the efferent
ducts have the highest expression of ERa within the male reproductive tract; secondly,
studies on ERKO mice (which are infertile) show fluid accumulation within the rete testis
and excurrent ducts and, finally, the characterisation of a second oestrogen receptor
(ERp), suggested that there were even more targets for oestrogen action within the male
reproductive tract. The effects of neonatal oestrogen exposure were studied due to the
current concerns over human male reproductive health. The literature currently suggests
that the sperm count is falling with later year of birth, and there is evidence to suggest
increases in the incidence of testicular cancer, cryptorchidism and hypospadias (Toppari
et al., 1996). These conditions were also shown to be increased in prevalence in the sons
of mothers administered DES during pregnancy. These similarities led to the hypothesis
that oestrogenic chemicals in the environment could be involved in the increases in
disorders of the male reproductive tract (Sharpe and Skakkebaek, 1993). There are now
many reports in the literature regarding chemicals, which are widespread in the
environment, and which have been found to be weakly oestrogenic. Whether weakly
oestrogenic chemicals pose any real risk to reproductive health is a hotly debated issue.
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These studies were performed to determine the effects of neonatal administration of
potent oestrogens (DES and ethinyl oestradiol) on the male excurrent ducts and to
determine whether similar effects could be induced after exposure to weakly oestrogenic
'environmental oestrogens'.
8.1 The Sites of Oestrogen Receptor ExpressionWithin the Male
Reproductive Tract
Chapter 3 examined the sites of ER(3 expression within the marmoset testis and excurrent
ducts from postnatal day 1 to adulthood. The expression of ERp was compared to those
of ERa and the AR in the adult marmoset testis and excurrent ducts. The results are
summarised below
1. ERp imunoexpression in the testis and excurrent ducts of the marmoset
•The adult pattern of immunostaining was present by 8 weeks of age. At this age
there was immunoexpression in Sertoli cells, spermatogonia, peritubular myoid
cells and interstitial cells of the testis
•Similarly, within the efferent ducts, nuclear immunostaining was present in both
the ciliated and nonciliated cells but not all cell nuclei were stained.
• At 8 weeks postnatal, nuclear immunostaining was present in the principal, basal
and apical cells of the caput epididymis, and again this was comparable to the
adult expression pattern.
2. Comparison of ER (a and p) and the AR in the testis and excurrent ducts of the
marmoset revealed that:
• All three steroid receptors displayed a different cellular expression pattern
within the testis and excurrent ducts, but of the three, ERp had the widest cellular
distribution.
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• Within the testis all three steroid receptors were localised to Leydig cells, only
ER(3 and the AR were localised to Sertoli cells but ERp was the only steroid
receptor to be localised to gonocytes and the developing spermatogonia.
• All three steroid receptors were localised to the efferent ducts and all were
evident within both ciliated and nonciliated cells. All three had a checker-board
pattern of expression. Only ERp was localised within the surrounding stromal
tissue.
• ERa did not localise to any cell types within the epididymal epithelium but ERp
and the AR displayed similar sites of immunolocalisation to principal, basal and
apical cells.
These studies demonstrated that there were overlapping sites of AR, ERa and ERp within
the testis and male reproductive tract. All three steroid receptors were expressed within
the Leydig cells of the testis and the epithelial cells of the efferent ducts. The checker¬
board pattern of immunostaining observed within the efferent ducts (that was common to
all three steroid receptors) raised the question as to whether the cells were only expressing
one of the steroid hormone receptors, hence the reason why the other cells were not
immunopositive. To address this issue, double or even triple immunofluorescence could
have been performed in order to determine whether these steroid receptors were being
expressed in discrete cells or whether all of the steroid receptors were expressed together
in the same cell. Similarly, in the epididymis ERp and AR shared a very similar
expression pattern i.e. within the same cell types. This suggests that there may be
interplay between the actions of oestrogens and androgens within these cells. The exact
nature of the interplay between androgens and oestrogens within the male reproductive
tract is not understood. The recent localisation of aromatase to developing germ cells
(Nitta et al., 1993) suggests that the conversion of androgen to oestrogen can occur within
the testis and during the transit of sperm through the efferent ducts and epididymis,
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therefore the balance of androgen to oestrogen may be determined by the local
environment.
These studies were important initial steps to clarify the sites within the excurrent ducts
that oestrogens could be expected to act and they also heightened awareness of the
potential existence of a locally controlled androgen to oestrogen balance in the excurrent
ducts. Therefore subsequent studies focussed on the excurrent ducts when examining the
effects of neonatal oestrogen treatment.
8.2 Morphological Changes Induced in the Rete Testis and Efferent
Ducts After Neonatal Oestrogen Exposure in the Rat
The experiments conducted in this study were performed on animals after neonatal
treatment with potent oestrogens (DES or ethinyl oestradiol). The treatment was
originally developed to coincide with the period of Sertoli cell multiplication. Animals
were assessed at days 18 and 25 postnatal (around the initiation of puberty), day 35 (late
puberty) and day 75 (early adulthood). A cohort of animals was also assessed at day 10
while the animals were still within the treatment phase.
Morphological changes observed in the rete testis and efferent ducts of rats treated
neonatally with oestrogens were discussed in Chapter 5 and 6. The major morphological
findings are summarised below:
•The lumens of the rete testis and efferent ducts were grossly distended after
exposure to DES (10pg and l.Opg) or ethinyl oestradiol.
• Rete testis distension was evident (to a lesser degree) in adult life, while efferent
duct distension was not readily detected after day 35 postnatal.
•Epithelial cell height was grossly reduced in the rete testis, efferent ducts and the
caput epididymis after neonatal exposure to DES and ethinyl oestradiol. Epithelial
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cell height was measured in the efferent ducts and was found to be reduced dose-
dependently by DES.
• Weakly oestrogenic compounds also induced small but significant reductions in
efferent duct epithelial cell height (except parabens).
•No significant reduction in epithelial cell height was detected in any treatment
group by adulthood.
The reason why neonatal oestrogen exposure induced morphological changes in cell
shape and height or why treatment induced fluid accumulation within the rete testis and
efferent ducts is not known. All of these changes were concluded to be direct effects of
oestrogen as none of them were observed in animals treated neonatally with a GnRHa, a
treatment that suppressed gonadotrophin secretion, and thus testicular development, to a
comparable degree to that induced by treatment with lOgg DES.
In these studies, distension and fluid accumulation were evident as early as postnatal day
10 in both the rete testis and efferent ducts, which raised the question as to the source of
the fluid. In adult animals, STF is secreted by the Sertoli cell and forms the fluid which
enters the excurrent duct system. The Sertoli cells of the adult testis form a barrier via
intercellular tight junctions, which creates a separate luminal compartment within the
seminiferous tubules. This barrier enables a unique microenvironment to be created and
maintained in the adluminal compartment that is different from that in the interstitium.
However, in early neonatal life, neither the Sertoli cell barrier nor seminiferous tubule
lumens have developed (i.e. tight junction formation has not yet occurred) therefore the
source of the fluid which accumulates after neonatal oestrogen exposure is not obvious.
The most likely source of fluid is the Sertoli cell but the lack of barrier and lumen
formation mean that fluid flow is difficult to detect as fluid is free to diffuse into the testis
from the interstitial fluid. Fluid may also enter the excurrent duct system via some other
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source i.e. the lymphatic system. In order to determine if the fluid is flowing via the testis
or an extra testicular source, efferent duct ligation could be performed on neonatal
animals. If the efferent ducts remain patent after ligation, this would suggest an
extratesticular source for the fluid accumulation but if the fluid dilation was more severe
behind the ligature this would suggest a testicular source for the fluid.
Changes in epithelial cell height were observed in the rete testis, efferent ducts and
epididymis but this change were only quantified in the efferent ducts. DES and ethinyl
oestradiol induced gross reductions in epithelial cell height, whereas weakly oestrogenic
compounds induced small but significant reductions. However, no significant decrease in
epithelial cell height was detected in adulthood after any of the treatments. The regulation
of epithelial cell height within the reproductive tract is not understood. However, a tall,
columnar appearance is a characteristic of the differentiated cell (Raczek et al., 1994).
The lack or loss of this characteristic suggests that neonatal oestrogen administration
delays or disrupts the differentiation of this cell type. The alteration is, however, not
permanent. The exact pathway involved in epithelial cell differentiation is not known but
is bound to be complex and so determining whether this pathway could be disrupted by
neonatal oestrogen exposure will not be simple.
Cell and organ culture experiments suggest that androgens are important for maintaining
cell height in vitro (Tezon and Blaquier, 1981),(Vazquez et al., 1989). However, no
studies have assessed the influence of oestrogen on epithelial cell height. Epithelial cell
height is reduced in the male ERKO mouse which has elevated serum testosterone levels,
suggesting that testosterone is not the only factor involved. A more likely explanation
may come from an alteration of the underlying basal lamina. The basal lamina is a mat of
specialised extra cellularmatrix which underlies all epithelial sheets and tubes. Aside
from a structural role, the basal lamina can influence cell polarity, cell metabolism, the
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organisation of proteins in the adjacent plasma membrane and it can induce cell
differentiation (Alberts et al., 1994). As the basal lamina is largely secreted by the
epithelial cells on which it rests, any alteration in its secretion and subsequent functions
could disrupt the normal function and/or morphology of the epithelial cells. Whether
oestrogen can alter the composition or function of the basal lamina, is unknown, but this
could be examined using in vitro studies. However, all epididymal cell and organ cultures
have reduced cell height suggesting that there are many factors involved in regulating cell
height and the normal functioning of epithelial cells.
The changes in cell height and rete testis/efferent duct distension always occurred in
parallel and with similar severity which was dose-dependent. This makes it difficult to
determine cause and effect. The most logical interpretation for the distension and
reduction in cell height is that neonatal oestrogen exposure induced a disruption in
endocytosis. Such a disruption would prevent the resorption of fluid within the efferent
ducts leading to their dilation and subsequent backflow and dilation within the rete testis.
To investigate this studies could be performed using electron dense tracers such as
cationic ferritin to determine whether the endocytoyic pathway is disrupted.
8.3 Functional Changes Within the Excurrent Ducts After Neonatal
Oestrogen Treatment
Functional changes within the rete testis, efferent ducts and epididymis were assessed in
Chapters 4, 6 and 7. The major strategy involved determining the major function of this
tissue (fluid resorption) and investigating likely candidate proteins from the homologous
kidney structure, the proximal tubule. This strategy suggested that a water channel
protein originally termed CHIP28 and subsequently renamed AQP-1, was a good
candidate molecule. A previously published report demonstrated that AQP-1 was
expressed by the adult efferent duct epithelium. An antibody was kindly gifted by Prof.
Chapter 8 General Discussion 189
Dennis Brown and was used initially to determine if AQP-1 was expressed in the efferent
ducts during neonatal life. AQP-1 was found to be expressed from fetal life, throughout
neonatal and, pubertal life and into adulthood. Within the rat, this protein was localised to
the efferent ducts and was not expressed in the testis or epididymis. As the efferent ducts
are a major site of ERa expression it was not inconceivable to suggest that AQP-1 could
be modulated by oestrogen. However, AQP-1 was located along the apical and
basolateral membranes of all non-ciliated cells and was not present along the membranes
of ciliated cells. In contrast, ERa is expressed in both cell types although not all cell
nuclei expressed the receptor at a given time.
The immunoexpression of AQP-1 was assessed after neonatal treatment with potent
oestrogens (DES and ethinyl oestradiol) and the weakly oestrogenic 'environmental
oestrogens'. These studies demonstrated that neonatal exposure to 10gg DES or ethinyl
oestradiol induced almost a complete loss of AQP-1 immunostaining in animals aged 18
and 25 days of age. This reduction in protein levels was corroborated by Western
Blotting. Subjective analysis of AQP-1 immunostaining suggested that DES dose-
dependently reduced the level of immunostaining when assessed in 18 and 25 day old
animals, but by adulthood the immunostaining levels were indistinguishable from control
animals. Some of the animals treated with weakly oestrogenic compounds consistently
displayed a slight reduction in the intensity of immunostaining but this was not an
objective assessment and only gross changes could be detected with certainty. The
promoter region of the AQP-1 gene does not contain any consensus EREs but does
contain an AP-1 site which can activate target genes after binding the proto-oncogenes
cFos and cJun. This suggests that there is the potential for oestrogen to regulate AQP-1
gene transcription.
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However, the reduction in AQP-1 did not occur in isolation but was observed in parallel
with the changes in cell height and fluid distension suggesting that neonatal oestrogen
treatment is unlikely to be responsible for regulating the expression of a single gene such
as AQP-1. If oestrogen directly induced the loss of AQP-1 then the lack of fluid
resorption might induce distension, but this is unlikely as water resorption can also occur
secondary to ion transport in this epithelium. But even if a loss of AQP-1 did induce fluid
accumulation through a lack of fluid resorption this could still not necessarily account for
the loss of cell height observed after neonatal oestrogen treatment.
The overall impression from these changes was that oestrogen has control over a central
cellular process which could account for the range of effects observed instead of just one
aspect of them. The type of changes observed after neonatal oestrogen treatment (loss of
cell height, possible disruption of the endocytotic pathway, loss of proteins from the
apical membrane), and supportive data from the literature, suggest that the most probable
site of oestrogen action is on the cytoskeleton. Oestrogen has been shown to have
nongenomic effects on microtubules. Oestrogen administration can induce a rapid loss of
microtubules in endometrial cells within 80 seconds and which returns to control levels
after 30mins but then re-occurs after 1 hour (Szego et al., 1988). Microtubules are critical
for both the maintenance of cell polarity and membrane trafficking. Disrupting
microtubule formation in kidney proximal tubule cells induces a breakdown in
endocytosis as no endocytotic invaginations or large vacuoles are formed (Elkjaer et al.,
1995). In this study, disrupting microtubule formation also reduced the level of
membrane recycling and induced almost a complete loss of AQP-1 immunolocalisation.
A similar explanation would account for the loss of AQP-1 immunostaining from the
apical membrane of epithelial cells in the efferent ducts, the fluid accumulation via a
disruption of endocytosis and the loss in cell height due to the lack of formation of the
apical tubules and other structures involved in the endocytotic pathway which comprise a
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major proportion of the apical cytoplasm. Studies need to be performed to determine
whether this is a viable hypothesis. Studies of oestrogen action on cell structure may be
feasible by short-term organ culture experiments. This would allow assessment of the
effect of oestrogen administration on the membrane architecture, and microtubule
formation. Knowing the speed at which any changes occurred would help to differentiate
genomic and non-genomic effects.
Similarly, within the epididymis the preliminary data presented in Chapter 7 suggested
that the number of H+ATPase positive cells/mm epididymis was reduced after neonatal
exposure to DES and ethinyl oestradiol. However, there was also a significant reduction
in H+ATPase staining after GnRHa administration though this reduction was not as severe
as that induced after either DES or ethinyl oestradiol administration. A larger sample size
is required to determine whether this decrease in cell staining is an effect of oestrogen
acting indirectly by altering gonadotrophin secretion. However, both GnRHa and 10gg
DES treatments produced different immunostaining patterns for H+ATPase. The GnRHa
still induced a bright apical band of H+ATPase although the intensity was much reduced
compared to control animals. After DES treatment, there were very few cells which
displayed any apical membrane staining. There were no particular areas of intense
staining but instead there was diffuse staining throughout the cytoplasm. The diffuse
H+ATPase staining suggests that vesicles are not being directed to the apical membrane
and underlying cytoplasm. If this were the explanation, such an alteration in H+ATPase
distribution could only be induced by alteration to the cytoskeleton and studies in kidney
and liver have shown that microtubules are involved in the insertion and removal of
H+ATPases to and from the plasma membrane.
In summary the studies presented in this thesis have demonstrated that potent oestrogens
can have a detrimental effect on the postnatal development and functioning of the
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excurrent duct system. In particular, the normal fluid dynamics of this system were
disrupted as evidenced by the loss of AQP-1 immunostaining, the dilation of both the rete
testis and efferent duct lumens and the alterations to efferent duct epithelial cell
morphology. These findings could be best explained by changes to the epithelial cell
cytoskeleton, although the studies performed in this thesis did not address this possibility.
In contrast, weakly oestrogenic compounds did not induce gross changes in fluid
dynamics and only minor changes in AQP-1 immunostaining and efferent duct epithelial
cell height. Within the controlled laboratory environment these chemicals had little effect
on the male reproductive tract when administered at extremely high doses (not relevant to
man) and at what is considered the most sensitive time-point. However, the consequences
of chronic exposure of animals to a combination of these weak oestrogens (as occurs in
reality) was not assessed, and more research needs to be performed to assess whether
realistic mixtures of these compounds pose any risk to human health.
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Appendix 1 Table comparing the bodyweight of animals at necropsy after the neonatal
administration of various compounds







































































Key : a p<0.001, b p<0.01,c p<0.05
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